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A B S T R A C T
Background
Cervical cerclage is a well-known surgical procedure carried out during pregnancy. It involves positioning of a suture (stitch) around the
neck of the womb (cervix), aiming to give mechanical support to the cervix and thereby reduce risk of preterm birth. The effectiveness
and safety of this procedure remains controversial. This is an update of a review last published in 2012.
Objectives
To assess whether the use of cervical stitch in singleton pregnancy at high risk of pregnancy loss based on woman’s history and/or
ultrasound finding of ’short cervix’ and/or physical exam improves subsequent obstetric care and fetal outcome.
Search methods
We searched Cochrane Pregnancy and Childbirth’s Trials Register (30 June 2016) and reference lists of identified studies.
Selection criteria
We included all randomised trials of cervical suturing in singleton pregnancies. Cervical stitch was carried out when the pregnancy was
considered to be of sufficiently high risk due to a woman’s history, a finding of short cervix on ultrasound or other indication determined
by physical exam. We included any study that compared cerclage with either no treatment or any alternative intervention. We planned
to include cluster-randomised studies but not cross-over trials. We excluded quasi-randomised studies. We included studies reported
in abstract form only.
Data collection and analysis
Three review authors independently assessed trials for inclusion. Two review authors independently assessed risk of bias and extracted
data. We resolved discrepancies by discussion. Data were checked for accuracy. The quality of the evidence was assessed using the
GRADE approach.
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Main results
This updated review includes a total of 15 trials (3490 women); three trials were added for this update (152 women).
Cerclage versus no cerclage
Overall, cerclage probably leads to a reduced risk of perinatal death when compared with no cerclage, although the confidence interval
(CI) crosses the line of no effect (RR 0.82, 95% CI 0.65 to 1.04; 10 studies, 2927 women; moderate quality evidence). Considering
stillbirths and neonatal deaths separately reduced the numbers of events and sample size. Although the relative effect of cerclage is
similar, estimates were less reliable with fewer data and assessed as of low quality (stillbirths RR 0.89, 95% CI 0.45 to 1.75; 5 studies,
1803 women; low quality evidence; neonatal deaths before discharge RR 0.85, 95% CI 0.53 to 1.39; 6 studies, 1714 women; low quality
evidence). Serious neonatal morbidity was similar with and without cerclage (RR 0.80, 95% CI 0.55 to 1.18; 6 studies, 883 women;
low-quality evidence). Pregnant women with and without cerclage were equally likely to have a baby discharged home healthy (RR 1.02,
95% CI 0.97 to 1.06; 4 studies, 657 women; moderate quality evidence).
Pregnant women with cerclage were less likely to have preterm births compared to controls before 37, 34 (average RR 0.77, 95% CI
0.66 to 0.89; 9 studies, 2415 women; high quality evidence) and 28 completed weeks of gestation.
Five subgroups based on clinical indication provided data for analysis (history-indicated; short cervix based on one-off ultrasound in
high risk women; short cervix found by serial scans in high risk women; physical exam-indicated; and short cervix found on scan in
low risk or mixed populations). There were too few trials in these clinical subgroups to make meaningful conclusions and no evidence
of differential effects.
Cerclage versus progesterone
Two trials (129 women) compared cerclage to prevention with vaginal progesterone in high risk women with short cervix on ultrasound;
these trials were too small to detect reliable, clinically important differences for any review outcome. One included trial compared
cerclage with intramuscular progesterone (75 women) which lacked power to detect group differences.
History indicated cerclage versus ultrasound indicated cerclage
Evidence from two trials (344 women) was too limited to establish differences for clinically important outcomes.
Authors’ conclusions
Cervical cerclage reduces the risk of preterm birth in women at high-risk of preterm birth and probably reduces risk of perinatal deaths.
There was no evidence of any differential effect of cerclage based on previous obstetric history or short cervix indications, but data were
limited for all clinical groups. The question of whether cerclage is more or less effective than other preventative treatments, particularly
vaginal progesterone, remains unanswered.
P L A I N L A N G U A G E S U M M A R Y
Can inserting a cervical stitch prevent early births of single babies?
What is the issue?
Cervical cerclage is a surgical procedure performed during pregnancy to place a stitch around the neck of the womb (cervix). The stitch
is aimed to support the cervix and reduce risk of an early birth.
Why is this important?
The cervix stays tightly closed until towards the end of normal pregnancies, before starting to shorten and gradually soften to prepare
for labour and delivery. However, sometimes the cervix starts to shorten and widen too early, causing either late miscarriage or an early
birth. Inserting a cervical stitch may reduce the chance of late miscarriage or early birth.
What evidence did we find?
We searched for evidence up to 30 June 2016. This review includes 15 studies involving 3490 women (3 studies involving 152 women
were added for this update).
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Women with a stitch are less likely to have a baby who is born too early. Babies whose mothers had a stitch are also less likely to die
during the first week of life. It is not clear whether a cervical stitch can prevent stillbirth or improve the baby’s health once born.
What does this mean?
Inserting a stitch helps pregnant women who are at high risk avoid early births compared to no stitch. Inserting a stitch may also
improve a baby’s chance for survival. We found too few clinical trials to understand whether cervical stitch is more effective than other
treatments for preventing early births, such as progesterone (a hormone drug used to prevent early birth). We found too few data to
understand if it is better to have a stitch inserted early in pregnancy (based on the mother’s previous history) or to wait to perform an
ultrasound scan later in pregnancy to see if the cervix has become shortened.
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S U M M A R Y O F F I N D I N G S F O R T H E M A I N C O M P A R I S O N [Explanation]
Cerclage versus no cerclage
Patient or population: prevent ing preterm birth in women with singleton pregnancy
Setting: Belgium, Brazil, Canada, Chile, France, Greece, Hungary, Iceland, Ireland, Italy, Netherlands, Norway, South Af rica, Slovenia, UK, USA, Zimbabwe
Intervention: cerclage
Comparison: no cerclage
Outcomes Anticipated absolute effects∗ (95% CI) Relative effect
(95% CI)
of participants
(studies)
Quality of the evidence
(GRADE)
Comments
Risk with no cerclage
(SoF outcomes)
Risk with cerclage
All perinatal losses Study population RR 0.82
(0.65 to 1.04)
2927
(10 RCTs)
⊕⊕⊕©
MODERATE1
92 per 1000 75 per 1000
(60 to 96)
Serious neonatal mor-
bidity
Study population RR 0.80
(0.55 to 1.18)
883
(6 RCTs)
⊕⊕©©
LOW 2
116 per 1000 93 per 1000
(64 to 136)
Baby discharged home
healthy
Study population RR 1.02
(0.97 to 1.06)
657
(4 RCTs)
⊕⊕⊕©
MODERATE3
912 per 1000 930 per 1000
(885 to 967)
Stillbirths Study population RR 0.89
(0.45 to 1.75)
1803
(5 RCTs)
⊕⊕©©
LOW 2
19 per 1000 17 per 1000
(9 to 33)
Neonatal deaths before
discharge
Study population RR 0.85
(0.53 to 1.39)
1714
(6 RCTs)
⊕⊕©©
LOW 2
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35 per 1000 30 per 1000
(19 to 49)
Preterm birth before 34
completed weeks
Study population average RR 0.77
(0.66 to 0.89)
2415
(9 RCTs)
⊕⊕⊕⊕
HIGH4
238 per 1000 183 per 1000
(157 to 212)
* The risk in the intervention group (and its 95% conf idence interval) is based on the assumed risk in the comparison group and the relative effect of the intervent ion (and its
95% CI).
CI: Conf idence interval; RR: Risk rat io; OR: Odds rat io;
GRADE Working Group grades of evidence
High quality: We are very conf ident that the true ef fect lies close to that of the est imate of the ef fect
M oderate quality: We are moderately conf ident in the ef fect est imate: The true ef fect is likely to be close to the est imate of the ef fect, but there is a possibility that it is
substant ially dif f erent
Low quality: Our conf idence in the ef fect est imate is lim ited: The true ef fect may be substant ially dif f erent f rom the est imate of the ef fect
Very low quality: We have very lit t le conf idence in the ef fect est imate: The true ef fect is likely to be substant ially dif f erent f rom the est imate of ef fect
1 Wide conf idence interval crossing the line of no ef fect (-1).
2 Wide conf idence interval crossing the line of no ef fect and small sample size (-2)
3 Estimate based on small sample size (-1).
4 Random ef fects model retained f rom primary analysis; there is no substant ive dif ference in the risk est imate or the
conf idence intervals with f ixed or random ef fects.
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B A C K G R O U N D
Description of the condition
During normal pregnancy the neck of the womb (cervix) stays
tightly closed, allowing the pregnancy to reach full term. Towards
the end of pregnancy, the cervix starts to shorten and progressively
becomes softer (more favourable) - these changes are physiological
preparations for normal labour and delivery.
Sometimes, the cervix starts to shorten and dilates too early, caus-
ing either late miscarriage or preterm birth. In the absence of
uterine contractions, the cause of this pathological condition is
considered to be cervical insufficiency (sometimes also called in-
competence). The condition has been described as early as the
17th century (Riverius 1658). It has been suggested that cervi-
cal insufficiency complicates about 1% of an obstetric population
(McDonald 1980) and 8% of a recurrent miscarriage population
who have experienced mid-trimester pregnancy losses (Drakeley
1998). There is however, no consistent definition of cervical in-
sufficiency (Berry 1995) which hampers any attempt to establish
the true incidence.
Some researchers have defined cervical insufficiency as “the history
of painless dilatation of the cervix resulting in second or early third
trimester delivery and the passage, without resistance, of size nine
Hegar dilator (an instrument which is used to measure the size of
cervical dilatation in millimetres)” (Berry 1995). Other descrip-
tions include: recurrent second trimester or early third trimester
loss of pregnancy caused by the inability of the uterine cervix to
retain a pregnancy until term (Althuisius 2001) and a physical
defect in the strength of the cervical tissue that is either congen-
ital (inherited) or acquired, i.e. caused by previous damage (Rust
2000).
Description of the intervention
Cervical cerclage is one of the best known surgical procedures in
obstetrics. It involves the positioning of a suture (stitch) around the
neck of the womb (cervix), aimed to provide mechanical support
to the cervix and keep the cervix closed during the pregnancy.
There are a number of proposed surgical methods designed to keep
the cervix closed until the expected time of birth. All interventions
require at least regional anaesthesia in the form of a spinal or
epidural block. Shirodkar 1955 reported the insertion of a cervical
stitch (suture) at around 14 weeks of pregnancy. The anterior
vaginal wall is cut and the bladder reflected (pushed) back and
upwards allowing an access close to the level of the internal cervical
os by the vaginal route. A stitch, usually silk, tape, or other non-
absorbable material, is inserted around the cervix, enclosing it.
McDonald 1957 described a simpler purse string stitch technique,
whereby the stitch is inserted around the body of the cervix visible
in the vagina in three or four bites. Athough the internal os is often
not reached, the procedure is easier to perform with less bleeding.
These techniques were described as elective (planned) procedures.
Total cervical occlusion is another proposed variation where, in
addition to the standard cerclage, the external cervical os is closed
with continuous nylon (Saling 1984; Secher 2007). The rationale
for this technique is based on the observation that the mucous
plug has a double role in preventing preterm labour. The plug is a
mechanical barrier between the vagina and uterus, but its intrinsic
richness in immune components also makes it a very important
element in defending the fetal compartment from ascending in-
fections. Intuitively, protective nylon could keep the plug in situ,
thereby increasing the innate defence of the cervical canal.
There has been some suggestion recently that suture material may
have an important influence on the outcome of pregnancy. How-
ever, the surgical methods for cerclage, including the choice of
material, are beyond the scope of this review.
Stitches are normally inserted via the vaginal route, but transab-
dominal cerclage has also been proposed. This approach is used for
women when vaginal stitches have failed, or when a woman has
a short, scarred cervix making vaginal stitch insertion technically
difficult (Anthony 1997; Gibb 1995). Initally, cerclage procedures
have been carried out in early pregnancy around 12 weeks of gesta-
tion, but are increasingly being scheduled before pregnancy. Either
way, during laparotomy, the bladder is reflected downwards away
from the uterus and the cervical stitch is placed at the level of the
internal cervical os. Vaginally inserted cervical stitches are either
taken out at 37 weeks’ gestation, or when the woman presents in
labour, usually without an anaesthetic. Abdominal cervical stitches
are left in place and the baby is delivered by caesarean section.
Cervical cerclage, by whichever technique employed, carries risks
for the pregnancy. Surgical manipulation of the cervix can cause
uterine contractions, bleeding or infection which may lead tomis-
carriage or preterm labour. These risks must be carefully balanced
against the benefit from mechanical support of the cervix.
Cervical cerclage can either be inserted as a planned procedure
based on previous history (history-indicated), because of a short
cervical length detected on transvaginal ultrasound (ultrasound-
indicated), or as an emergency procedure when women with
threatenedmiscarriage present at the hospital (physical exam-indi-
cated) (Chanrachakul 1998; Wong 1993). Ultrasound- and phys-
ical exam-indicated cerclages tend to be performed later in preg-
nancy; history-indicated procedures are usually planned around
14 weeks.
How the intervention might work
Intuitively, in the presence of a short cervix at ultrasound, or his-
tory of recurrent spontaneous mid-trimester losses, reinforcing the
cervix by positioning a mechanical support should prolong preg-
nancy and reduce the risk of preterm birth and its sequelae.
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Why it is important to do this review
Controversies concerning cervical cerclage include effectiveness,
safety and risk/benefit to both mother and unborn baby. The
avoidance of surgical trauma to the cervix may be as effective as in-
tervention. Grant 1989 reviewed the evidence for the benefits and
hazards of treatment by cervical cerclage to prolong pregnancy and
suggested that cervical cerclage in women with a previous mid-
trimester loss (or preterm delivery) may help to prevent one deliv-
ery before 33 weeks for every 20 stitches inserted (Grant 1989).
Since 1989 there have been a number of randomised and non-
randomised studies published, however, the issues surrounding ef-
fectiveness in preventing neonatal sequelae of prematurity, timing
of cerclage and optimal techniques have not been addressed ade-
quately. The evidence on which to base practice for physical exam-
indicated cerclage is even less robust. A meta-analysis estimated
the effectiveness of physical examination-indicated cerclage versus
expectant management in the setting of second-trimester cervical
dilatation (14 to 27 gestational weeks) (Ehsanipoor 2015). The
physical examination-indicated cerclage was associated with a sig-
nificant increase in neonatal survival and prolongation of preg-
nancy. However, as well as including randomised controlled tri-
als, Ehsanipoor 2015 also included retrospective and prospective
cohort studies in the meta-analysis. A previous Cochrane Review
on this topic did not find clear benefit, although heterogeneity
was high for some important obstetric outcomes. In their meta-
analysis of individual patient data, Berghella 2005 concluded that
cerclage could be beneficial in women with singleton pregnan-
cies, short cervix and experience of prior preterm birth. In a sim-
ilar meta-analysis, no statistical significance was found for single-
ton pregnancies (Jorgensen 2007). Both meta-analyses showed no
benefit for multiple gestation pregnancies. In an indirect compari-
sonmeta-analysis of randomised controlled trials, Conde-Agudelo
2013 et al found that either cerclage or vaginal progesterone are
equally efficacious in the prevention of preterm birth in women
with sonographic short cervix in the mid trimester, singleton ges-
tation and previous preterm birth.
A Cochrane Review investigating cervical cerclage for preventing
pretermbirth inmultiple gestationpregnancies has been published
(Rafael 2014).
O B J E C T I V E S
To assess whether the use of cervical stitch in singleton pregnancy
at high risk of pregnancy loss based on woman’s history and/or
ultrasound finding of ’short cervix’ and/or physical exam improves
subsequent obstetric care and fetal outcome.
M E T H O D S
Criteria for considering studies for this review
Types of studies
All randomised trials comparing cervical stitch in singleton preg-
nancies of women considered to be at high risk of pregnancy loss.
We planned to include cluster-randomised studies but not cross-
over trials. We excluded quasi-randomised studies. We included
studies reported in abstract form only.
Types of participants
Women with singleton pregnancies considered to be at high risk
for pregnancy loss based any of the following: woman’s history
(e.g. previous preterm birth); prior cervical surgery (loop excision,
cone biopsy, surgical termination of pregnancy); short cervix on
ultrasound scanning; or physical exam-detected cervical changes
(including emergency or rescue cerclage). Cervical cerclage for
multiple pregnancieswas investigated in anotherCochraneReview
(Rafael 2014).
Types of interventions
Cervical stitch in singleton pregnancies considered for women to
be at high risk for pregnancy loss.
Comparisons
1. Cervical stitch (cerclage) versus no stitch according to
clinical subgroups (history- versus ultrasound- versus physical
exam-indicated cerclage).
2. Cervical stitch (cerclage) versus any alternative preventative
treatment (e.g. progesterone or pessary).
3. Any comparison of different cerclage protocols (history-
versus ultrasound- versus physical exam-indicated cerclage).
Types of outcome measures
We selected outcome domains based on consensus work under-
taken to define core outcome measures for clinical research and
evidence synthesis for pregnancy and childbirth generally (Devane
2007) and for preterm birth prevention specifically (van ’t Hooft
2016).
Primary outcomes
• Perinatal loss: all losses including miscarriages, stillbirth and
neonatal deaths.
• Serious neonatal morbidity (as defined by trialists).
• Baby discharged home healthy (without obvious pathology
- as defined by trialists).
It may seem unusual to not include preterm birth rates as the
primary outcome. In the context of this review, preterm births
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should be regarded as a surrogate for mortality and morbidity.
More importantly, there is a real possibility that prolongation of
pregnancy may be misinterpreted as benefit, when in fact, an early
birth in a setting with adequate neonatal care resources may be
better for the infant.
Secondary outcomes
Neonatal
• Stillbirth: intra-uterine death at 24 weeks or more weeks; or
greater than 500 g fetal weight or reaching viability as defined by
trialist.
• Neonatal death before discharge.
• Miscarriages: perinatal loss before 24 weeks.
• Preterm birth (birth before 28, 34 and 37 completed weeks
of pregnancy).
• Serious intracranial pathology, e.g. intraventricular
haemorrhage or periventricular leukomalacia (as defined by
trialists).
• Serious respiratory morbidity, e.g. respiratory distress
syndrome or oxygen dependency after 28 days of life.
• Necrotising enterocolitis requiring surgery.
• Retinopathy of prematurity.
• Apgar less than seven at five minutes.
Maternal
• Caesarean section (elective and emergency).
• Maternal infection requiring intervention, e.g. antibiotics
or delivery.
• Maternal side effects (vaginal discharge, bleeding, pyrexia
not requiring antibiotics).
We also planned to report non-prespecified outcomes if they were
reported by more than one included trial.
Not prespecified outcomes
• Any intravenous, oral or combined tocolysis.
• Preterm premature rupture of the membranes (PPROM).
• Chorioamnionitis.
Search methods for identification of studies
The followingmethods section of this review is based on a standard
template used by Cochrane Pregnancy and Childbirth.
Electronic searches
We searched Cochrane Pregnancy and Childbirth’s Trials Register
by contacting their Information Specialist (30 June 2016).
The Register is a database containing over 22,000 reports of con-
trolled trials in the field of pregnancy and childbirth. For full search
methods used to populate Pregnancy andChildbirth’s Trials Regis-
ter including the detailed search strategies for CENTRAL, MED-
LINE, Embase and CINAHL; the list of handsearched journals
and conference proceedings, and the list of journals reviewed via
the current awareness service, please follow this link to the edi-
torial information about the Cochrane Pregnancy and Childbirth
in the Cochrane Library and select the ‘Specialized Register’ section
from the options on the left side of the screen.
Briefly, Cochrane Pregnancy and Childbirth’s Trials Register is
maintained by their Information Specialist and contains trials
identified from:
1. monthly searches of the Cochrane Central Register of
Controlled Trials (CENTRAL);
2. weekly searches of MEDLINE (Ovid);
3. weekly searches of Embase (Ovid);
4. monthly searches of CINAHL (EBSCO);
5. handsearches of 30 journals and the proceedings of major
conferences;
6. weekly current awareness alerts for a further 44 journals
plus monthly BioMed Central email alerts.
Search results are screened by two people and the full text of all
relevant trial reports identified through the searching activities de-
scribed above is reviewed. Based on the intervention described,
each trial report is assigned a number that corresponds to a spe-
cific Pregnancy and Childbirth review topic (or topics), and is
then added to the Register. The Information Specialist searches
the Register for each review using this topic number rather than
keywords. This results in a more specific search set which has
been fully accounted for in the relevant review sections (Included
studies; Excluded studies; Studies awaiting classification; Ongoing
studies).
Searching other resources
We searched the reference lists of the studies identified. We did
not apply any language or date restrictions.
Data collection and analysis
Methods used in the previous version of this review are presented
inAlfirevic 2012. The followingmethodswere used for this update
to assess records identified as a result of the 2016 search.
Selection of studies
Two review authors independently assessed all potential studies
identified as a result of the search for inclusion. We resolved any
disagreement through discussion or, if required, we consulted the
third review author.
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Data extraction and management
We designed a data extraction form. Two review authors extracted
data fromeligible studies using the form.We resolved discrepancies
through discussion or, if required, we consulted the third review
author.Datawere entered intoReviewManager software (RevMan
2014) and checked for accuracy.
When information was unclear, we planned to contact authors of
the original reports to provide further details.
Assessment of risk of bias in included studies
Two review authors independently assessed risk of bias for each
study using the criteria outlined in theCochrane Handbook for Sys-
tematic Reviews of Interventions (Higgins 2011). Any disagreement
was resolved by discussion or by involving a third assessor.
(1) Random sequence generation (checking for possible
selection bias)
We described for each included study the method used to generate
the allocation sequence in sufficient detail to allow an assessment
of whether it should produce comparable groups.
We assessed the method as:
• low risk of bias (any truly random process, e.g. random
number table; computer random number generator);
• high risk of bias (any non-random process, e.g. odd or even
date of birth; hospital or clinic record number);
• unclear risk of bias.
(2) Allocation concealment (checking for possible selection
bias)
We described for each included study the method used to con-
ceal allocation to interventions prior to assignment and assessed
whether intervention allocation could have been foreseen in ad-
vance of, or during recruitment, or changed after assignment.
We assessed the methods as:
• low risk of bias (e.g. telephone or central randomisation;
consecutively numbered sealed opaque envelopes);
• high risk of bias (open random allocation; unsealed or non-
opaque envelopes, alternation; date of birth);
• unclear risk of bias.
(3.1) Blinding of participants and personnel (checking for
possible performance bias)
We described for each included study the methods used, if any, to
blind study participants and personnel from knowledge of which
intervention a participant received. We considered that studies
were at low risk of bias if they were blinded, or if we judged that
the lack of blinding unlikely to affect results. We assessed blinding
separately for different outcomes or classes of outcomes.
We assessed the methods as:
• low, high or unclear risk of bias for participants;
• low, high or unclear risk of bias for personnel.
(3.2) Blinding of outcome assessment (checking for possible
detection bias)
We described for each included study the methods used, if any, to
blind outcome assessors from knowledge of which intervention a
participant received. We assessed blinding separately for different
outcomes or classes of outcomes.
We assessed methods used to blind outcome assessment as:
• low, high or unclear risk of bias.
(4) Incomplete outcome data (checking for possible attrition
bias due to the amount, nature and handling of incomplete
outcome data)
We described for each included study, and for each outcome or
class of outcomes, the completeness of data including attrition and
exclusions from the analysis. We stated whether attrition and ex-
clusions were reported and the numbers included in the analysis at
each stage (compared with the total randomised participants), rea-
sons for attrition or exclusion where reported, and whether miss-
ing data were balanced across groups or were related to outcomes.
Where sufficient information was reported, or could be supplied
by the trial authors, we planned to re-include missing data in the
analyses which we undertook.
We assessed methods as:
• low risk of bias (e.g. no missing outcome data; missing
outcome data balanced across groups);
• high risk of bias (e.g. numbers or reasons for missing data
imbalanced across groups; ‘as treated’ analysis done with
substantial departure of intervention received from that assigned
at randomisation);
• unclear risk of bias.
(5) Selective reporting (checking for reporting bias)
We described for each included study how we investigated the
possibility of selective outcome reporting bias and what we found.
We assessed the methods as:
• low risk of bias (where it is clear that all of the study’s pre-
specified outcomes and all expected outcomes of interest to the
review have been reported);
• high risk of bias (where not all the study’s pre-specified
outcomes have been reported; one or more reported primary
outcomes were not pre-specified; outcomes of interest are
reported incompletely and so cannot be used; study fails to
include results of a key outcome that would have been expected
to have been reported);
• unclear risk of bias.
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(6) Other bias (checking for bias due to problems not
covered by (1) to (5) above)
We described for each included study any important concerns we
had about other possible sources of bias.
(7) Overall risk of bias
We made explicit judgements about whether studies were at high
risk of bias, according to the criteria given in the Handbook (
Higgins 2011). With reference to (1) to (6) above, we planned to
assess the likely magnitude and direction of the bias and whether
we considered it is likely to impact on the findings. In future
updates, we will explore the impact of the level of bias through
undertaking sensitivity analyses - see Sensitivity analysis.
Assessment of the quality of the evidence using the
GRADE approach
For this update, we assessed evidence quality using the GRADE
approach as outlined in the GRADE handbook relating to the
following outcomes:
1. perinatal loss: all losses including miscarriages, stillbirth and
neonatal deaths;
2. serious neonatal morbidity (as defined by trialists);
3. baby discharged home healthy (without obvious morbidity,
as defined by trialists);
4. Stillbirth: intra-uterine death at 24 or more weeks or more
than 500 g fetal weight or reaching viability as defined by trialists;
5. neonatal death before discharge; and
6. preterm birth before 34 completed weeks of pregnancy.
GRADEpro GDT was used to import data from Review Man-
ager 5.3 (RevMan 2014) to create ’Summary of findings’ tables.
A summary of the intervention effect and a measure of quality
for each of the above outcomes was produced using the GRADE
approach. The GRADE approach uses five considerations (study
limitations, consistency of effect, imprecision, indirectness and
publication bias) to assess the quality of the body of evidence for
each outcome. The evidence can be downgraded from ’high qual-
ity’ by one level for serious (or by two levels for very serious) limi-
tations, depending on assessments for risk of bias, indirectness of
evidence, serious inconsistency, imprecision of effect estimates or
potential publication bias.
Measures of treatment effect
Dichotomous data
We presented results as summary risk ratio with 95% confidence
intervals for dichotomous data.
Continuous data
No continuous data were analysed in this review. In future up-
dates, if applicable, we will use the mean difference if outcomes
are measured in the same way between trials. We will use the stan-
dardised mean difference to combine trials that measure the same
outcome, but use different methods.
Unit of analysis issues
Cluster-randomised trials
For this update, we did not include any cluster-randomised trials.
If in future updates of the review we find cluster-randomised trials,
we will include these trials in the analyses along with individually
randomised trials. We will adjust their sample sizes or standard er-
rors using the methods described in theHandbook (Section 16.3.4
or 16.3.6) (Higgins 2011) using an estimate of the intracluster
correlation co-efficient (ICC) derived from the trial (if possible),
from a similar trial, or from a study of a similar population. If
we use ICCs from other sources, we will report this and conduct
sensitivity analyses to investigate the effect of variation in the ICC.
If we identify both cluster-randomised trials and individually-ran-
domised trials, we plan to synthesise the relevant information.
We will consider it reasonable to combine the results from both
if there is little heterogeneity between the study designs and the
interaction between the effect of intervention and the choice of
randomisation unit is considered to be unlikely.
We will also acknowledge heterogeneity in the randomisation unit
and perform a sensitivity analysis to investigate the effects of the
randomisation unit.
Cross-over trials
Cross-over trials are not feasible for the population of interest or
for interventions relevant to this systematic review.
Other unit of analysis issues
Multiple pregnancy was not eligible for inclusion in this review.
Where trials reported both singleton and multiple pregnancy, we
used data for women with singleton pregnancies.
Dealing with missing data
Levels of attrition were noted for included studies. In future up-
dates, if more studies are included, the impact of including studies
with high levels of missing data in the overall assessment of treat-
ment effect will be explored in sensitivity analyses.
Analyses for all outcomes were carried out, as far as possible, on
an intention-to-treat basis, i.e. we attempted to include all partici-
pants randomised to each group in the analyses. The denominator
for each outcome in each trial was the number randomised minus
any participants whose outcomes were known to be missing.
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Assessment of heterogeneity
We assessed statistical heterogeneity in each meta-analysis using
the Tau², I² and Chi² statistics. We regarded heterogeneity as sub-
stantial if I² was greater than 30% and either Tau² was greater
than zero, or there was a low P value (less than 0.10) in the Chi²
test for heterogeneity. If we identified substantial heterogeneity
(above 30%), we explained in the text possibly sources of clinical
heterogeneity between trials. See also Data synthesis.
Assessment of reporting biases
In future updates, if there are 10 or more studies in the meta-
analysis, we will investigate reporting biases (such as publication
bias) using funnel plots. We will assess funnel plot asymmetry
visually. If asymmetry is suggested by a visual assessment, we will
perform exploratory analyses to investigate.
Data synthesis
We carried out statistical analysis using Review Manager software
(RevMan 2014). We used fixed-effect meta-analysis for combin-
ing data where it was reasonable to assume that studies were esti-
mating the same underlying treatment effect: i.e. where trials were
examining the same intervention, and the trials’ populations and
methods were judged sufficiently similar.
If there was clinical heterogeneity sufficient to expect that the un-
derlying treatment effects differed between trials, or if substan-
tial statistical heterogeneity was detected, we used random-effects
meta-analysis to produce an overall summary if an average treat-
ment effect across trials was considered clinically meaningful. The
random-effects summary was treated as the average range of possi-
ble treatment effects.We also discussed the clinical implications of
treatment effects differing between trials. If the average treatment
effect was not clinically meaningful, we did not combine trials. If
we used random-effects analyses, the results were presented as the
average treatment effect with 95% confidence intervals, and the
estimates of Tau² and I².
Within each comparison, analyses for all outcomes are displayed
according to clinical groups (history-indicated, physical-exam in-
dicated, etc). Subgroup analysis was conducted only for compari-
son of cerclage versus no cerclage.
Subgroup analysis and investigation of heterogeneity
If we found substantial heterogeneity (I² > 30%) for our primary
outcomes, and had adequate numbers of included trials in each rel-
evant subgroup, we planned to investigate sources using subgroup
analyses to consider whether an overall summary was meaningful,
and if so, to use random-effects analysis to investigate.
We planned to carry out the following subgroup analyses for the
main comparison (cerclage versus no cerclage). Five potential sub-
groups were examined: history-indicated cerclage; one-off ultra-
sound-indicated cerclage in high-risk women, serial ultrasound-
indicated cerclage, physical exam-indicated cerclage (rescue cer-
clage) and one-off ultrasound-indicated cerclage in low or unspec-
ified risk women. There were too few trials in each subgroup to
make meaningful conclusions regarding differences in effect in
subgroups. Forest plots show trials within the appropriate sub-
group for display only.
If in future updates, if we have adequate numbers of trials, we will
assess subgroup differences by interaction tests available within
RevMan (RevMan 2014). If evidence of subgroup differences are
identified, we plan to report the results of subgroup analyses quot-
ing the Chi² statistic and P value, and the interaction test I² value.
Sensitivity analysis
For primary outcomes only, we carried out sensitivity analyses to
explore the impact of trial quality, assessed as high quality if the trial
reported adequatemethods for sequence generation and allocation
concealment and had no other clear markers of poor trial quality
(unacceptable attrition, for example). We reported whether or not
the exclusion of studies with substantial risks of bias changed the
overall effect estimate or its interpretation.
R E S U L T S
Description of studies
Results of the search
An updated search (June 2016) identified 22 new reports. We also
re-assessed Althuisius 2001, and included Althuisius 2003, which
hadpreviously been listed as a report of this study.We also included
twonew studies (five reports) from the 2016 search (Chandiramani
2010; Ionescu 2012), added five additional reports of two already
included studies (MRC/RCOG 1993 (1 report); Owen 2009 (4
reports)). We also identified and excluded another report of a pre-
viously excluded study (Secher 2007).We excluded six new studies
(Hui 2013; Israfil-Bayli 2014 (two reports); Ismail 2014; Üçyi it
2013 (two reports); Zakhera 2015; Zolghadri 2014). There are
two ongoing studies (Hezelgrave 2015; Koulalli 2014) and one
study (Ragab 2015) awaiting classification. See Figure 1.
11Cervical stitch (cerclage) for preventing preterm birth in singleton pregnancy (Review)
Copyright © 2017 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Figure 1. Study flow diagram
Included studies
Interventions
Most included studies (n = 10) compared cerclage versus no cer-
clage (Althuisius 2001; Althuisius 2003; Berghella 2004; Ezechi
2004; Lazar 1984; MRC/RCOG 1993; Owen 2009; Rush 1984;
Rust 2000; To 2004). Of these, two studies required women in
both the intervention (cerclage) and control (no cerclage) groups
to undertake bed rest (Althuisius 2001; Berghella 2004). Three
studies incorporated a rescue arm for women randomised to the
control group based on physical exam (Owen 2009) or ultrasound-
detected changes of the cervix (Althuisius 2001; Rust 2000).
Two studies compared cerclage versus progesterone for pregnant
women with a history of preterm birth undergoing serial ultra-
sound who developed short cervix (< 25 mm) (Chandiramani
2010; Ionescu 2012). One study compared cervical cerclage versus
weekly intramuscular injections of 17 OHP-C (Keeler 2009).
Two studies compared different management protocols for cervi-
cal cerclage: elective cerclage based on previous obstetrical history
versus cerclage based on cervical changes on serial transvaginal ul-
trasound scans (Beigi 2005; Simcox 2009).
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Setting
Studies took place in many countries including: USA (4), UK (2),
France (2), Netherlands (3), South Africa (2), Brazil, Slovenia,
Greece, Chile, Iran, Nigeria, Romania, Hungary, Norway, Italy,
Belgium, Zimbabwe, Iceland, Ireland, Belgium and Canada. Two
trials took place in multiple countries (MRC/RCOG 1993; To
2004).
Population
Only women at high risk of preterm labour were included in 11
studies. Risk of preterm labour was assessed based on previous
obstetrical history (n = 5; Beigi 2005; Ezechi 2004; MRC/RCOG
1993; Rush 1984; Simcox 2009) and serial ultrasound scans
(Owen 2009). Lazar 1984 used a mixed scoring system based on
obstetrical history, serial ultrasound scans of the cervix and phys-
ical exam. Althuisius 2001 assessed risk of preterm labour based
on previous obstetrical history in half the population and serial
ultrasound scans of the cervix in the other half. Althuisius 2003
assessed women with ultrasound and physical exam. Ionescu 2012
andChandiramani 2010 included pregnant women with both his-
tory of preterm birth and short cervix < 25 mm on serial ultra-
sound.
To 2004 included an unselected general obstetric population with
the need for cerclage assessed using a one-off ultrasound scan.
Three studies included a mixed population, with indication for
cerclage based either on serial ultrasound scans of the cervix in
women at high risk of preterm birth, or a one-off ultrasound scan
in women at low risk (Berghella 2004; Keeler 2009; Rust 2000).
Nine studies involved singletonpregnancies only (Althuisius 2001;
Beigi 2005; Chandiramani 2010; Keeler 2009; Lazar 1984; Owen
2009; Rush 1984; Simcox 2009; To 2004) and four assessed both
singleton and multiple pregnancies (Althuisius 2003; Berghella
2004; MRC/RCOG 1993; Rust 2000). Two trials did not state if
only singleton pregnancies were included (Ezechi 2004; Ionescu
2012); however, Ezechi 2004 reported individual patient data for
singletons only.
We classified trials according to clinical groups for display purposes
only: pregnant womenwith a history of pretermbirth (Beigi 2005;
Ezechi 2004; Lazar 1984;MRC/RCOG1993;Rush 1984; Simcox
2009); pregnant women with one-off ultrasound (To 2004); se-
rial ultrasound (Althuisius 2001; Owen 2009) or using both ul-
trasound protocols (Berghella 2004; Rust 2000). We included
Althuisius 2003 in the physical exam-indicated subgroup. Three
trials compared cerclage with natural progesterone (Chandiramani
2010; Ionescu 2012) or 17 OHP-C (Keeler 2009).
See Characteristics of included studies.
Excluded studies
We excluded a total of 17 studies; of these, six were excluded based
on assessments for the 2016 search. Three studies included only
twin pregnancies (Dor 1982; Nicolaides 2001; Rust 2001); six
compared different types of cervical cerclage (Broumand 2011;
Caspi 1990; Secher 2007; Tsai 2009; Üçyi it 2013; Zolghadri
2014). We excluded two studies that did not use adequate ran-
domisation procedures (Kassanos 2001; Von Forster 1986). Blair
2002 compared outpatient cerclage with inpatient cerclage. Hui
2013 compared Arabin pessary with no treatment for women with
sort cervix at 20 to 24 weeks’ gestation. Three trials compared
suture materials (Israfil-Bayli 2014; Ismail 2014). Zakhera 2015
included women for cerclage on the basis of recurrent early bleed-
ing in pregnancy; women did not have a short cervix or history of
preterm birth. Varma 1986 is a study protocol, and we doubt that
this trial was carried out.
See Characteristics of excluded studies.
Risk of bias in included studies
The overall quality of most studies was good, with adequate re-
porting of sequence generation, allocation concealment and out-
come data. However, several trials had insufficient information in
published reports to inform assessment of these key domains. It
is not feasible to blind cerclage treatment, and therefore, all trials
were assessed at high risk of performance bias due to lack of blind-
ing. We feel that the impact of lack of blinding in trials will vary
by outcomes, and we took this into consideration for our GRADE
assessments (Characteristics of included studies; Figure 2).
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Figure 2. Risk of bias summary: review authors’ judgements about each risk of bias item for each included
study
14Cervical stitch (cerclage) for preventing preterm birth in singleton pregnancy (Review)
Copyright © 2017 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Allocation
Six studies reported adequatemethods for random sequence gener-
ation and concealment allocation (Berghella 2004; Chandiramani
2010; Keeler 2009; Owen 2009; Simcox 2009; To 2004). Alloca-
tion concealment was judged as low risk of bias, but sequence gen-
eration was unclear in three studies (Althuisius 2001; Althuisius
2003;MRC/RCOG 1993). Six studies had both unclear sequence
generation and concealment allocation (Beigi 2005; Ezechi 2004;
Ionescu 2012; Lazar 1984; Rush 1984; Rust 2000).
Blinding
Blinding of participants and personnel was not feasible due to the
nature of the intervention. Nevertheless, information on attempts
to protect against biased assessment of the outcomes (detection
bias)was available in one study (Owen 2009).Chandiramani 2010
had adequate blinding for laboratory staff assessing the primary
aim of the study (cytokine concentrations).
Incomplete outcome data
Eleven studies adequately addressed the issue of incomplete out-
come data assessment (attrition bias) (Althuisius 2001; Althuisius
2003; Berghella 2004; Chandiramani 2010; Ionescu 2012; Keeler
2009;MRC/RCOG 1993; Owen 2009; Rust 2000; Simcox 2009;
To 2004). In four studies, the quality of outcome data assessment
was judged as unclear (Beigi 2005; Ezechi 2004; Lazar 1984; Rush
1984). Only a few studies provided information on the number of
women approached to take part in the study, the number eligible
for inclusion, and the overall refusal rate. Although not sources of
bias, high exclusion and refusal rates may affect the generalisability
of findings and interpretation of results.
Selective reporting
With one exception(To 2004), trial protocols were not available
to inform assessment of prespecified primary and secondary out-
comes. Despite this, we judged nine studies to be free of se-
lective reporting on the basis that prespecified data extraction
forms were provided by the authors (Althuisius 2001; Althuisius
2003; Berghella 2004; Ezechi 2004; MRC/RCOG 1993; Owen
2009; Rush 1984; Rust 2000; To 2004). Selective reporting was
judged as unclear in the remaining included studies (Beigi 2005;
Chandiramani 2010; Ionescu 2012; Keeler 2009; Lazar 1984;
Simcox 2009).
Other potential sources of bias
We assessed 10 studies to be free of other sources of bias (Althuisius
2001; Althuisius 2003; Beigi 2005; Chandiramani 2010; MRC/
RCOG 1993; Owen 2009; Rush 1984; Rust 2000; Simcox 2009;
To 2004); three studies were judged as unclear (Berghella 2004;
Ezechi 2004; Ionescu 2012). Two studies were stopped early and
considered to be of high risk of bias (Keeler 2009; Lazar 1984).
Sensitivity analyses
To determine which studies to exclude in sensitivity analyses based
on their quality, we referred to both adequate (low risk of bias) la-
belled sequence generation and adequate (low risk of bias) alloca-
tion concealment as essential criteria for adequate quality. If there
were obvious additional sources of risk of bias, such as unaccept-
able attrition or the was trial stopped early, we also considered these
factors. We assessed five studies (Berghella 2004; Chandiramani
2010; Owen 2009; Simcox 2009; To 2004) to be at overall low
risk of bias (Figure 2).
Effects of interventions
See: Summary of findings for the main comparison Cerclage
versus no cerclage
Some trial data included in the analyses for all perinatal losses and
baby discharged home healthy outcomes were based on individual
patient data meta-analyses published in Jorgensen 2007. Data for
some trials may not match the published reports because we ob-
tained data sets from trial authors (see Characteristics of included
studies).
The denominator used for the outcomes of neonatal death, baby
discharged home healthy andApgar less than seven at fiveminutes,
was as far as possible, live births (where reported, we subtracted
the number of stillbirths and miscarriages from the total number
randomised to calculate live births). The denominator for all other
outcomes was the total number of participants randomised. The
all perinatal losses outcome includes miscarriage, stillbirth and
neonatal death events.
Trial effect estimates are reported according to clinical groups
based on indication for cerclage (history- or physical-exam indi-
cated) and trial protocol (one-off or serial ultrasound) for Com-
parison 1.We pooled effect estimates for all analyses where hetero-
geneity was not substantial and did not formally discuss subgroup
interaction tests. The small number of trials in clinical groups
means these interaction tests are not valid. Plausible explanations
for sources of substantial heterogeneity are provided.
GRADEpro GDT software is unable to analyse data split into
clinical groups. Therefore, we collapsed the clinical groups for
summary of findings outcomes from Comparison 1 and assessed
these in Comparison 5 (Cerclage versus no cerclage (Summary of
findings outcomes)).
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Comparison 1. Cerclage versus no cerclage
Several trials in this comparison were split according to clinical
groups as shown in the forest plots.
Primary outcomes
1.1 All perinatal losses
Cerclage may lead to reduced risk of perinatal death when com-
pared with no cerclage, although the confidence interval (CI) just
crosses the line of no effect (RR 0.82, 95% CI 0.65 to 1.04; 10
studies, 2927 participants; moderate-quality evidence; Analysis
1.1).
1.2 Serious neonatal morbidity
Treatment groups had similar rates of serious neonatal morbidity
(RR 0.80, 95% CI 0.55 to 1.18; 6 studies, 883 participants; low-
quality evidence; Analysis 1.2).
1.3 Baby discharged home healthy
In four trials similar numbers of women with and without cer-
clage had healthy babies discharged home (RR 1.02, 95% CI 0.97
to 1.06; 4 studies, 657 participants; moderate-quality evidence;
Analysis 1.3).
Secondary outcomes
1.4 Stillbirth and 1.6 Miscarriage
There was no evidence that cerclage had an impact on rates of
stillbirth (RR 0.89, 95% CI 0.45 to 1.75; 5 studies, 1803 par-
ticipants; low-quality evidence; Analysis 1.4) or miscarriage (RR
0.84, 95% CI 0.58 to 1.22; 7 studies, 2091 participants; Analysis
1.6).
1.5 Neonatal deaths before discharge
There was no clear evidence that cerclage prevented neonatal
deaths before discharge (RR 0.85, 95% CI 0.53 to 1.39; 6 studies,
1714 participants; low-quality evidence; Analysis 1.5).
1.7 Preterm birth < 37 weeks, 1.8 Preterm birth < 34 weeks,
1.9 Preterm birth < 28 weeks
Cerclage was associated with reduced risk of preterm births before
37 weeks, with some heterogeneity noted (average RR 0.80, 95%
CI 0.69 to 0.95; 9 studies, 2898 participants; I² = 39%; Analysis
1.7). Pregnant womenwhounderwent cerclage were also less likely
to give birth before 34 weeks’ gestation (average RR 0.77, 95% CI
0.66 to 0.89; 9 studies, 2415 participants; high-quality evidence;
Analysis 1.8) and also probably less likely to give birth before 28
weeks, although this result was marginal, with the CI meeting the
line of no effect (RR 0.80, 95% CI 0.64 to 1.00; 8 studies, 2392
participants; Analysis 1.9).
Reporting of various aspects of neonatal morbidity was incon-
sistent and meta-analyses showed no clear evidence of an effect
from cerclage. There was marginally more respiratory morbidity
in the cerclage group (Analysis 1.11), but less intracranial pathol-
ogy (Analysis 1.10), less necrotising enterocolitis (Analysis 1.12)
and less retinopathy of prematurity (Analysis 1.13) with cerclage.
None of these differences reached statistical significance.
One small trial reported similar numbers of babies with Apgar
score less than seven at five minutes in both treatment arms (RR
0.68, 95% CI 0.40 to 1.15; 301 participants; Analysis 1.14).
1.15 Caesarean section (emergency and elective)
Women with cerclage were more likely to have caesarean sections,
although the CI for this result was marginal (RR 1.19, 95% CI
1.01 to 1.40; 8 studies, 2817 participants; Analysis 1.15).
1.16 Maternal side effects
Cervical cerclage was associated with a higher rate of maternal side
effects (vaginal discharge and bleeding and pyrexia) although this
result did not reach statistical significance and had substantial het-
erogeneity (average RR 2.25, 95% CI 0.89 to 5.69; 3 studies, 953
participants; I² = 66%; Analysis 1.16). An increased risk of pyrexia
appears to be a particular problem, with three trials reporting sig-
nificantly higher rates in cerclage groups (6% versus 2.4%) (RR
2.39, 95% CI 1.35 to 4.23; 1245 participants; Analysis 1.17).
Two small trials reported similar numbers of women receiving any
intravenous, oral or combined tocolysis in both arms (RR 1.28,
95% CI 0.80 to 2.05; 2 studies, 217 participants; Analysis 1.18).
1.19 Preterm premature rupture of membranes (PPROM)
(not prespecified)
There was no evidence of a difference in the rates of PPROM,
although this analysis had substantial heterogeneity (average RR
0.96, 95%CI 0.62 to 1.48; 6 studies, 2010 participants; I² = 33%;
Analysis 1.19).
1.20 Chorioamnionitis (not prespecified)
There were similar group rates of chorioamnionitis showing no
evidence of benefit of cerclage, with the exception of Althuisius
2001. However, Althuisius 2001 contributed to substantial het-
erogeneity in the analysis (average RR 0.84, 95% CI 0.26 to 2.72;
3 studies, 1506 participants; I² = 58%; Analysis 1.20).
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Subgroup analysis
Where possible, five potential subgroups were examined: history-
indicated cerclage; one-off ultrasound-indicated cerclage in high
risk women, serial ultrasound-indicated cerclage, physical exam-
indicated cerclage (rescue cerclage) and one-off ultrasound-indi-
cated cerclage in low or unspecified risk women. There were too
few trials in each subgroup to make meaningful conclusions.
Sensitivity analysis
Three studies were assessed as high quality (Berghella 2004; Owen
2009; To 2004) based on adequate reported methods of sequence
generation and allocation concealment. Confidence intervals over-
lapped for estimates of primary outcomes, and conclusions re-
garding effect estimates for our primary outcomes did not change
when trials of worse quality were removed from analyses (data not
shown).
Comparison 2. Cerclage versus vaginal progesterone
Chandiramani 2010 compared cerclage and natural progesterone
(Cyclogest) in a small randomised study nested in a larger prospec-
tive observational study. All pregnant women underwent serial ul-
trasound, but only those with a history of preterm birth who de-
veloped a short cervix (< 25 mm) at less than 24 weeks’ gestation
were randomised to receive treatment. Ionescu 2012 randomised
pregnant women with short cervix (< 25 mm) at 19 to 24 weeks’
gestation; this trial was reported as an abstract only, but received
additional information and unpublished data through correspon-
dence with the author. Few data per outcome limit the conclusions
that can be made for this comparison.
There was considerable heterogeneity for several outcomes in this
comparison.Differences in relative effectsmay be due to the differ-
ent trial objectives (the primary outcome in Chandiramani 2010
was cervical cytokines); the dose of progesterone also differed (400
mg/day Chandiramani 2010 and 200 mg/day Ionescu 2012).
There were no group differences detected for any review outcome,
apart from greater incidence of PPROM in the cerclage arm in a
single small trial (N = 92)(Ionescu 2012).
Primary outcomes
2.1 All perinatal losses
Cerclage and progesterone had similar efficacy to prevent perinatal
deaths (RR 0.94, 95%CI 0.36 to 2.48; 2 studies, 108 participants;
Analysis 2.1).
2.2 Serious neonatal morbidity
Two small trials reacheddifferent conclusions regarding the relative
effect of progesterone on seriousmorbidity (average RR0.49, 95%
CI 0.05 to 4.52; 2 studies, 120 participants; I² = 84%; Analysis
2.2).
2.3 Baby discharged home healthy
There were no clear differences in the number of babies who went
home healthy (RR 0.97, 95% CI 0.88 to 1.07; 2 studies, 119
participants; Analysis 2.3).
Secondary outcomes
2.4 Stillbirth
There were no treatment group differences detected in rates of
stillbirth (RR 2.70, 95% CI 0.12 to 62.17; 2 studies, 128 partic-
ipants; Analysis 2.4).
2.5 Neonatal deaths before discharge
There were no treatment group differences detected for rates of
neonatal death (RR 2.18, 95% CI 0.34 to 13.86; 2 studies, 120
participants; Analysis 2.5).
2.6 Miscarriages
Similar numbers of pregnant women miscarried in each treatment
group (RR 0.58, 95%CI 0.17 to 2.01; 2 studies, 128 participants;
Analysis 2.6).
2.7 Preterm birth < 37 weeks, 2.8 Preterm birth < 34 weeks,
2.9 Preterm birth < 28 weeks
Data were sparse, and results for preterm birth at all time points
showed no evidence of a difference between treatments: preterm
birth < 37 weeks (RR 1.16, 95% CI 0.64 to 2.08; 2 studies, 128
participants; Analysis 2.7); preterm birth < 34 weeks (RR 1.01,
95% CI 0.51 to 2.01; 2 studies, 128 participants; Analysis 2.8);
preterm birth < 28 weeks (RR 0.92, 95% CI 0.37 to 2.27; 2
studies, 128 participants; Analysis 2.9).
Therewas no evidence of groupdifferences for the following review
outcomes: serious intracranial pathology (intraventricular haem-
orrhage or periventricular leukomalacia: RR 0.96, 95% CI 0.17
to 5.28; 2 studies, 128 participants; Analysis 2.10); serious res-
piratory morbidity (respiratory distress syndrome or oxygen de-
pendency after 28 days of life (average RR 0.48, 95% CI 0.04 to
6.41; 2 studies, 128 participants; I² = 64%; Analysis 2.11); Apgar
less than seven at five minutes (RR 1.90, 95% CI 0.37 to 9.80; 2
studies, 120 participants; Analysis 2.14); caesarean section (aver-
age RR 0.67, 95% CI 0.18 to 2.47; 2 studies, 128 participants;
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I² = 70%; Analysis 2.15); and chorioamnionitis (RR 1.53, 95%
CI 0.10 to 23.61; 2 studies, 128 participants; I² = 54%; Analysis
2.21).
Ionescu 2012 reported very few events and no group differences
for necrotising enterocolitis (RR 3.00, 95% CI 0.13 to 71.78; 92
participants; Analysis 2.12) and retinopathy of prematurity (RR
1.00, 95% CI 0.06 to 15.51; 92 participants; Analysis 2.13).
Ionescu 2012 reported very few maternal side effects (vaginal dis-
charge, bleeding or pyrexia not requiring antibiotics) (RR 3.00,
95% CI 0.32 to 27.79; 92 participants; Analysis 2.17) and no
instances of maternal pyrexia in either treatment arm (RR not cal-
culated due to zero events in both arms; 92 participants).
No trials reported maternal infection requiring intervention (an-
tibiotics or delivery).
Progesterone led to fewer women with preterm premature rupture
of membranes, although this result was based on a single trial
(Ionescu 2012) with few events and small sample size (RR 8.00,
95% CI 1.04 to 61.42; 92 participants; Analysis 2.20).
Sensitivity analysis
There were too few studies in this comparison to conduct sensi-
tivity analysis.
Comparison 3. Cerclage versus intramuscular
progesterone
Keeler 2009 (79 participants) compared cerclage with weekly in-
tramuscular injections of 17 α-hydroxyprogesterone caproate in
women with a short cervix detected by transvaginal ultrasound
scan. The study was interrupted after three years of recruitment
because interim analysis did not reveal any obvious differences in
obstetric and neonatal outcomes. Therefore the results of this trial
must be interpreted with caution (Keeler 2009).
Primary outcomes
3.1 All perinatal losses
There was no evidence of a difference in prevention of perinatal
death (RR 1.12, 95% CI 0.58 to 2.16; Analysis 3.1).
3.2 Serious neonatal morbidity
There were similar rates of neonatal morbidity in treatment groups
(RR 1.13, 95% CI 0.47 to 2.74; Analysis 3.2).
3.3 Baby discharged home healthy
Similar numbers of healthy infantswere reported in both treatment
arms (RR 1.17, 95% CI 0.82 to 1.67; Analysis 3.3).
Secondary outcomes
No trials reported the following secondary outcomes: stillbirth,
neonatal death before discharge, preterm birth less than 34
weeks, serious intracranial pathology, serious respiratory morbid-
ity, necrotising enterocolitis, retinopathy of prematurity, Apgar
less than seven at five minutes, caesarean section, maternal infec-
tion, maternal side effects or maternal pyrexia. Keeler 2009 (79
participants) provided data for the following analyses.
3.6 Miscarriages
There was no clear evidence of an impact on the risk of miscarriage
(RR 1.47, 95% CI 0.38 to 5.73; Analysis 3.6).
Data were sparse, and results for preterm birth at all time points
showed no evidence of a difference between treatments.
3.7 Preterm birth < 37 weeks
Cerclage and intramuscular progesteronewere associatedwith sim-
ilar risks of preterm birth (RR 0.88, 95%CI 0.60 to 1.30; Analysis
3.7).
3.9 Preterm birth < 28 weeks
There was no clear evidence of group differences for preterm birth
less than 28 weeks, although data were few (RR 1.26, 95% CI
0.53 to 2.97; Analysis 3.9).
3.19 Preterm premature rupture of membranes
Pregnant women with cerclage and intramuscular progesterone
experienced similar rates of preterm premature rupture of mem-
branes (RR 0.88, 95% CI 0.47 to 1.65; Analysis 3.19).
3.20 Chorioamnionitis
Pregnant women in both treatment groups had similar rates of
chorioamnionitis (RR 1.32, 95% CI 0.61 to 2.88; Analysis 3.20).
Sensitivity analysis
There were too few studies in this comparison to conduct sensi-
tivity analysis.
Comparison 4. Cerclage versus pessary
There were no included trials eligible for this comparison and
therefore no data for any review outcome.
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Comparison 5. Comparisons of different cerclage
protocols
Simcox 2009 and Beigi 2005 compared the benefits of two cer-
clage protocols in women at high risk of preterm birth. In one
group, the indication to perform cerclage was based on previous
history, in the other women had cerclage only if the cervix was
found to be short on transvaginal ultrasound (≤ 20 mm). The
trials were not entirely comparable because only 20% of high risk
women in Simcox 2009 received cerclage when assigned to elec-
tive management (80% were left untreated). Beigi 2005 treated all
women; one arm were treated with elective cerclage and the other
arm with serial transvaginal sonography followed by ultrasound-
indicated cerclage. Of the women randomised to this second arm,
54% received cerclage.
There was no significant difference in any of the primary and
secondary outcomes in either of these trials. Miscarriage rate was
the only prespecified outcome reported by both trials (Analysis
5.6).
Sensitivity analysis
Simcox 2009 was assessed as a high-quality study, but with only
two studies included in this comparison, formal sensitivity analysis
based on quality was not appropriate.
Comparison 6. Summary of findings outcomes
We include GRADE assessments in our reporting of Comparison
1; the outcomes reported under this comparison are identical to
those above in Comparison 1.
D I S C U S S I O N
Summary of main results
The evidence from 15 included randomised trials demonstrated
that, compared with expectant management, the placement of
cervical cerclage in women at risk of preterm birth reduced risk of
preterm birth.
The key issue is whether such prolongation of pregnancy improves
the outcome for the baby; there is a distinct possibility that a baby
may be better off after an early birth in a setting with adequate
neonatal care resources. The difference in all perinatal losses was
not established because the upper limit for the 95% confidence
interval (CI) for the pooled effect estimate crossed the line of no
effect (RR 0.82, 95% CI 0.65 to 1.04; 10 studies, 2927 partic-
ipants). Women with cerclage and expectant management had a
similar rate of serious neonatal morbidity and a similar chance of
having a healthy baby at discharge.
The key question regarding long-term development in terms of
neurological and respiratory outcomes was not addressed; most
trials did not follow-up mother and baby after discharge from
hospital. Data for short-term neonatal morbidity are also sparse
because of inconsistencies between trials in terms of how this out-
come was defined and reported.
In terms of safety, it is clear that cerclage is associated with a higher
rate of maternal side effects, especially pyrexia. However, side ef-
fects tend to be self-limiting (vaginal discharge and bleeding) or
treatable (pyrexia) and do not appear to put maternal health at
risk. The higher rates of caesarean section after cervical cerclage
have not been reported previously. This is unsurprising given few
participants in primary studies and relatively modest increase in
absolute terms (3% absolute risk increase; 95%CI 0.06% to 5.5%
increase). The exact mechanism is difficult to establish, but we
were mindful that none of the trials was double-blind. The deci-
sion to perform caesarean section is very subjective, and therefore,
the knowledge of allocated treatment may have been a significant
source of bias. It is possible that cervical cerclage causes damage to
the cervix that increases the need for caesarean section. However,
we also speculate that increased caesarean section is due to biased
(more frequent) diagnosis of failed induction or failure to progress
in labour when clinicians know that a woman had cervical cerclage
earlier in pregnancy.
We prespecified three clinical scenarios based on the indications
for cervical cerclage in current clinical practice:
1. history-indicated cerclage - usually because of previous
preterm births and sometimes referred to as elective cerclage;
2. cerclage performed because a short cervix is found on
transvaginal sonography (one-off ultrasound indicated cerclage
and serial ultrasound-indicated cerclage); and
3. physical exam-indicated cerclage, also called emergency or
rescue cerclage, when symptomatic women are found to have
either significant cervical shortening or cervical dilatation
detected on vaginal examination (performed digitally or with
speculum).
We found four trials of history-indicated cerclage, five trials of
ultrasound-indicated cerclage and one small trial of physical exam-
indicated cerclage.
Women with previous preterm birth are often extremely anxious
in subsequent pregnancies and there are an increasing number of
specialist clinics for these women. The issue of prevention is clearly
a hot topic, particularly when a cervix is found to be short on
transvaginal sonography. Treatment options include daily vaginal
pessaries of natural progesterone (Fonseca 2007; Hassan 2011),
weekly intramuscular injections of 17 α-hydroxyprogesterone (
Meis 2003), or Arabin pessary (Arabin 2003).
No robust conclusions could be made about cerclage versus al-
ternative interventions such as vaginal and intramuscular proges-
terone or pessary. Two studies compared cerclage to vaginal proges-
terone (Chandiramani 2010; Ionescu 2012). These two trials had
different objectives (the primary outcome of the Chandiramani
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2010 trial was cervical cytokines) and used different dose of pro-
gesterone - differences which likely contributed to the significant
heterogeneity noted in meta-analyses.
OnlyKeeler2009 attempted to compare ultrasound-indicated cer-
clage with 17 α-hydroxyprogesterone, but this trial was halted pre-
maturely and was too small for any meaningful conclusions to be
made. No included trials assessed cerclage versus pessary. These
findings underline the necessity of high quality data.
There is also the question of whether it is better to perform a
prophylactic procedure electively in early pregnancy, or wait and
see if the cervix gets shorter before performing cerclage. Simcox
2009 and Beigi 2005 attempted to answer this question but both
studies were quite small and important clinical outcomes were
reported inconsistently, precluding meaningful comparisons and
conclusions from pooled data. Interestingly, in the Simcox 2009
study only 20% of the women managed without ultrasound scans
had cerclage, despite being identified as of high risk. An improved
design may have been for women to be randomised only if clini-
cians were in equipoise whether to perform prophylactic cerclage
or wait for ultrasound shortening of the cervix, as was the case in
Beigi 2005.
Overall completeness and applicability of
evidence
The consistency in the size and direction of effects across all clinical
scenarios is reassuring. However, the lack of robust neonatal mor-
bidity data and lack of long-term follow-up studies, in particular,
are considerable weaknesses. As the data are emerging that natu-
ral vaginal progesterone has a more pronounced protective effect
for women with a short cervix (Fonseca 2007; Hassan 2011), the
role of cervical cerclage in the prevention of preterm birth remains
unclear.
There is often a lot of pressure to perform cervical cerclage in
early pregnancy as a prophylaxis for women who have experienced
late miscarriage in a previous pregnancy. Unfortunately, the results
from Simcox 2009 and Beigi 2005 are inconclusive and further
similar studies are urgently needed with strict inclusion criteria
and firm management protocols.
We were unable to provide what would be considered as defini-
tive evidence regarding benefits, or harms, associated with rescue
cerclage, i.e. cerclage performed when women are found to have
a dilated cervix in the second trimester of pregnancy. Published
observational data are likely to be biased (Pereira 2007), but con-
senting and randomising this group of patients is very difficult.
Quality of the evidence
Overall, most included trials were at low risk of bias. Selective
reporting of the results is always a concern when trial protocols
are unavailable for review. We significantly minimised this risk by
asking study authors to provide outcome data for prespecified out-
comes, including individual patient data if available. It was partic-
ularly gratifying that the response was excellent and additional in-
formation was provided by Althuisius 2001; Chandiramani 2010;
MRC/RCOG 1993; Owen 2009; Rush 1984; Rust 2000 and To
2004.
Performance bias (blinding of personnel and participants) will al-
ways be an issue in cerclage trials; it is not practical to blind par-
ticipants to the type of treatment. However, several key outcomes
(perinatal mortality, serious neonatal morbidity) and gestational
age at birth are objective and therefore, unlikely to be influenced
by lack of blinding.
For the comparison of cerclage versus no cerclage we assessed six
primary and secondary outcomes using GRADEmethods. Perina-
tal deaths evidence was assessed as moderate quality (good quality
trials and adequate sample size); we downgraded the evidence one
level because the confidence interval just crossed 1. We assessed
evidence for preterm birth before 34 weeks’ gestation to be of high
quality. Evidence for baby discharged home healthywas assessed as
moderate quality, downgraded one level due to small sample size.
Serious neonatal morbidity, neonatal death and stillbirth were all
assessed as low quality due to small sample size and wide confi-
dence intervals crossing the line of no effect.
Potential biases in the review process
We followed the proscribed Cochrane methods for reducing bias
in the process of writing a systematic review. We conducted a com-
prehensive search of the literature and have no reason to believe
any relevant trials were left out. We completed study selection,
appraisal and data extraction in duplicate.
Agreements and disagreements with other
studies or reviews
Systematic reviews
An indirect meta-analysis compared progesterone and cerclage for
women with ultrasound-detected short cervix (< 25 mm), single-
ton pregnancy and history of preterm birth. Treatments were esti-
mated to be of similar efficacy for preventing preterm birth. Com-
pared with placebo or no cerclage, both interventions reduced the
risk of preterm birth before 32 weeks and composite perinatal
morbidity and mortality (Conde-Agudelo 2013).
A recent network meta-analysis compared use of cerclage, pro-
gesterone and pessary. The review included 40 trials and 11,637
women and found pessary ranked best for preterm birth before 37
weeks, followed by progesterone with cerclage not more effective
than control. For births before 34 weeks, no single treatment (cer-
clage, pessary or progesterone) was significantly better than con-
trol (Jarde 2016).
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An individual patient data meta-analysis comparing cerclage ver-
sus no cerclage in patients at high risk of preterm labour did not
demonstrate a statistically significant reduction of perinatal loss in
the cerclage group (Jorgensen 2007). Furthermore, the main indi-
cation for cerclage (obstetric history versus short cervical length)
did not influence the effect estimate for pregnancy loss.
A meta-analysis by Berghella 2011a compared cerclage versus no
cerclage in a subgroup of women with short cervix and previous
preterm delivery. Berghella 2011a reported a significant decrease
in preterm births in the cerclage group, together with a signif-
icant decrease in composite perinatal mortality and morbidity.
When considered individually, perinatal mortality and compos-
ite morbidity decreased in the cerclage group (perinatal mortality
8.8% versus 13.8% and composite neonatal morbidity 8.2% ver-
sus 14.3% respectively), although statistical significance was not
achieved. These data were broadly in accordance with our results.
Berghella and colleagues published a separate meta-analysis com-
paring history-indicated cerclage with ultrasound-indicated cer-
clage in women at high risk for preterm labour (Berghella 2011b).
Berghella 2011b did not identify any differences in terms of
preterm birth or perinatal outcomes between management strate-
gies and concluded that women with prior preterm birth may
be monitored safely with ultrasound-indicated cerclage. Berghella
2011b suggested that history-indicated cerclage should be re-
served for women with three prior early preterm births or second-
trimester losses.
Our analysis did not find significant differences in key primary
and secondary outcomes; however, we urge caution in interpreting
data. Unlike Berghella 2011b, we excluded Kassanos 2001 from
our analysis, because thiswas likely to be a quasi-randomised study.
Data from Althuisius 2001 were not included because primary
randomisation was to prophylactic cerclage or no treatment. Two
included studies comparing history-indicated with ultrasound-in-
dicated cerclage (Beigi 2005; Simcox 2009) are not entirely com-
parable because in Simcox 2009 only 20% of women randomised
to the elective cerclage group received the intervention. For this
reason, we feel that it is too premature to conclude that both man-
agement strategies are equally safe.
Emergency cerclage
A recent meta-analysis pooled data on the use of emergency cer-
clage in pregnant women with singleton pregnancy and cervi-
cal dilation of at least 0.5 cm. Evidence comparing cerclage with
no cerclage from 10 studies (1 randomised controlled trial and 9
cohort studies) and 757 women showed an association between
emergency cerclage and improved neonatal survival as well as pro-
longation of pregnancy for approximately one month (Ehsanipoor
2015).
A retrospective study of 158 pregnant women receiving emergency
cerclage for cervical dilation and bulging membranes (mean gesta-
tion 21.45 weeks; SD 2.23) reported that cerclage placement led
to live birth for 130/158 women. The study authors compared
women with dilation > 3 cm and women with dilation < 3 cm; sur-
vival, birthweight and suture-to-delivery interval were all greater
for women with cervical dilation < 3 cm (Zhu 2015).
Observational evidence
A retrospective, multicentre cohort study examined a specific sub-
set of pregnant women with singleton pregnancy. All included
women had a preterm birth before 37 weeks for their first preg-
nancy. All women had ultrasound-indicated cerclage for short
cervix (< 25 mm) during their second pregnancy. At the third
singleton pregnancy, women received either history-indicated cer-
clage or transvaginal ultrasound screening. The cohort study com-
pared outcomes from the third pregnancy; 38 women received cer-
vical length screening and 64 women underwent cerclage. Preg-
nancy outcomes were similar for women managed with either cer-
clage or ultrasound, but just under half of women receiving ul-
trasound screening developed short cervix < 25 mm and required
cerclage (Suhag 2015).
Khalifeh 2016 argued for a cervical length screening programme
for all pregnant women, with cut-off of < 25 mm as standard; the
study authors proposed that such a test is acceptable to women,
effective in preventing the prevalent condition of preterm birth,
and cost-effective.
A U T H O R S ’ C O N C L U S I O N S
Implications for practice
Cervical cerclage prevents preterm births, but so does the natural
progesterone given vaginally towomenwith a short cervix, without
an increased risk of caesarean section (Romero 2012). However,
transvaginal sonography and prolonged treatment with proges-
terone may not be affordable for all. Also, the progesterone option
may be unacceptable to women who have already had a successful
pregnancy with cervical cerclage. Therefore, the decision on how
best to minimise the risk of recurrent preterm birth in women at
risk, either because of poor history or a short or dilated cervix,
has to be personalised and based on the clinical circumstances, the
skill and expertise of the clinical team and, most importantly, the
woman’s informed choice.
Implications for research
• Women with a short cervix on transvaginal sonography
should be randomised to either cervical cerclage, natural
progesterone, neither, or both. It would be important to report
separately results for women who had routine transvaginal
sonography screening (low risk) and for those who had serial
ultrasound scans because of previous preterm birth or other risk
factors.
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• Further randomised data that includes women with a
dilated cervix found on physical examination (digital/speculum)
would be welcome.
• We need definitive studies to ascertain whether it is better
for women at particularly high risk of preterm birth to have
cervical cerclage early (as prophylaxis), or to have serial
transvaginal scanning.
All future studies should have neonatal morbidity as the primary
outcome on which sample size calculations should be based. Such
studies will have more than adequate power to address the impact
on preterm births and most safety aspects. Studies that use gesta-
tional age as the primary outcome do so primarily to justify the
smaller (more feasible) sample size. It is unlikely that these will
have adequate power to answer the key question of whether there
is a benefit for mother and baby.
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C H A R A C T E R I S T I C S O F S T U D I E S
Characteristics of included studies [ordered by study ID]
Althuisius 2001
Methods RCT - block randomisation.
July 1995 to July 2000.
University Hospital Vrije Universiteit and Olze Lieve Vrouwe Gastus, Amsterdam
Participants Eligible participants from 3 populations:
• Group I: “Women with a previous PTL before 34 weeks of gestation who met
clinical criteria for the diagnosis of cervical incompetence or previous PPROM before
32 weeks were allocated to receive a prophylactic cerclage or not in a proportion of 1:2”
“TV US follow-up examination of the cervix was performed in both groups. When a
patient of the group without prophylactic cerclage had a cervical length of < 25 mm
before 27 weeks, a secondary randomisation was performed that allocated women for
treatment with therapeutic cerclage with bed rest vs bed rest only”.
• Group II: “Women with a gynaecological history with one or more accepted risk
factors for cervical incompetence, such as cold knife conization, exposure to
diethylstilbestrol in utero, and uterine anomaly, were followed by TV US of the cervix;
and when a cervical length of < 25 mm was found before 27 weeks of gestation,
randomisation allocated women to therapeutic cerclage and bed rest vs bed rest only”.
In both the first and second groups, women were included before a GA of 15 weeks.
• Group III: ”Women who met the inclusion criteria of I and II group but who
had a gestational age of > 15 weeks with a cervical length of < 25 mm before 27 weeks
of gestation or women who had symptoms of cervical incompetence, such as the
feeling of pressure low in the abdomen and mucous vaginal discharge and a cervical
length of < 25 mm before 27 weeks, were randomised to receive therapeutic cerclage
and bed rest vs bed rest only”.
Women randomised and included in this review came from groups I ( N = 18), II (N =
8) and III (N = I0)
Inclusion criteria: “high risk of PTL as diagnosed by cervical length of < 25 mm before
gestational age of 27 weeks.” “…cervical length was measured by TV US in women
with risk factors or symptoms of cervical incompetence” “only patients with singleton
pregnancies were included”
Exclusion criteria: women with pregnancies complicated by fetal congenital/chromo-
somal anomalies, PROM, membranes bulging into the vagina, or intrauterine infection
in the current pregnancy were not eligible for trial entry
Interventions Therapeutic cerclage (N = 20) with bed rest compared to bed rest only (N = 16). One
woman was excluded due to bulging membranes, leaving 19 women in the cerclage
group
Outcomes Primary: PTL < 34 weeks, neonatal morbidity defined as admission to NICU and/or
neonatal death and neonatal survival
Secondary: not stated
Notes Additional information and the database for cross-checking of the published results
provided by the first author
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Althuisius 2001 (Continued)
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Random allocation was stratified for the
different inclusion criteria and the 2 partic-
ipating hospitals and organised in balanced
blocks. It is not stated how was the random
sequence generated
Allocation concealment (selection bias) Low risk Telephone randomisation
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Impossible to blind for participants and
clinicians
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Not stated if outcome assessors were
blinded
Incomplete outcome data (attrition bias)
All outcomes
Low risk Any loss of participants to follow-up at each
data collection point:
• 3 lost to follow-up.
Any exclusion of participants after ran-
domisation:
• 1 patient was excluded because the
membrane was bulging into the vagina.
Intention-to-treat analysis
Selective reporting (reporting bias) Low risk Full study protocol not available, but pre-
specified data extraction form provided by
authors.
Secondary outcome not prespecified in the
article
Other bias Low risk Study was not stopped early.
No baseline imbalance
Althuisius 2003
Methods RCT - block randomisation.
July 1995 to July 2000.
University Hospital Vrije Universiteit and Olze Lieve Vrouwe Gastus, Amsterdam
This trial recruited women alongside Althuisius 2001 and reported identical methodol-
ogy
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Althuisius 2003 (Continued)
Participants Women were recruited at the same time as for Althuisius 2001. For Althuisius 2003,
all women were < 27 weeks’ gestation and had imminent preterm birth due to cervical
incompetence with membranes bulging at or beyond the cervical os
Women were evaluated for trial entry with transvaginal ultrasound and an additional
speculum examination when cervical length < 25 mm
Exclusion criteria: signs of infection including fever, uterine tenderness, fetal tachycar-
dia, leukocytosis, and/or elevated C-reactive protein
Interventions Emergency cerclage (N = 13, 10 singleton and 3 twins): Emergency cerclage (Mac-
Donald) and indomethacin 100 mg suppository 2 hours before and 6 hours after the
operation
Bed rest (N = 10, 6 singleton and 4 twins)
Women in both arms received amoxicillin/clavulanic acid 1 g intravenously every 6 hours
and metronidazole 500 mg intravenously every 8 hours for 1 week. All women remained
hospitalised and on bed rest until 30 weeks’ gestation. Cerclage removed on indication
or at 37 weeks’ gestation
One woman had membranes rupture during cerclage placement and the intervention
was abandoned
Outcomes Preterm delivery at < 34 weeks of gestation, compound neonatal morbidity (defined
as admission to the neonatal intensive care unit and/or neonatal death), and neonatal
survival
We did not include deaths in the review outcome of ’neonatal morbidity’
Notes Data from this trial were not included in previous versions of this review. We included
women reported here in the ’physical-exam indicated’ subgroup
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Sequence generation not described
Allocation concealment (selection bias) Low risk Telephone allocation
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Not blinded
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Not stated if outcomes assessors were
blinded
Incomplete outcome data (attrition bias)
All outcomes
Low risk ITT analysis. No losses to follow-up
Selective reporting (reporting bias) Low risk Stated outcomes are reported
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Althuisius 2003 (Continued)
Other bias Unclear risk Demographics at baseline comparable
Beigi 2005
Methods RCT.
January 2001 to September 2003.
Arash Maternity Hospital, Tehran University of Medical Sciences
Participants N = 97
Inclusion criteria: “singleton pregnancies with an obstetric history of spontaneous
midtrimester loss or early preterm delivery (between 15 and 32 weeks) accompanied by
painless and progressive dilatation of cervix and/or PROM without preceding contrac-
tions, in the absence of other possible causes of midtrimester loss or early PTD were
included”
Exclusion criteria:multiple pregnancies, major fetal defect and intra-uterine fetal death
Interventions Elective cerclage - cerclage placement at 12 to 15weeks’ gestation versus serial transvaginal
sonography of the cervix and cerclage only if indicated by cervical changes. Serial TV
sonography of the cervix performed every 2 weeks, beginning at 14 weeks’ gestation,
and were offered an emergency cerclage placement only if the endocervical canal length
shortened to 20 mm or less
Outcomes Primary: GA at delivery.
Secondary: not stated
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk ”Random assignment was performed im-
mediately after inclusion in the trial and
women were allocated to receive either
an elective cerclage or serial transvaginal
sonography of the cervix.”
Allocation concealment (selection bias) Unclear risk Not stated
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Impossible to blind to participants and per-
sonnel
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Not stated if outcome assessors were
blinded
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Beigi 2005 (Continued)
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Any loss of participants to follow-up at each
data collection point:
• not stated.
Any exclusion of participants after ran-
domisation:
• not stated.
Was the analysis intention-to-treat?
• Not stated
Selective reporting (reporting bias) Unclear risk Study protocol not available.
Secondary outcome not prespecified in the
article
Other bias Low risk Study was not stopped early
There seemed to be no baseline imbalance
Berghella 2004
Methods RCT
Thomas Jefferson University Hospital from February 1998 until June 2003 and Univer-
sity of Pennsylvania Hospital from February 2002 until June 2003
Participants Participants (N = 61)
• “Asymptomatic pregnant women who were identified… To have high risk factors
for PTB were screened by TVU of the cervix every 2 weeks between 14 + 0 weeks of
gestation and 23 + 6 weeks of gestation”.
• “twin pregnancies also were screened prospectively”.
Inclusion criteria
• Singletons and twins.
• High risk for PTD.
• Screened twin pregnancies and non screened low-risk women (who were
identified incidentally, first on routine trans-abdominal anatomy ultrasound scanning)
with trans-vaginal ultrasound criteria for a short cervix were also offered enrolment,
with twin pregnancies randomly assigned separately.
• Advanced cervical dilatation or membrane bulging in the vagina in asymptomatic
women was not an exclusion criteria.
Exclusion criteria
• Prophylactic cerclage that was placed on the basis of historic high-risk criteria.
• Last pregnancy delivered at term.
• Major fetal anomaly.
• Triplets or higher multiple gestations.
• Previous inclusion in another trial.
• Current drug abuse.
• Regular contractions that led to PTL after identification of abnormal cervix by
US scanning
Interventions Cerclage with bed rest
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Berghella 2004 (Continued)
Outcomes Primary:
• PTB < 35 weeks.
Secondary:
• GA at delivery, PTL, PPROM, interval from enrolment to delivery.
• Neonatal outcomes: death; for the survivors, neonatal intensive care nursery
admission, days in the NICU, and composite morbidity (any of respiratory distress
syndrome, intraventricular haemorrhage (III or IV), NEC, or sepsis
Notes Additional information and the data base for cross-checking published results provided
by the first author
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk “Randomization included allocation that
was accomplished by computer-generated
numbers in permuted blocks of 6.”
Allocation concealment (selection bias) Low risk “These were concealed in sequentially
numbered, opaque, sealed envelopes.”
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Impossible to blind to participants and per-
sonnel
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Not stated if the outcome assessors were
blinded
Incomplete outcome data (attrition bias)
All outcomes
Low risk No losses of participants.
Describe any exclusion of participants after
randomisation:
• 1 woman was excluded from low-risk
group because of current illicit drug abuse;
• 14/333 women in the high-risk
group were excluded (9 included in
another study, 3 with persistent
contractions, 2 current illicit drug abuse);
• 1/92 woman in twin group was
excluded because of current illicit drug
abuse.
Although not stated, from numbers, study
seems to be intention-to-treat
Selective reporting (reporting bias) Low risk Full study protocol not available, but pre-
specified data extraction form provided by
authors
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Berghella 2004 (Continued)
Other bias Unclear risk Study was not stopped early.
• 15/26 women in low-risk group
declined participation;
• 46/333 women in high-risk group
declined participation;
• 6/92 women in twin group declined
participation
Chandiramani 2010
Methods • Prospective observational study that randomised women to treatment to ensure
equal groups.
• Aim was to prospectively investigate cervico-vaginal fluid inflammatory markers
longitudinally in tandem with cervical length and to examine the influence of cervical
cerclage and progesterone treatment. The prospective study investigated cervico-
vaginal fluid inflammatory markers and cervical length. Women were randomised to
cerclage or progesterone.
• June 2006 to November 2008.
• Teaching hospitals, London, UK
Participants 1223 women assessed for eligibility; 112 women enrolled for study. 101 allocated to
treatment arms
Inclusion criteria: pregnant women (14 to 24 weeks’ gestation) with at least 1 previous
preterm delivery and short cervix (< 25 mm) at < 24 weeks’ gestation were randomised.
Women who did not develop a short cervix served as an additional third arm of controls.
We have only included data for randomised women in this review
Exclusion criteria: multiple pregnancy, previous iatrogenic preterm birth, unable to
consent
Interventions Cerclage versus progesterone; N = 37
• Cerclage arm: 20.
• Vaginal progesterone (Cyclogest 400 mg once daily): 17.
• ”Recruits were initially assessed every 2 weeks by transvaginal cervical length
assessment as well as cervico-vaginal fluid and blood sampling between 16 and 28
weeks’ gestation.“ The study then randomly allocated women who developed short
cervix < 25 mm before 24 weeks’ gestation to either cerclage or progesterone. Women
who did not develop short cervix served as controls; we have not used data for controls
Outcomes Cytokine concentrations in the cervico-vaginal fluid prior to cervical shortening, and
before and after the treatment; many obstetric/delivery outcomes were also recorded and
not reported in published reports. We obtained data directly from study authors
Notes Authors: ”The study was not designed or powered to directly compare the two treatment
groups (e.g. for cytokine concentrations, cervical length or pretermbirth), although some
exploratory comparisons have been included”
Funding: Action Medical Research and Tommy’s Charity.
Results from this study formed the rationale for the NIHR funded SUPPORT trial
comparing progesterone, cerclage and pessary
35Cervical stitch (cerclage) for preventing preterm birth in singleton pregnancy (Review)
Copyright © 2017 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Chandiramani 2010 (Continued)
4 women in the progesterone group received cerclage for bulging membranes
We obtained unpublished individual patient data from the authors for this review from
Rachel Tribe, MD. Where events are discrepant between reports, we used data from the
data set
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Computer generated sequence
Allocation concealment (selection bias) Low risk Personal communication from authors: al-
location concealed in password-protected
database. Investigator performing alloca-
tions blind to assignment
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Impossible to blind these interventions
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk Laboratory staff were blind to allocation for
the principal aims of the study (cytokine
concentrations). It is unclear if those col-
lecting delivery data were blinded
Incomplete outcome data (attrition bias)
All outcomes
Low risk 1 woman excluded from cerclage arm due
to incomplete sample collection
Selective reporting (reporting bias) Unclear risk We obtained unpublished outcome data
relevant to this review directly from authors
Other bias Low risk Personal communication from authors
clarified methods and data in published re-
ports
Ezechi 2004
Methods July 2000 to June 2002.
Havana Specialist Hospital Lagos, Nigeria
Participants • N = 81.
• “Women with previous preterm delivery.”
• Exclusion criteria: not stated
Interventions Cerclage at 14 weeks of gestation versus no cerclage
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Ezechi 2004 (Continued)
Outcomes GA at delivery, birthweight, neonatal admission and outcome, hospital stay and cumu-
lative hospital bill
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk “The women were randomised into cer-
clage (cases) and non cerclage (controls) af-
ter their consent had been obtained.”
Allocation concealment (selection bias) Unclear risk Not stated
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Impossible to blind to participants and per-
sonnel
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Not stated if outcome assessors were
blinded
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk No description available
Selective reporting (reporting bias) Low risk Full study protocol not available, but pre-
specified data extraction form provided by
authors
Primary outcome only described in the ar-
ticle
Other bias Unclear risk No description available
Ionescu 2012
Methods RCT (abstract only); unpublished data and additional information obtained from au-
thors
Tertiary care obstetrics and gynaecology department at a University Hospital, Romania
Participants Women were recruited between 19 and 24 weeks’ gestation. Pregnant women had a
history of 1 or more previous preterm birth (N = 92 randomised); all women also had
short cervix detected with serial TVU (< 25 cm) at 19 to 24 weeks’ gestation and were
randomised to treatment with cerclage or vaginal progesterone
Singleton pregnancy only.
Exclusion criteria: not stated
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Ionescu 2012 (Continued)
Interventions All women: cerclage (N = 46) and progesterone (N = 46).
All women with short cervix:
Cerclage (N = 46) treatment Shrodikar cerclage.
Progesterone (N = 46) 200 mg/day intravaginal capsule of progesterone
Outcomes Mean GA at delivery; preterm birth < 34 weeks; several other unpublished data obtained
directly from author
Notes Study reported in abstract form only. Data reported as percentages only. Mean GA
reportedwithout standard deviations in published abstract. All data used inmeta-analyses
for this review came directly from trial author
This trial followed 92 women with serial TVU.Of these 92, 90% had 1 previous preterm
birth; the remaining had more than 1 previous preterm birth
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Study described as randomised; no further
details
Allocation concealment (selection bias) Unclear risk Not described
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Not described but not possible to blind
these interventions
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Not described
Incomplete outcome data (attrition bias)
All outcomes
Low risk No loss to follow up described. Unpub-
lished data for all 92 women randomised
Selective reporting (reporting bias) Unclear risk Not apparent, but study reported in ab-
stract form only.We have obtained unpub-
lished outcome data from authors
Other bias Unclear risk Baseline characteristics not described; reg-
imen and dose of progesterone not de-
scribed in abstract but obtained from au-
thors
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Keeler 2009
Methods RCT.
November 2003 to December 2006.
Lehigh Valley Hospital Perinatal Testing Center. Pennsylvania, USA
Participants Participants (N = 79)
• “…women …with risk factors for spontaneous PTB were screened with serial
transvaginal US beginning at 16 weeks’ gestation”. “Risk factors for PTB included
history of spontaneous PTB, second-trimester pregnancy loss, previous cervical surgery
(conization or loop excision), or documented uterine anomaly.”
• “Also low-risk, asymptomatic singleton pregnancies between 16 and 24 weeks’
gestation were screened for evidence of cervical shortening with transabdominal
ultrasound as part of routine anatomical survey.”
• “Patients with ultrasonographic evidence of short cervix, defined as transvaginal
CL ≤ 25 mm, were offered enrolment into study”.
Exclusion criteria
• “…any known fetal chromosomal or structural anomaly, multiple gestation,
known allergy to progesterone, ruptured membranes, vaginal bleeding, evidence of an
active intra-amniotic infection (diagnosed clinically or by amniocentesis), prolapse of
endocervical membranes beyond the external cervical os, persistent uterine activity
accompanied by cervical change, or an obstetrically indicated delivery.”
Interventions McDonald cerclage versus weekly intramuscular injections of 17 OHP-C
Outcomes Primary: spontaneous preterm birth prior to 35 weeks’ gestation.
Secondary: obstetrical complications and neonatal morbidity and mortality
• Obstetrical complications: included chorioamnionitis, abruption placentae,
PPROM, need for a rescue procedure, days from study enrolment to delivery, and GA
at delivery.
• Neonatal morbidity was stratified as follows: no morbidity was defined as no
NICU admission and routine newborn care; mild morbidity was defined as NICU
admission without severe morbidity; severe morbidity was defined as life threatening
morbidity including respiratory distress syndrome requiring mechanical ventilation >
24 h, intraventricular haemorrhage, neonatal sepsis, or NEC.
• Perinatal death included any stillbirth or neonatal death during the study period
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk “Randomisation was accomplished by
computer generated assignment…”
“The randomisation sequence was secured
by administrative stuff until enrolment was
terminated.”
Allocation concealment (selection bias) Low risk “Assignments were concealed in sequen-
tially numbered opaque envelopes by a co-
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Keeler 2009 (Continued)
ordinator not involved in screening, enrol-
ment, or randomisation.”
“Randomisation was accomplished by
handing out the sequentially numbered
opaque envelopes.”
Blinding of participants and personnel
(performance bias)
All outcomes
High risk “Due to the intrinsic nature of the study
design, there was no masking in this trial.”
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Not stated if outcome assessors were
blinded
Incomplete outcome data (attrition bias)
All outcomes
Low risk • 8/91 participants declined
randomisation;
• no participants lost to follow-up;
• 4/91 patients were excluded (2
PPROM, 2 positive amniocentesis);
• Analysis was intention-to-treat
Selective reporting (reporting bias) Unclear risk Study protocol not
available
Other bias High risk Study was stopped early: “We anticipated
randomising 160 patients to allow for at-
trition during the study. However, the trial
was stopped early by the authors because
3 years of recruitment, an interim analysis
showed no difference in outcome between
treatment groups”
No known baseline imbalance
Lazar 1984
Methods RCT
Dates of data collection: not stated.
Setting:
• 4 obstetric teams used cervical cerclage for “obvious cervical incompetence”;
• an initial partial score was established at the first visit, and then recalculated at
each visit between 10 and 28 weeks’ gestation;
• hospitals in France
Participants N = 506 (268 cerclage, 238 no cerclage)
Inclusion criteria
“The eligibility of the rest was assessed using a scoring system.“ The scores were estab-
lished by points given to two kinds of risk factors: ”permanent” (factors present before
the index pregnancy) and “evolving” (factors that appeared or changed during the preg-
nancy).”
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Lazar 1984 (Continued)
“Patients with score ≥ 20 points at the first visit were deemed to be ineligible for the
trial. Similarly, low risk patients with scores < 9 at the first or subsequent visits were also
deemed to be ineligible. Women became eligible for the entry into the trial as soon as a
score of ≥ 9 had been reached, and they remained in the trial whether or not the score
subsequently rose to≥ 20. The target trial population were pregnant women who had a
risk of cervical incompetence that was lower than the pregnant women excluded for the
following”
Exclusion criteria
• Previous late spontaneous abortion of a living fetus at 14 to 28 weeks.
• State of the cervix (cervix torn up to the lateral cul de sac; cervix open including
inner os (1 finger width).
• Enlargement of uterine isthmus ≥ 1 cm in width demonstrated at hysterogram.
• Twin pregnancies
Interventions Cerclage versus no cerclage
Outcomes Not specified
Notes 242/268 women in cerclage arm received cerclage; 26 women in no cerclage arm had
cerclage
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk “…eligible patients were randomly allo-
cated (using prepared envelopes) into…”
Allocation concealment (selection bias) Unclear risk “…eligible patients were randomly allo-
cated (using prepared envelopes) into…”
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Impossible to blind to participants and per-
sonnel
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Not stated if the outcome assessors were
blinded
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Losses to follow up not
reported.
Exclusion of participants after randomisa-
tion not reported.
Analysis appears to be intention-to-treat
“Of the women entered into the trial, 90%
received the management to which they
had been allocated.”
Selective reporting (reporting bias) Unclear risk Study protocol not available
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Lazar 1984 (Continued)
Other bias High risk Study stopped early: “Itwas decided to con-
duct a first analysis of the data after about
500 patients had been recruited, and to de-
cide in the light of the results whether or
not to pursue the trial. The results reported
here are those of the first analysis.”
Baseline imbalance: “Women allocated to
the cerclage policy, however, were more
likely to have had previous abortions. This
difference is largely a reflection of a differ-
ence between the experimental and con-
trol groups in one of the four centres. Al-
though selection bias may have been oper-
ating in this centre we have included data
derived from cases and controls managed
there because analyses conducted after ex-
cluding these patients did notmake any dif-
ference to the conclusions we have reached
after analysing data derived from all four
centres.”
MRC/RCOG 1993
Methods RCT - block randomisation.
1981 to 1988.
Multicentre - the trial involved more than 200 obstetricians in the UK and 11 other
countries: UK, France, Hungary, Norway, Italy, Belgium, Zimbabwe, South Africa, Ice-
land, Ireland, Netherlands, Canada
Participants Participants (N = 1292): twins and singletons.
Inclusion criteria: “Women whose obstetricians were uncertain whether to recommend
cervical cerclage, most of whom had a history of early delivery or cervical surgery”
Exclusion criteria: not specified
Interventions Recommendation to insert suture as soon as possible versus recommendation to avoid
the suture
Outcomes Primary: length of pregnancy (deliveries < 33 and < 37 weeks); vital status of the baby
at the time of completion of the form
Secondary: postpartum pyrexia; causes of fetal/neonatal death; indications for CS; usual
technique of cervical cerclage
Notes Additional information and the data base for cross-checking of the published results
provided by the authors
Risk of bias
Bias Authors’ judgement Support for judgement
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MRC/RCOG 1993 (Continued)
Random sequence generation (selection
bias)
Unclear risk “Most obstetricians used the randomisa-
tion service provided by the Clinical Trial
ServiceUnit inOxford, but other randomi-
sation centres were established in Hungary,
Italy and Zimbabwe.”
“Randomisation was organized in balanced
blocks, but no prognostic stratification was
used.”
Allocation concealment (selection bias) Low risk “Most women were entered and assigned a
random allocation by telephone; a fewwere
registered by post.”
“Once basic identifying and descriptive
data had been given over the telephone, a
random allocation was made to one of two
clinical policies.”
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Impossible to blind participants and per-
sonnel
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Not stated if the outcome assessors were
blinded
Incomplete outcome data (attrition bias)
All outcomes
Low risk 2% participants lost to follow-
up.
Not stated if participants were excluded of
after randomisation
Analysis intention-to-treat analysis: 598/
647 in cerclage group received cerclage; 49/
645 in no cerclage group received cerclage
Selective reporting (reporting bias) Low risk Study protocol not available, but the au-
thors provided individual data for indepen-
dent data extraction
Other bias Low risk Study was not stopped early.
No baseline imbalance
Owen 2009
Methods RCT
January 2003 to November 2007.
15 ultrasound clinical centres
Participants Participants (N = 302)
“Healthy multiparous women carrying a singleton gestation who enrolled for prenatal
care were screened to identify those with at least 1 prior spontaneous preterm birth
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Owen 2009 (Continued)
between 17 + 0 and 33 + 6 weeks’ gestation.”
Inclusion criteria
• “Eligible women consented to serial TV US examinations to measure their
cervical length.”
• “If on any evaluation the cervical length was less than 25 mm, the woman became
eligible for randomisation.”
Exclusion criteria
• “fetal anomaly, planned history indicated cerclage for a clinical diagnosis of
cervical insufficiency, and clinically significant maternal-fetal complications (e.g. fetal
red cell iso-immunisation, treated chronic hypertension, insulin-dependent diabetes)
that would increase the risk of an indicated preterm birth and potentially confound the
primary study outcome.”
• Uterine anomalies
Interventions Cerclage versus “Women in the no-cerclage group could receive a physical examination
indicated cerclage for acute cervical insufficiency diagnosed on clinical examination”
Outcomes Primary
• “birth at < 35 weeks’ project gestational age.”
Secondary
• Rates of birth less than 7 days from randomisation.
• Perinatal death defined as either a stillbirth or a postnatal death prior to hospital
discharge.
• Preterm birth before 37 weeks
Notes Additional information and data provided by the first author
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk “Centralized random assignment.”
“Randomization in predetermined blocks
was stratified by each centre and qualifying
cervical length less than 20 mm vs 20-24
mm.”
Stratified randomisation sequence was gen-
erated by SAS, permuted in blocks of size
2, 4, and 6. There was a 1:1 cerclage to no-
cerclage allocation ratio throughout. Early
in the study the intent to use progesterone
stratification was added
Allocation concealment (selection bias) Low risk Centralised randomisation - via the cer-
clage web site
Blinding of participants and personnel
(performance bias)
All outcomes
High risk “Because the cerclage intervention was not
masked, managing physicians might infer
that the cervical length was less than 25
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Owen 2009 (Continued)
mm, but they were otherwise masked to
the results of the sonographic evaluations
except in cases of complete placenta previa,
oligohydramnios, or fetal death.”
Impossible to blind
Blinding of outcome assessment (detection
bias)
All outcomes
High risk At delivery, randomisation assignment may
or may not have been known. There was
no attempt to blind at delivery
Incomplete outcome data (attrition bias)
All outcomes
Low risk • 1 participant lost to follow-up from
cerclage group after randomisation.
• 30/1044 exclusions - 16 ineligible on
further review and 14 withdrew from trial.
• 673/1014 cervical length ≥ 25 mm
(23 exclusions: 16 lost or unable to
contact; 4 withdrew from trial; 3 became
ineligible).
• 318/1014 cervical length < 25 mm
(16 exclusions: 13 declined
randomisation; 2 ineligible at
randomisation visit; 1 withdrew from
trial).
• 302 randomised.
• 149 cerclage group: 138/149
received assigned treatment (3 cerclage
contraindication; 8 declined to undergo
surgery; 1 emergent cerclage revision).
• 153 no cerclage group: 139/153
received no cerclage (10 received emergent
cerclage; 4 received off-protocol cerclage).
• 673/1014 cervical length ≥ 25 mm
(23 exclusions: 16 lost or unable to
contact; 4 withdrew from trial; 3 became
ineligible).
• 318/1014 cervical length < 25 mm
(16 exclusions: 13 declined
randomisation; 2 ineligible at
randomisation visit; 1 withdrew from
trial).
• 302 randomised.
• 149 cerclage group: 138/149
received assigned treatment (3 cerclage
contraindication; 8 declined to undergo
surgery; 1 emergent cerclage revision).
• 153 no cerclage group: 139/153
received no cerclage (10 received emergent
cerclage; 4 received off-protocol cerclage).
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Owen 2009 (Continued)
• 149 cerclage group: 138/149
received assigned treatment (3 cerclage
contraindication; 8 declined to undergo
surgery; 1 emergent cerclage revision).
• 153 no cerclage group: 139/153
received no cerclage (10 received emergent
cerclage; 4 received off-protocol cerclage).
Analysis was intention-to-treat
Selective reporting (reporting bias) Low risk Study protocol not available, but Cochrane
data extraction sheet completed by the au-
thors, so any selective reporting unlikely
Other bias Low risk Study was not stopped early.
Baseline imbalance: 691 participants de-
clined participation; 1044 met initial crite-
ria and consented
Rush 1984
Methods RCT.
20 January 1979 to 19 April 1982.
Reproductive failure clinic at the Groote Schuur Maternity Centre, Peninsula Maternity
and Neonatal Service, Capetown, South Africa
Women entered the study at 15 to 21 weeks’ gestation.
Participants Participants (N = 194): high-risk women for PTL or late abortion
Inclusion criteria:
1. 2, 3 or 4 previous pregnancies which has ended spontaneously before 37
completed weeks’ gestation; and
2. at least 1 previous pregnancy which ended spontaneously between 14 and 36
completed weeks’ gestation.
Exclusion criteria: age > 35 years; smoking > 5 cigarettes/day; medical disorders (car-
diac disease, hypertension, diabetes, thyroid disease); obstetric/gynaecological conditions
(recurrent 1st trimester abortions, multiple gestation in present pregnancy, congenital
uterine abnormality, uterine fibromyomata, previous cervical surgery - cone biopsy, tra-
chelorrhaphy, cervical cerclage); cervix < 2.0 cm long or dilated at entry
Interventions Cervical suture versus no suture
Outcomes Not stated
Notes Additional information and the data base for cross-checking of the published results
provided by the first author
Risk of bias
Bias Authors’ judgement Support for judgement
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Rush 1984 (Continued)
Random sequence generation (selection
bias)
Unclear risk “…patientswere allocated at randomeither
to have a cervical suture (96 patients) or to
be managed without a suture (98 patients)
by reference to a series of sealed envelopes.
”
Allocation concealment (selection bias) Unclear risk “…reference to a series of sealed envelopes.
”
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Impossible to blind to participants and per-
sonnel
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Not stated if outcome assessors were
blinded
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Loss of participants not
stated.
Exclusion of participants after randomisa-
tion not stated.
Intention-to-treat analysis: “All but two of
194 women entered into the trial received
the management to which they were allo-
cated.”
Selective reporting (reporting bias) Low risk Study protocol not
available. The full database was provided
by the authors, so any selective reporting
unlikely
Other bias Low risk Study was not stopped early.
Baseline imbalance: “Although the fre-
quency of two or more previous second
trimester abortions or preterm deliveries
was somewhat greater in women allocated
to cerclage, this difference was not statisti-
cally significant.”
Rust 2000
Methods RCT.
May 1998 to August 2000.
Lehigh Valley Hospital Outpatient Perinatal Testing Center. USA
Participants Participants (N=61): “Any patients between the gestational ages of 16 and24weekswith
transvaginal ultrasound demonstration of (1) dilatation of the internal os, (2) prolapse
of the membranes into the endocervical canal but not beyond the external os, (3) a
shortened distal cervical length, and (4) exacerbation of these 3 findings associated with
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Rust 2000 (Continued)
transfundal pressure was considered a candidate for enrolment”
Inclusion criteria: “Inclusion criteria consisted of demonstrable dilatation of the internal
os and either prolapse of membranes at least 25% of the total cervical length or a distal
cervical length of < 2.5 cm”. “Those patients, whomet the inclusion criteria and provided
informed consent, underwent an amniocentesis to rule out infection.”
“A rescue arm of the study was designed for each group. Any patient at < 24 weeks.
gestationwhohadprolapsedmembranes beyond the level of the cerclage or to the external
os (without cerclage) was offered a revision, or rescue cerclage procedure”
Exclusion criteria: “Exclusion criteria included membrane prolapse beyond the external
os, any fetal lethal congenital or chromosomal anomaly, clinical evidence of abruption
placenta, unexplained vaginal bleeding, chorioamnionitis (diagnosed by clinical or am-
niocentesis criteria and confirmed by histopathologic features), persistent uterine activity
accompanied by cervical change (consistent with the diagnose of preterm labour), or any
other contraindication for a cerclage procedure.”
Interventions McDonald cerclage (N = 31) versus no cerclage (N = 30)
All prospective participants had indomethacin and clindamycin before randomisation.
Women in the cerclage group had indomethacin and clindamycin for 24 h after the
cerclage procedure, while women in the no cerclage group had indomethacin and clin-
damycin stopped at 24 h after randomisation
Women were send home after 24 h and monitored weekly by ultrasound
Outcomes Perinatal death, neonatal morbidity according to 4 categories: none (routine neonatal
care), minimal (intensive care admission with no mechanical ventilation or serious mor-
bidity), serious (mechanical ventilation, respiratory distress syndrome, necrotizing ente-
rocolitis, intraventricular haemorrhage, sepsis, or other life-threatening morbidity), and
perinatal death (stillborn fetus or death during the first 28 days after birth)
Notes Additional information and the data base for cross-checking of the published results
provided by the first author
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk “If the patients continued to meet inclu-
sion criteria, they were randomly assigned
to receive a McDonald cerclage under re-
gional anaesthesia or not cerclage therapy.
”
Allocation concealment (selection bias) Unclear risk Not stated
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Impossible to blind to participants and per-
sonnel
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Rust 2000 (Continued)
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Not stated if the outcome assessors were
blinded
Incomplete outcome data (attrition bias)
All outcomes
Low risk Loss of participants:
• 135 patients met the inclusion
criteria;
• 20/135 declined randomisation.
Exclusion of participants after randomisa-
tion:
• 2/135 were excluded because of
chorioamnionitis that was diagnosed by
amniocentesis.
Intention-to-treat analysis: “A rescue arm
of the study was designed for each group.
Any patient at < 24 weeks’ gestation who
had prolapsedmembranes beyond the level
of the cerclage or to the external os (without
cerclage) was offered a revision or rescue
cerclage procedure. Data were analysed on
the basis of intention to treat”
Selective reporting (reporting bias) Low risk Study protocol not available. The full
database was provided by the authors, so
any selective reporting unlikely
Other bias Low risk Study was not stopped early.
No apparent baseline imbalance
Simcox 2009
Methods RCT.
November 2003 to March 2006.
9 UK hospitals
Participants Participants (N = 248): pregnant women < 24 weeks of gestation
Inclusion criteria: singleton pregnancy with at least 1 previous spontaneous delivery
between 16 + 0 and 34 + 0 weeks
Exclusion criteria: unable to give informed consent
Interventions Cerclage based on history
“For those women allocated to the history-indicated arm of the trial, a history-indicated
suture was offered if the treating clinicians considered that the obstetric history justified
a cerclage. There were no prescribed minimum criteria for history-indicated suture in-
sertion. The decision to insert a cerclage or not, based on history, was made in every case
before randomisation by the attending clinician, and then carried out if the patient was
randomised to history arm”
versus
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Simcox 2009 (Continued)
Cerclage based on serial US scanning
“Women allocated to the scanning arm of the trial underwent cervical length assessment
by transvaginal US every 2 weeks from entry into the trial until 24 + 0 weeks of gestation.
If the cervix shortened to ≤ 20 mm, a cervical cerclage was inserted.”
Outcomes Primary: PTD before 34 weeks.
Secondary: frequency of suture insertion, incidence of histological chorioamnionitis,
incidence of maternal pyrexia, hospital admissions, bed rest, use of steroids, tocolysis
and progesterone
Neonatal outcomes: need for oxygen therapy at 28 days and US evidence of brain
abnormality
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk “The randomisation sequence was com-
puter generated in balanced block multi-
ples. Stratification was performed to con-
trol for gestation of last delivery before 24
weeks.”
Allocation concealment (selection bias) Low risk “Allocation was made by telephone to the
central trials office in London, UK.”
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Impossible to blind to participants and per-
sonnel
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Not stated if the outcome assessors were
blinded
Incomplete outcome data (attrition bias)
All outcomes
Low risk Loss of participants to follow-up: “primary
outcome data were available on 247/248
women (99.6%)”.
Exclusion of participants after randomisa-
tion: 5 women were excluded
“three were subsequently identified as not
fitting eligibility criteria and a further two
were excluded from analysis as they elected
to terminate the pregnancy after a diagnosis
of fetal anomaly”
Intention-to-treat analysis: “There were 9
patients who did not receive the randomi-
sation intervention. Eight women in the
history arm were scanned” “All analysis was
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Simcox 2009 (Continued)
conducted according to the original alloca-
tion, following the intention to treat prin-
ciple.”
Selective reporting (reporting bias) Unclear risk Study protocol not available. All outcomes
prespecified in the article were reported
Other bias Low risk Study was not stopped early
Baseline imbalance: “One women in each
arm declined a suture.”
To 2004
Methods RCT - block randomisation.
January 1998 to May 2002.
“Women with singleton pregnancies undergoing routine antenatal care in 12 hospitals
in UK, Brazil, South Africa, Slovenia, Greece and Chile.”
Participants N = 253
“Women with singleton pregnancies”, “women attending for the 22-24 week scan were
offered a transvaginal scan to measure cervical length, as a screening test for spontaneous
preterm delivery.”
Inclusion criteria: “women with a cervical length of 15 mm or less were invited to
participate in the randomised study of cervical cerclage”
Exclusion criteria: “women with major fetal abnormalities, painful regular uterine con-
tractions, or history of ruptured membranes and cervical cerclage in situ were excluded
from screening, and women with dilatated cervix during screening were excluded from
the randomised study.”
Interventions Shirodkar cerclage (N = 127) versus no cerclage (N = 126).
Outcomes Primary: delivery before 33 completed weeks (231 days) of gestation.
Secondary: centile-adjusted birthweight, stillbirth, and neonatal death or major adverse
outcome before discharge from hospital (bronchopulmonary dysplasia, intraventricular
or periventricular haemorrhage grade 3 or 4, retinopathy of prematurity, or positive fetal
blood culture), maternal morbidity during antenatal hospital stay (fever of 38°C or more
on 2 occasions), or symptomatic vaginal discharge.“
Notes Additional information and the data base for cross-checking of the published results
provided by the first author
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk “the randomisation sequencewas computer
generated for individual centres in balanced
block multiples of ten. These codes were
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To 2004 (Continued)
held at a central trials office in London,
UK.”
Allocation concealment (selection bias) Low risk “…allocation was made by telephone.”
Blinding of participants and personnel
(performance bias)
All outcomes
High risk “Because of the invasive nature of the cer-
vical cerclage, masking of treatment alloca-
tion to participants and investigators was
not practical in this study.”
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Not stated if the outcome assessors were
blinded
Incomplete outcome data (attrition bias)
All outcomes
Low risk Loss of participants to follow-up: 1
neonate lost to follow-up in cerclage
group.
Exclusion of participants after randomisa-
tion: 2 in cerclage group ruptured themem-
branes
Intention-to-treat analysis: 4/127 in cer-
clage group did not have cerclage; 2/126 in
no cerclage group had cerclage
Selective reporting (reporting bias) Low risk Study protocol available, but primary out-
come only specified. The full database was
provided by the authors, so any selective re-
porting unlikely
Other bias Low risk Baseline imbalance: 470 eligible patients,
217 (54%) declined participation. Women
who declined participation did not differ
from the study group in their main demo-
graphic characteristics and preterm deliv-
ery rate (data not shown)
CS: caesarean section
GA: gestational age
h: hour
NEC: necrotising enterocolitis
NICU: neonatal intensive care unit
PROM: premature rupture of membranes
PPROM: preterm premature rupture of membranes
PTB: preterm birth
PTD: preterm delivery
PTL: preterm labour
RCT: randomised controlled trial
TA: transabdominal
52Cervical stitch (cerclage) for preventing preterm birth in singleton pregnancy (Review)
Copyright © 2017 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
TVU: transvaginal ultrasound
US: ultrasound
Characteristics of excluded studies [ordered by study ID]
Study Reason for exclusion
Blair 2002 Outpatient cerclage versus inpatient cerclage
Broumand 2011 Double cerclage versus traditional cerclage
Caspi 1990 Cervical internal os cerclage versus Shirodkar cerclage
Dor 1982 Twin pregnancies
Hui 2013 This trial compared use of Arabin pessary with no treatment for pregnant women with short cervix < 25 mm at
20 to 24 weeks’ gestation
Ismail 2014 This protocol described a trial to compare suture types for cervical cerclage
Israfil-Bayli 2014 This was a feasibility RCT to compare 2 types of suture materials for cervical cerclage
Kassanos 2001 Likely to be quasi-randomised study:
“the patients were randomised to be treated either by elective cerclage or by weekly serial vaginal US (every second
patient) with the possibility of an emergency cerclage and were divided into 2 groups.”
Nicolaides 2001 Twin pregnancies
Rust 2001 Multiple gestation
Secher 2007 Protocol for a randomised study comparing double cerclage compared with a single cerclage
Tsai 2009 Double cervical cerclage versus traditional single cervical cerclage
Varma 1986 We have been unable to find any published report to suggest that this proposed study of cerclage was ever carried
out. Therefore, we have moved this report from awaiting assessment to excluded studies
Von Forster 1986 Quasi-randomised study: “patients were divided into 3 groups on the basis of initial letter of their surname.”
Zakhera 2015 The inclusion criteria for this trial was recurrent bleeding in early pregnancy. Women did not have short cervix
on US or physical exam or previous history of preterm birth
Zolghadri 2014 This report describes and RCT to compare McDonald cerclage vs a double cerclage method
Üçyi it 2013 RCT, Compared low vaginal, high vaginal and abdominal cerclage
RCT: randomised controlled trial
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Characteristics of studies awaiting assessment [ordered by study ID]
Ragab 2015
Methods • Prospective randomised trial.
• Mansoura University Hospitals, Egypt.
• June 2013 to October 2014
Participants • Inclusion criteria: singleton pregnancy (24 to 28 weeks’ gestation) with regular labour pains, cervical dilation <
5 cm, effacement < 50%, intact membranes bulging inside cervical canal but not outside the external os.
• Exclusoin criteria: preterm premature rupture of membranes, intact membranes bulging outside the external
os, multiple pregnancy, infection (as known by pyrexia, discharge, positive swab or high white cell count),
antepartum haemorrhage, placenta previa. Women < 24 weeks’ gestation were also excluded due to poor postnatal
infant survival and unfeasibility of intensive care in trial setting
Interventions Cerclage + progesterone versus progesterone alone (N = 100)
• Intervention: Group A: emergency cervical cerclage stitch McDonald procedure. Natural progesterone 100
mg/2 mL intramuscular injection daily dose for 48 h maintenance by single vaginal pessary 200 mg daily to
delivery or 37 weeks. Women were observed for 48 h after cerclage placement in the emergency department and
then kept inpatient for the remainder of pregnancy. Total number randomised: 50.
• Control/comparison intervention: progesterone as per protocol above. Women were kept inpatient for the
duration of the pregnancy. Total number randomised: 50.
• All randomised women in both arms had prophylactic antibiotics 1 g amoxicillin in admission followed by
500 mg/8 h for 48 h and single course dexamethasone 12 mg/12 h intramuscular in 2 doses (the preferred
betamethasone was unavailable). All women were inpatients in hospital from treatment to delivery
Outcomes Primary outcome: duration of prolongation of pregnancy, live birth, neonatal morbidity and mortality
Notes Authors contacted to clarify preterm birth outcome data (reported only in the discussion of the paper) and the high
number of neonatal deaths in published report (emailed May 2016). We are still awaiting the response - it should be
noted that these data, as published, significantly change the result of meta-analysis for the outcome of neonatal death
h: hour
Characteristics of ongoing studies [ordered by study ID]
Hezelgrave 2015
Trial name or title SuPPoRT: Stitch, Progesterone or Pessary: a randomised controlled trial
The prevention of pre-term birth in women who develop a short cervix. Amulti-centre randomised controlled
trial to compare 3 treatments; cervical cerclage, cervical pessary and vaginal progesterone
Methods 3-arm randomised controlled trial.
Main objective of the trial: for asymptomatic women at risk of preterm birth who develop a short cervix on
transvaginal ultrasound scan, which is the optimal preventative strategy; cervical cerclage, arabin pessary or
vaginal progesterone?
Secondary objectives of the trial: does the success of the intervention depend on early pregnancy biomarker
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expression?
Participants Planned number of subjects: 540
Principal inclusion criteria: women with singleton pregnancies who are found to have cervical length < 25
mm on transvaginal ultrasound between 14 + 0 weeks’ gestation (dated by ultrasound or LMP and adjusted for
ultrasound estimated date of delivery once ultrasound performed if no miscarriage prior to dating ultrasound)
until 23 + 6 weeks’ gestation and 1 or more of the following risk factors
• Written informed consent to participate
• History of previous preterm premature rupture of the fetal membranes (≤ 37 weeks’)
• History of previous PTB/second trimester loss (≥ 16 weeks’ or ≤ 37 weeks’ gestation).
• Any cervical procedure to treat abnormal smears, i.e. large loop excision, laser conisation, cold knife
conisation or radical diathermy.
• Incidental finding of a short cervix on ultrasound scan (e.g. at the time of anomaly scan).
Principal exclusion criteria:
• Women with persistent fresh vaginal bleeding evident on speculum examination.
• Women with visible membranes evident on speculum examination or open cervix on ultrasound scan.
• Women with severe abdominal pain/evidence of sepsis (as judged by attending clinician).
• Known significant congenital or structural or chromosomal fetal abnormality.
• Suspected or proven rupture of the fetal membranes at the time of recruitment.
• Women currently using progesterone pessaries or who have taken progesterone beyond 18 weeks’
gestation.
• Women who have a cervical suture in situ.
• Women who already have a cervical pessary in situ.
• Insufficiuent understanding of the trial in the opinion of the Investigator.
Any contra-indications or cautions to the investigational medicinal product including:
• known allergy or hypersensitivity to progesterone.
• hepatic dysfunction;
• undiagnosed vaginal bleeding;
• mammary or genital tract carcinoma;
• thrombophlebitis;
• thromboembolic disorders;
• cerebral haemorrhage; and
• porphyria.
Interventions Cervical cerclage versus progesterone (Cyclogest 200 mg) versus arabin pessary
Outcomes Primary end point: delivery < 37 completed weeks’ gestation (powered).
Timepoint of evaluation of this end point: date of delivery.
Secondary end point(s):
1. Adverse perinatal outcome, defined as a composite outcome of death (antepartum/intrapartum
stillbirths plus neonatal deaths prior to discharge from neonatal services) or 1 (or more) of intraventricular
haemorrhage, periventricular leukomalacia, hypoxic ischaemic encephalopathy, necrotising enterocolitis,
bronchopulmonary dysplasia and sepsis.
2. Delivery < 30 and 34 completed weeks’ gestation.
3. Gestation at delivery.
4. Time between intervention and delivery.
5. Requirement for rescue cerclage (bulging fetal membranes).
6. Other maternal and fetal outcomes: clinical course, therapies administered, maternal and fetal
morbidity and mortality data.
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7. Participant and clinician’s perceptions of treatment: questionnaires with a selection of participants at 0
to 2 weeks post procedure. Questionnaires at 1 year are planned if funding is obtained participant and
clinician adherence to protocol.
• Health costs at 28 days postnatal.
• Biochemical end-points (if performed): endocervical swabs will be taken to determine the presence of
cervico-vaginal infection and concentrations of biomarkers of preterm birth, infection and inflammation.
Saliva samples will be collected for salivary hormone levels, and blood samples taken for inflammatory
markers and genetic analysis. Results will be correlated with maternal and fetal outcomes.
Starting date Ethical approval May 2015
Contact information Dr Natahsa Hezelgrave, natasha.hezelgrave@gstt.nhs.uk
Notes EudraCT Number: 2015-000456-15
Funding: NIHR (UK), Tommy’s Charity, Guys and St Thomas’ NHS Foundation Trust
Koulalli 2014
Trial name or title PC-study.
Pessary or Cerclage to Prevent Preterm birth in women with short cervical length and a history preterm birth
Methods Parallel randomised controlled trial
Participants Target number of participants: 440
Inclusion criteria:
1. singleton pregnancy
2. previous preterm birth < 34 weeks of gestation
3. cervical length < 25 mm or multiple preterm births.
Exclusion criteria:
1. maternal age < 18 years
2. inability to give informed consent
3. placenta praevia
4. vasa praevia
5. preterm premature rupture of the membranes
6. uterine anomalies
7. cervical dilatation (the cut off is unclear in the published report)
8. cervical length < 5 mm
9. identified major congenital abnormalities
10. women with clinical signs of chorioamnionitis or signs of intra uterine infection
11. women whose child has signs of fetal distress defined as abnormal cardiotocograph or abnormal
biophysical profile
Interventions Pessary versus cervical cerclage
Outcomes Primary outcome: preterm birth < 32 weeks’ gestation.
Secondary outcomes: preterm rate birth before 24, 28, 34 and 37 weeks, time from intervention to delivery,
(early) premature rupture of membranes, maternal infection, maternal side effects and composite bad neonatal
outcome including both morbidity and mortality rate of children as well as costs
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Starting date 2014. End date 2018
Contact information Dr B Koullali, pc@studies-obsgyn.nl and Dr E Pajkrt, d.pajkrt@amc.uva.nl
Notes NTR4415
Sponsor: Academic Medical Center, Amsterdam
Funding: ZON-MW, The Netherlands Organization for Health Research and Development
57Cervical stitch (cerclage) for preventing preterm birth in singleton pregnancy (Review)
Copyright © 2017 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
D A T A A N D A N A L Y S E S
Comparison 1. Cerclage versus no cerclage
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 All perinatal losses 10 2927 Risk Ratio (M-H, Fixed, 95% CI) 0.82 [0.65, 1.04]
1.1 History-indicated cerclage
vs no cerclage
4 2045 Risk Ratio (M-H, Fixed, 95% CI) 0.82 [0.60, 1.12]
1.2 One-off
ultrasound-indicated cerclage
in high risk for PTL vs no
cerclage
1 56 Risk Ratio (M-H, Fixed, 95% CI) 0.77 [0.14, 4.25]
1.3 Serial ultrasound-indicated
cerclage in high risk for PTL vs
no cerclage
4 509 Risk Ratio (M-H, Fixed, 95% CI) 0.66 [0.41, 1.06]
1.4 Physical exam indicated
cerclage vs no cerclage
1 30 Risk Ratio (M-H, Fixed, 95% CI) 1.97 [0.77, 5.01]
1.5 One-off
ultrasound-indicated cerclage
in low/unspecified risk for PTL
vs no cerclage
3 287 Risk Ratio (M-H, Fixed, 95% CI) 1.01 [0.46, 2.22]
2 Serious neonatal morbidity 6 883 Risk Ratio (M-H, Random, 95% CI) 0.84 [0.57, 1.25]
2.1 History-indicated cerclage
vs no cerclage
0 0 Risk Ratio (M-H, Random, 95% CI) 0.0 [0.0, 0.0]
2.2 One-off
ultrasound-indicated cerclage
in high risk for PTL vs no
cerclage
1 56 Risk Ratio (M-H, Random, 95% CI) 0.77 [0.14, 4.25]
2.3 Serial ultrasound-indicated
cerclage in high risk for PTL vs
no cerclage
4 510 Risk Ratio (M-H, Random, 95% CI) 0.77 [0.48, 1.25]
2.4 Physical exam-indicated
cerclage in high risk for PTL vs
no cerclage
1 30 Risk Ratio (M-H, Random, 95% CI) 0.22 [0.03, 1.73]
2.5 One-off
ultrasound-indicated cerclage
in low/unspecified risk for PTL
vs no cerclage
3 287 Risk Ratio (M-H, Random, 95% CI) 1.38 [0.60, 3.17]
3 Baby discharged home healthy 4 657 Risk Ratio (M-H, Fixed, 95% CI) 1.02 [0.97, 1.06]
3.1 History-indicated cerclage
vs no cerclage
1 183 Risk Ratio (M-H, Fixed, 95% CI) 1.00 [0.93, 1.07]
3.2 One-off ultrasound-
indicated cerclage in high risk
for PTL vs no cerclage
0 0 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
3.3 Serial ultrasound-indicated
cerclage in high risk for PTL vs
no cerclage
2 238 Risk Ratio (M-H, Fixed, 95% CI) 1.04 [0.94, 1.14]
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3.4 Physical exam-indicated
cerclage in high risk for PTL vs
no cerclage
0 0 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
3.5 One-off
ultrasound-indicated cerclage
in low/unspecified risk for PTL
vs no cerclage
1 236 Risk Ratio (M-H, Fixed, 95% CI) 1.01 [0.95, 1.08]
4 Stillbirths 5 1803 Risk Ratio (M-H, Fixed, 95% CI) 0.89 [0.45, 1.75]
4.1 History-indicated cerclage
vs no cerclage
2 1458 Risk Ratio (M-H, Fixed, 95% CI) 1.00 [0.45, 2.20]
4.2 One-off
ultrasound-indicated cerclage
in high risk for PTL vs no
cerclage
1 56 Risk Ratio (M-H, Fixed, 95% CI) 0.23 [0.01, 4.58]
4.3 Serial ultrasound-indicated
cerclage in high risk for PTL vs
no cerclage
2 82 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
4.4 Physical exam-indicated
cerclage in high risk for PTL vs
no cerclage
0 0 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
4.5 One-off
ultrasound-indicated cerclage
in low/unspecified risk for PTL
vs no cerclage
2 207 Risk Ratio (M-H, Fixed, 95% CI) 0.95 [0.20, 4.59]
5 Neonatal deaths before discharge 6 1714 Risk Ratio (M-H, Fixed, 95% CI) 0.85 [0.53, 1.39]
5.1 History-indicated cerclage
vs no cerclage
2 1350 Risk Ratio (M-H, Fixed, 95% CI) 0.61 [0.29, 1.27]
5.2 One-off
ultrasound-indicated cerclage
in high risk for PTL vs no
cerclage
1 54 Risk Ratio (M-H, Fixed, 95% CI) 2.15 [0.21, 22.37]
5.3 Serial ultrasound-indicated
cerclage in high risk for PTL vs
no cerclage
2 73 Risk Ratio (M-H, Fixed, 95% CI) 0.79 [0.12, 5.26]
5.4 Physical exam-indicated
cerclage in high risk for PTL vs
no cerclage
1 30 Risk Ratio (M-H, Fixed, 95% CI) 1.97 [0.77, 5.01]
5.5 One-off
ultrasound-indicated cerclage
in low/unspecified risk for PTL
vs no cerclage
2 207 Risk Ratio (M-H, Fixed, 95% CI) 0.63 [0.18, 2.18]
6 Miscarriages 7 2091 Risk Ratio (M-H, Fixed, 95% CI) 0.84 [0.58, 1.22]
6.1 History-indicated cerclage
vs no cerclage
3 1539 Risk Ratio (M-H, Fixed, 95% CI) 0.86 [0.57, 1.30]
6.2 One-off
ultrasound-indicated cerclage
in high risk for PTL vs no
cerclage
1 56 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
6.3 Serial ultrasound-indicated
cerclage in high risk for PTL vs
no cerclage
3 209 Risk Ratio (M-H, Fixed, 95% CI) 0.65 [0.25, 1.66]
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6.4 Physical exam-indicated
cerclage in high risk for PTL vs
no cerclage
0 0 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
6.5 One-off
ultrasound-indicated cerclage
in low/unspecified risk for PTL
vs no cerclage
3 287 Risk Ratio (M-H, Fixed, 95% CI) 1.72 [0.16, 18.22]
7 Preterm birth before 37
completed weeks
9 2898 Risk Ratio (M-H, Random, 95% CI) 0.80 [0.69, 0.95]
7.1 History-indicated cerclage
vs no cerclage
4 2045 Risk Ratio (M-H, Random, 95% CI) 0.86 [0.59, 1.27]
7.2 One-off
ultrasound-indicated cerclage
in high risk for PTL vs no
cerclage
1 56 Risk Ratio (M-H, Random, 95% CI) 0.55 [0.30, 0.99]
7.3 Serial ultrasound-indicated
cerclage in high risk for PTL vs
no cerclage
4 510 Risk Ratio (M-H, Random, 95% CI) 0.78 [0.60, 1.02]
7.4 Physical exam-indicated
cerclage in high risk for PTL vs
no cerclage
0 0 Risk Ratio (M-H, Random, 95% CI) 0.0 [0.0, 0.0]
7.5 One-off
ultrasound-indicated cerclage
in low/unspecified risk for PTL
vs no cerclage
3 287 Risk Ratio (M-H, Random, 95% CI) 0.80 [0.55, 1.16]
8 Preterm birth before 34
completed weeks
9 2415 Risk Ratio (M-H, Random, 95% CI) 0.77 [0.66, 0.89]
8.1 History-indicated cerclage
vs no cerclage
3 1539 Risk Ratio (M-H, Random, 95% CI) 0.76 [0.40, 1.46]
8.2 One-off
ultrasound-indicated cerclage
in high risk for PTL vs no
cerclage
1 56 Risk Ratio (M-H, Random, 95% CI) 0.63 [0.27, 1.46]
8.3 Serial ultrasound-indicated
cerclage in high risk for PTL vs
no cerclage
4 510 Risk Ratio (M-H, Random, 95% CI) 0.77 [0.55, 1.10]
8.4 Physical exam-indicated
cerclage in high risk for PTL vs
no cerclage
1 23 Risk Ratio (M-H, Random, 95% CI) 0.56 [0.34, 0.93]
8.5 One-off
ultrasound-indicated cerclage
in low/unspecified risk for PTL
vs no cerclage
3 287 Risk Ratio (M-H, Random, 95% CI) 0.82 [0.55, 1.22]
9 Preterm birth before 28
completed weeks
8 2392 Risk Ratio (M-H, Fixed, 95% CI) 0.80 [0.64, 1.00]
9.1 History-indicated cerclage
vs no cerclage
3 1539 Risk Ratio (M-H, Fixed, 95% CI) 0.82 [0.59, 1.13]
9.2 One-off
ultrasound-indicated cerclage
in high risk for PTL vs no
cerclage
1 56 Risk Ratio (M-H, Fixed, 95% CI) 0.69 [0.18, 2.62]
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9.3 Serial ultrasound-indicated
cerclage in high risk for PTL vs
no cerclage
4 510 Risk Ratio (M-H, Fixed, 95% CI) 0.71 [0.48, 1.04]
9.4 Physical exam-indicated
cerclage in high risk for PTL vs
no cerclage
0 0 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
9.5 One-off
ultrasound-indicated cerclage
in low/unspecified risk for PTL
vs no cerclage
3 287 Risk Ratio (M-H, Fixed, 95% CI) 1.01 [0.55, 1.83]
10 Serious intracranial pathology
(IVH or periventricular
leukomalacia)
5 839 Risk Ratio (M-H, Random, 95% CI) 0.83 [0.23, 3.09]
10.1 History-indicated
cerclage vs no cerclage
1 194 Risk Ratio (M-H, Random, 95% CI) 1.02 [0.06, 16.09]
10.2 One-off
ultrasound-indicated cerclage
in high risk for PTL vs no
cerclage
1 56 Risk Ratio (M-H, Random, 95% CI) 0.38 [0.02, 9.01]
10.3 Serial
ultrasound-indicated cerclage
in high risk for PTL vs no
cerclage
3 382 Risk Ratio (M-H, Random, 95% CI) 0.96 [0.05, 19.53]
10.4 Physical exam-indicated
cerclage in high risk for PTL vs
no cerclage
0 0 Risk Ratio (M-H, Random, 95% CI) 0.0 [0.0, 0.0]
10.5 One-off
ultrasound-indicated cerclage
in low/unspecified risk for PTL
vs no cerclage
2 207 Risk Ratio (M-H, Random, 95% CI) 0.95 [0.06, 14.98]
11 Serious respiratory morbidity
(RDS or oxygen dependency
after 28 days of life)
5 839 Risk Ratio (M-H, Fixed, 95% CI) 1.11 [0.66, 1.88]
11.1 History-indicated
cerclage vs no cerclage
1 194 Risk Ratio (M-H, Fixed, 95% CI) 3.06 [0.32, 28.93]
11.2 One-off
ultrasound-indicated cerclage
in high risk for PTL vs no
cerclage
1 56 Risk Ratio (M-H, Fixed, 95% CI) 0.58 [0.06, 6.00]
11.3 Serial
ultrasound-indicated cerclage
in high risk for PTL vs no
cerclage
3 382 Risk Ratio (M-H, Fixed, 95% CI) 0.98 [0.53, 1.81]
11.4 Physical exam-indicated
cerclage in high risk for PTL vs
no cerclage
0 0 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
11.5 One-off
ultrasound-indicated cerclage
in low/unspecified risk for PTL
vs no cerclage
2 207 Risk Ratio (M-H, Fixed, 95% CI) 1.63 [0.39, 6.86]
12 Necrotising enterocolitis 3 372 Risk Ratio (M-H, Fixed, 95% CI) 0.81 [0.16, 4.12]
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12.1 History-indicated
cerclage vs no cerclage
0 0 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
12.2 One-off ultrasound-
indicated cerclage in high risk
for PTL vs no cerclage
0 0 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
12.3 Serial
ultrasound-indicated cerclage
in high risk for PTL vs no
cerclage
3 362 Risk Ratio (M-H, Fixed, 95% CI) 0.81 [0.16, 4.12]
12.4 Physical exam-indicated
cerclage in high risk for PTL vs
no cerclage
0 0 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
12.5 One-off
ultrasound-indicated cerclage
in low/unspecified risk for PTL
vs no cerclage
1 10 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
13 Retinopathy of prematurity 2 553 Risk Ratio (M-H, Fixed, 95% CI) 0.46 [0.14, 1.48]
13.1 History-indicated
cerclage vs no cerclage
0 0 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
13.2 One-off
ultrasound-indicated cerclage
in high risk for PTL vs no
cerclage
1 56 Risk Ratio (M-H, Fixed, 95% CI) 0.23 [0.01, 4.58]
13.3 Serial
ultrasound-indicated cerclage
in high risk for PTL vs no
cerclage
1 300 Risk Ratio (M-H, Fixed, 95% CI) 0.62 [0.15, 2.53]
13.4 Physical exam-indicated
cerclage in high risk for PTL vs
no cerclage
0 0 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
13.5 One-off
ultrasound-indicated cerclage
in low/unspecified risk for PTL
vs no cerclage
1 197 Risk Ratio (M-H, Fixed, 95% CI) 0.32 [0.01, 7.69]
14 Apgar < 7 at 5 minutes 1 301 Risk Ratio (M-H, Fixed, 95% CI) 0.68 [0.40, 1.15]
14.1 History-indicated
cerclage vs no cerclage
0 0 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
14.2 One-off ultrasound-
indicated cerclage in high risk
for PTL vs no cerclage
0 0 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
14.3 Serial
ultrasound-indicated cerclage
in high risk for PTL vs no
cerclage
1 301 Risk Ratio (M-H, Fixed, 95% CI) 0.68 [0.40, 1.15]
14.4 Physical exam-indicated
cerclage in high risk for PTL vs
no cerclage
0 0 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
14.5 One-off ultrasound-
indicated cerclage in low/
unspecified risk for PTL vs no
cerclage
0 0 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
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15 Caesarean section (elective and
emergency)
8 2817 Risk Ratio (M-H, Fixed, 95% CI) 1.19 [1.01, 1.40]
15.1 History-indicated
cerclage vs no cerclage
3 1964 Risk Ratio (M-H, Fixed, 95% CI) 1.21 [0.96, 1.52]
15.2 One-off
ultrasound-indicated cerclage
in high risk for PTL vs no
cerclage
1 56 Risk Ratio (M-H, Fixed, 95% CI) 1.35 [0.52, 3.50]
15.3 Serial
ultrasound-indicated cerclage
in high risk for PTL vs no
cerclage
4 510 Risk Ratio (M-H, Fixed, 95% CI) 1.10 [0.82, 1.46]
15.4 Physical exam-indicated
cerclage in high risk for PTL vs
no cerclage
0 0 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
15.5 One-off
ultrasound-indicated cerclage
in low/unspecified risk for PTL
vs no cerclage
3 287 Risk Ratio (M-H, Fixed, 95% CI) 1.31 [0.84, 2.04]
16 Maternal side effects (vaginal
discharge, bleeding, pyrexia not
requiring antibiotics)
3 953 Risk Ratio (M-H, Random, 95% CI) 2.25 [0.89, 5.69]
16.1 History-indicated
cerclage vs no cerclage
2 700 Risk Ratio (M-H, Random, 95% CI) 1.57 [0.76, 3.24]
16.2 One-off ultrasound-
indicated cerclage in high risk
for PTL vs no cerclage
0 0 Risk Ratio (M-H, Random, 95% CI) 0.0 [0.0, 0.0]
16.3 Serial ultrasound-
indicated cerclage in high risk
for PTL vs no cerclage
0 0 Risk Ratio (M-H, Random, 95% CI) 0.0 [0.0, 0.0]
16.4 Physical exam-indicated
cerclage in high risk for PTL vs
no cerclage
0 0 Risk Ratio (M-H, Random, 95% CI) 0.0 [0.0, 0.0]
16.5 One-off
ultrasound-indicated cerclage
in low/unspecified risk for PTL
vs no cerclage
1 253 Risk Ratio (M-H, Random, 95% CI) 5.95 [1.36, 26.06]
17 Pyrexia 3 1245 Risk Ratio (M-H, Fixed, 95% CI) 2.39 [1.35, 4.23]
17.1 History-indicated vs. no
cerclage
2 992 Risk Ratio (M-H, Fixed, 95% CI) 2.22 [1.22, 4.01]
17.2 One-off
ultrasound-indicated cerclage
in high risk for PTL vs no
cerclage
1 56 Risk Ratio (M-H, Fixed, 95% CI) 3.44 [0.15, 81.09]
17.3 One-off
ultrasound-indicated cerclage
in low/unspecified risk for PTL
vs no cerclage
1 197 Risk Ratio (M-H, Fixed, 95% CI) 6.66 [0.35, 127.20]
18 Any intravenous, oral or
combined tocolysis (not
prespecified)
2 217 Risk Ratio (M-H, Fixed, 95% CI) 1.28 [0.80, 2.05]
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18.1 History-indicated vs. no
cerclage
1 194 Risk Ratio (M-H, Fixed, 95% CI) 1.53 [0.66, 3.58]
18.2 Physical exam-indicated
cerclage in high risk for PTL
versus no cerclage
1 23 Risk Ratio (M-H, Fixed, 95% CI) 1.06 [0.72, 1.56]
19 PPROM (not prespecified) 6 2010 Risk Ratio (M-H, Random, 95% CI) 0.96 [0.62, 1.48]
19.1 History-indicated vs. no
cerclage
2 1458 Risk Ratio (M-H, Random, 95% CI) 1.63 [0.71, 3.70]
19.2 One-off
ultrasound-indicated cerclage
in high risk for PTL vs no
cerclage
1 56 Risk Ratio (M-H, Random, 95% CI) 0.49 [0.14, 1.72]
19.3 Serial
ultrasound-indicated cerclage
in high risk for PTL vs no
cerclage
3 209 Risk Ratio (M-H, Random, 95% CI) 0.51 [0.18, 1.45]
19.4 One-off
ultrasound-indicated cerclage
in low/unspecified risk for PTL
vs no cerclage
3 287 Risk Ratio (M-H, Random, 95% CI) 1.32 [0.78, 2.23]
20 Chorioamnionitis (not
prespecified)
3 1506 Risk Ratio (M-H, Random, 95% CI) 0.84 [0.26, 2.72]
20.1 History-indicated vs. no
cerclage
1 1264 Risk Ratio (M-H, Random, 95% CI) 2.97 [0.12, 72.81]
20.2 Serial
ultrasound-indicated cerclage
in high risk for PTL vs no
cerclage
2 162 Risk Ratio (M-H, Random, 95% CI) 0.41 [0.03, 6.21]
20.3 One-off
ultrasound-indicated cerclage
in low/unspecified risk for PTL
vs no cerclage
1 80 Risk Ratio (M-H, Random, 95% CI) 1.29 [0.39, 4.23]
Comparison 2. Cerclage versus vaginal progesterone
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 All perinatal losses 2 108 Risk Ratio (M-H, Fixed, 95% CI) 0.94 [0.36, 2.48]
2 Serious neonatal morbidity 2 120 Risk Ratio (M-H, Random, 95% CI) 0.49 [0.05, 4.52]
3 Baby discharged home healthy 2 119 Risk Ratio (M-H, Fixed, 95% CI) 0.97 [0.88, 1.07]
4 Stillbirths 2 128 Risk Ratio (M-H, Fixed, 95% CI) 2.7 [0.12, 62.17]
5 Neonatal deaths before discharge 2 120 Risk Ratio (M-H, Fixed, 95% CI) 2.18 [0.34, 13.86]
6 Miscarriages 2 128 Risk Ratio (M-H, Fixed, 95% CI) 0.58 [0.17, 2.01]
7 Preterm birth before 37
completed weeks
2 128 Risk Ratio (M-H, Fixed, 95% CI) 1.16 [0.64, 2.08]
8 Preterm birth before 34
completed weeks
2 128 Risk Ratio (M-H, Fixed, 95% CI) 1.01 [0.51, 2.01]
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9 Preterm birth before 28
completed weeks
2 128 Risk Ratio (M-H, Fixed, 95% CI) 0.92 [0.37, 2.27]
10 Serious intracranial pathology
(IVH or periventricular
leucomalacia)
2 128 Risk Ratio (M-H, Fixed, 95% CI) 0.96 [0.17, 5.28]
11 Serious respiratory morbidity
(RDS or oxygen dependency
after 28 days of life)
2 128 Risk Ratio (M-H, Random, 95% CI) 0.48 [0.04, 6.41]
12 Necrotising enterocolitis 1 92 Risk Ratio (M-H, Fixed, 95% CI) 3.0 [0.13, 71.78]
13 Retinopathy of prematurity 1 92 Risk Ratio (M-H, Fixed, 95% CI) 1.0 [0.06, 15.51]
14 Apgar < 7 at 5 minutes 2 120 Risk Ratio (M-H, Fixed, 95% CI) 1.90 [0.37, 9.80]
15 Caesarean section (elective and
emergency)
2 128 Risk Ratio (M-H, Random, 95% CI) 0.67 [0.18, 2.47]
16 Maternal infection requiring
intervention(antibiotics or
delivery)
0 0 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
17 Maternal side effects (vaginal
discharge, bleeding, pyrexia not
requiring antibiotics)
1 92 Risk Ratio (M-H, Fixed, 95% CI) 3.0 [0.32, 27.79]
18 Pyrexia 1 92 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
19 Any intravenous, oral or
combined tocolysis (not
prespecified)
1 92 Risk Ratio (M-H, Fixed, 95% CI) 3.75 [1.93, 7.29]
20 PPROM (not prespecified) 1 92 Risk Ratio (M-H, Fixed, 95% CI) 8.0 [1.04, 61.42]
21 Chorioamnionitis (not
prespecified)
2 128 Risk Ratio (M-H, Random, 95% CI) 1.53 [0.10, 23.61]
Comparison 3. Cerclage versus intramuscular progesterone
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 All perinatal losses 1 79 Risk Ratio (M-H, Fixed, 95% CI) 1.12 [0.58, 2.16]
2 Serious neonatal morbidity 1 79 Risk Ratio (M-H, Fixed, 95% CI) 1.13 [0.47, 2.74]
3 Baby discharged home healthy 1 79 Risk Ratio (M-H, Fixed, 95% CI) 1.17 [0.82, 1.67]
4 Stillbirths 0 0 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
5 Neonatal deaths before discharge 0 0 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
6 Miscarriages 1 79 Risk Ratio (M-H, Fixed, 95% CI) 1.47 [0.38, 5.73]
7 Preterm birth before 37
completed weeks
1 79 Risk Ratio (M-H, Fixed, 95% CI) 0.88 [0.60, 1.30]
8 Preterm birth before 34
completed weeks
0 0 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
9 Preterm birth before 28
completed weeks
1 79 Risk Ratio (M-H, Fixed, 95% CI) 1.26 [0.53, 2.97]
10 Serious intracranial pathology
(IVH or periventricular
leucomalacia)
0 0 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
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11 Serious respiratory morbidity
(RDS or oxygen dependency
after 28 days of life)
0 0 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
12 Necrotising enterocolitis 0 0 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
13 Retinopathy of prematurity 0 0 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
14 Apgar < 7 at 5 minutes 0 0 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
15 Caesarean section (elective and
emergency)
0 0 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
16 Maternal infection requiring
intervention(antibiotics or
delivery)
0 0 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
17 Maternal side effects (vaginal
discharge, bleeding, pyrexia not
requiring antibiotics)
0 0 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
18 Pyrexia 0 0 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
19 PPROM (not prespecified) 1 79 Risk Ratio (M-H, Fixed, 95% CI) 0.88 [0.47, 1.65]
20 Chorioamnionitis (not
prespecified)
1 79 Risk Ratio (M-H, Fixed, 95% CI) 1.32 [0.61, 2.88]
Comparison 4. Cerclage versus pessary
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 All perinatal losses 0 0 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
2 Serious neonatal morbidity 0 0 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
3 Baby discharged home healthy 0 0 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
4 Stillbirths 0 Risk Ratio (M-H, Fixed, 95% CI) Subtotals only
5 Neonatal deaths before discharge 0 0 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
6 Miscarriages 0 Risk Ratio (M-H, Fixed, 95% CI) Subtotals only
7 Preterm birth before 37
completed weeks
0 Risk Ratio (M-H, Fixed, 95% CI) Subtotals only
8 Preterm birth before 34
completed weeks
0 0 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
9 Preterm birth before 28
completed weeks
0 Risk Ratio (M-H, Fixed, 95% CI) Subtotals only
10 Serious intracranial pathology
(IVH or periventricular
leucomalacia)
0 0 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
11 Serious respiratory morbidity
(RDS or oxygen dependency
after 28 days of life)
0 0 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
12 Necrotising enterocolitis 0 0 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
13 Retinopathy of prematurity 0 0 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
14 Apgar < 7 at 5 minutes 0 0 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
15 Caesarean section (elective and
emergency)
0 0 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
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16 Maternal infection requiring
intervention(antibiotics or
delivery)
0 0 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
17 Maternal side effects (vaginal
discharge, bleeding, pyrexia not
requiring antibiotics)
0 0 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
18 Pyrexia 0 0 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
19 PPROM (not prespecified) 0 Risk Ratio (M-H, Fixed, 95% CI) Subtotals only
20 Chorioamnionitis 0 Risk Ratio (M-H, Fixed, 95% CI) Subtotals only
Comparison 5. Any comparison of different cerclage protocols
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 All perinatal losses 1 Risk Ratio (M-H, Fixed, 95% CI) Subtotals only
1.1 History-indicated cerclage
vs ultrasound-indicated
cerclage
1 247 Risk Ratio (M-H, Fixed, 95% CI) 1.37 [0.63, 2.96]
2 Serious neonatal morbidity 1 Risk Ratio (M-H, Fixed, 95% CI) Subtotals only
2.1 History-indicated cerclage
vs ultrasound-indicated
cerclage
1 247 Risk Ratio (M-H, Fixed, 95% CI) 1.71 [0.51, 5.69]
3 Baby discharged home healthy 0 0 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
3.1 History-indicated cerclage
vs ultrasound-indicated
cerclage
0 0 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
3.2 History-indicated cerclage
vs physical exam-indicated
cerclage
0 0 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
4 Stillbirths 1 Risk Ratio (M-H, Fixed, 95% CI) Subtotals only
4.1 History-indicated cerclage
vs ultrasound-indicated
cerclage
1 247 Risk Ratio (M-H, Fixed, 95% CI) 0.49 [0.04, 5.31]
5 Neonatal deaths before discharge 1 Risk Ratio (M-H, Fixed, 95% CI) Subtotals only
5.1 History-indicated cerclage
vs ultrasound-indicated
cerclage
1 247 Risk Ratio (M-H, Fixed, 95% CI) 0.24 [0.03, 2.15]
5.2 History-indicated cerclage
vs physical exam-indicated
cerclage
0 0 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
6 Miscarriages 2 344 Risk Ratio (M-H, Random, 95% CI) 1.71 [0.55, 5.30]
6.1 History-indicated cerclage
vs ultrasound-indicated
cerclage
2 344 Risk Ratio (M-H, Random, 95% CI) 1.71 [0.55, 5.30]
7 Preterm birth before 37
completed weeks
1 Risk Ratio (M-H, Fixed, 95% CI) Subtotals only
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7.1 History-indicated cerclage
vs ultrasound-indicated
cerclage
1 97 Risk Ratio (M-H, Fixed, 95% CI) 0.72 [0.25, 2.05]
8 Preterm birth before 34
completed weeks
1 Risk Ratio (M-H, Fixed, 95% CI) Subtotals only
8.1 History-indicated cerclage
vs ultrasound-indicated
cerclage
1 247 Risk Ratio (M-H, Fixed, 95% CI) 1.03 [0.57, 1.87]
9 Preterm birth before 28
completed weeks
0 0 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
9.1 History-indicated cerclage
vs ultrasound-indicated
cerclage
0 0 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
9.2 History-indicated cerclage
vs physical exam-indicated
cerclage
0 0 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
10 Serious intracranial pathology
(IVH or periventricular
leucomalacia)
1 Risk Ratio (M-H, Fixed, 95% CI) Subtotals only
10.1 History-indicated
cerclage vs ultrasound-indicated
cerclage
1 247 Risk Ratio (M-H, Fixed, 95% CI) 1.95 [0.36, 10.46]
10.2 History-indicated
cerclage vs physical exam-
indicated cerclage
0 0 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
11 Serious respiratory morbidity
(RDS or oxygen dependency
after 28 days of life)
1 Risk Ratio (M-H, Fixed, 95% CI) Subtotals only
11.1 History-indicated
cerclage vs ultrasound-indicated
cerclage
1 247 Risk Ratio (M-H, Fixed, 95% CI) 1.46 [0.25, 8.61]
11.2 History-indicated
cerclage vs physical exam-
indicated cerclage
0 0 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
12 Necrotising enterocolitis 0 0 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
12.1 History-indicated
cerclage vs ultrasound-
indicated cerclage
0 0 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
12.2 History-indicated
cerclage vs physical exam-
indicated cerclage
0 0 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
13 Retinopathy of prematurity 0 0 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
13.1 History-indicated
cerclage vs ultrasound-
indicated cerclage
0 0 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
13.2 History-indicated
cerclage vs physical exam-
indicated cerclage
0 0 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
14 Apgar < 7 at 5 minutes 0 0 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
68Cervical stitch (cerclage) for preventing preterm birth in singleton pregnancy (Review)
Copyright © 2017 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
14.1 History-indicated
cerclage vs ultrasound-
indicated cerclage
0 0 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
14.2 History-indicated
cerclage vs physical exam-
indicated cerclage
0 0 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
15 Caesarean section (elective and
emergency)
0 0 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
15.1 History-indicated
cerclage vs ultrasound-
indicated cerclage
0 0 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
15.2 History-indicated
cerclage vs physical exam-
indicated cerclage
0 0 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
16 Maternal infection requiring
intervention(antibiotics or
delivery)
1 Risk Ratio (M-H, Fixed, 95% CI) Subtotals only
16.1 History-indicated
cerclage vs ultrasound-indicated
cerclage
1 247 Risk Ratio (M-H, Fixed, 95% CI) 0.33 [0.01, 7.91]
16.2 History-indicated
cerclage vs physical exam-
indicated cerclage
0 0 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
17 Maternal side effects (vaginal
discharge, bleeding, pyrexia not
requiring antibiotics)
1 Risk Ratio (M-H, Fixed, 95% CI) Subtotals only
17.1 History-indicated
cerclage vs ultrasound-indicated
cerclage
1 243 Risk Ratio (M-H, Fixed, 95% CI) 0.54 [0.21, 1.42]
17.2 History-indicated
cerclage vs physical exam-
indicated cerclage
0 0 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
18 Tocolysis (not prespecified) 1 Risk Ratio (M-H, Fixed, 95% CI) Subtotals only
18.1 History-indicated
cerclage vs ultrasound-indicated
cerclage
1 247 Risk Ratio (M-H, Fixed, 95% CI) 0.44 [0.16, 1.24]
Comparison 6. Cerclage versus no cerclage (Summary of findings outcomes)
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 All perinatal losses 10 2927 Risk Ratio (M-H, Fixed, 95% CI) 0.82 [0.65, 1.04]
2 Serious neonatal morbidity 6 883 Risk Ratio (M-H, Fixed, 95% CI) 0.80 [0.55, 1.18]
3 Baby discharged home healthy 4 657 Risk Ratio (M-H, Fixed, 95% CI) 1.02 [0.97, 1.06]
4 Stillbirths 5 1803 Risk Ratio (M-H, Fixed, 95% CI) 0.89 [0.45, 1.75]
5 Neonatal deaths before discharge 6 1714 Risk Ratio (M-H, Fixed, 95% CI) 0.85 [0.53, 1.39]
6 Preterm birth before 34
completed weeks
9 2415 Risk Ratio (M-H, Random, 95% CI) 0.77 [0.66, 0.89]
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Analysis 1.1. Comparison 1 Cerclage versus no cerclage, Outcome 1 All perinatal losses.
Review: Cervical stitch (cerclage) for preventing preterm birth in singleton pregnancy
Comparison: 1 Cerclage versus no cerclage
Outcome: 1 All perinatal losses
Study or subgroup Cerclage No cerclage Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 History-indicated cerclage vs no cerclage
Lazar 1984 2/268 1/238 0.8 % 1.78 [ 0.16, 19.46 ]
Ezechi 2004 0/39 2/42 1.8 % 0.22 [ 0.01, 4.34 ]
Rush 1984 9/96 9/98 6.6 % 1.02 [ 0.42, 2.46 ]
MRC/RCOG 1993 53/635 66/629 49.3 % 0.80 [ 0.56, 1.12 ]
Subtotal (95% CI) 1038 1007 58.4 % 0.82 [ 0.60, 1.12 ]
Total events: 64 (Cerclage), 78 (No cerclage)
Heterogeneity: Chi2 = 1.43, df = 3 (P = 0.70); I2 =0.0%
Test for overall effect: Z = 1.26 (P = 0.21)
2 One-off ultrasound-indicated cerclage in high risk for PTL vs no cerclage
To 2004 2/26 3/30 2.1 % 0.77 [ 0.14, 4.25 ]
Subtotal (95% CI) 26 30 2.1 % 0.77 [ 0.14, 4.25 ]
Total events: 2 (Cerclage), 3 (No cerclage)
Heterogeneity: not applicable
Test for overall effect: Z = 0.30 (P = 0.76)
3 Serial ultrasound-indicated cerclage in high risk for PTL vs no cerclage
Althuisius 2001 0/19 3/16 2.8 % 0.12 [ 0.01, 2.19 ]
Berghella 2004 4/25 4/22 3.2 % 0.88 [ 0.25, 3.11 ]
Rust 2000 7/61 5/66 3.6 % 1.51 [ 0.51, 4.52 ]
Owen 2009 13/148 25/152 18.3 % 0.53 [ 0.28, 1.00 ]
Subtotal (95% CI) 253 256 27.9 % 0.66 [ 0.41, 1.06 ]
Total events: 24 (Cerclage), 37 (No cerclage)
Heterogeneity: Chi2 = 4.17, df = 3 (P = 0.24); I2 =28%
Test for overall effect: Z = 1.72 (P = 0.085)
4 Physical exam indicated cerclage vs no cerclage
Althuisius 2003 9/16 4/14 3.2 % 1.97 [ 0.77, 5.01 ]
Subtotal (95% CI) 16 14 3.2 % 1.97 [ 0.77, 5.01 ]
Total events: 9 (Cerclage), 4 (No cerclage)
Heterogeneity: not applicable
0.002 0.1 1 10 500
Favours cerclage Favours no cerclage
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(. . . Continued)
Study or subgroup Cerclage No cerclage Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Test for overall effect: Z = 1.42 (P = 0.16)
5 One-off ultrasound-indicated cerclage in low/unspecified risk for PTL vs no cerclage
Berghella 2004 0/3 0/7 Not estimable
Rust 2000 5/43 2/37 1.6 % 2.15 [ 0.44, 10.44 ]
To 2004 7/101 9/96 6.9 % 0.74 [ 0.29, 1.91 ]
Subtotal (95% CI) 147 140 8.5 % 1.01 [ 0.46, 2.22 ]
Total events: 12 (Cerclage), 11 (No cerclage)
Heterogeneity: Chi2 = 1.30, df = 1 (P = 0.26); I2 =23%
Test for overall effect: Z = 0.01 (P = 0.99)
Total (95% CI) 1480 1447 100.0 % 0.82 [ 0.65, 1.04 ]
Total events: 111 (Cerclage), 133 (No cerclage)
Heterogeneity: Chi2 = 10.95, df = 11 (P = 0.45); I2 =0.0%
Test for overall effect: Z = 1.60 (P = 0.11)
Test for subgroup differences: Chi2 = 4.44, df = 4 (P = 0.35), I2 =10%
0.002 0.1 1 10 500
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Analysis 1.2. Comparison 1 Cerclage versus no cerclage, Outcome 2 Serious neonatal morbidity.
Review: Cervical stitch (cerclage) for preventing preterm birth in singleton pregnancy
Comparison: 1 Cerclage versus no cerclage
Outcome: 2 Serious neonatal morbidity
Study or subgroup Cerclage No cerclage Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
1 History-indicated cerclage vs no cerclage
Subtotal (95% CI) 0 0 Not estimable
Total events: 0 (Cerclage), 0 (No cerclage)
Heterogeneity: not applicable
Test for overall effect: not applicable
2 One-off ultrasound-indicated cerclage in high risk for PTL vs no cerclage
To 2004 (1) 2/26 3/30 5.4 % 0.77 [ 0.14, 4.25 ]
Subtotal (95% CI) 26 30 5.4 % 0.77 [ 0.14, 4.25 ]
Total events: 2 (Cerclage), 3 (No cerclage)
Heterogeneity: not applicable
Test for overall effect: Z = 0.30 (P = 0.76)
3 Serial ultrasound-indicated cerclage in high risk for PTL vs no cerclage
Althuisius 2001 (2) 1/19 5/16 3.8 % 0.17 [ 0.02, 1.30 ]
Berghella 2004 (3) 6/25 6/22 16.5 % 0.88 [ 0.33, 2.33 ]
Owen 2009 16/148 18/153 39.1 % 0.92 [ 0.49, 1.73 ]
Rust 2000 (4) 3/61 6/66 8.8 % 0.54 [ 0.14, 2.07 ]
Subtotal (95% CI) 253 257 68.2 % 0.77 [ 0.48, 1.25 ]
Total events: 26 (Cerclage), 35 (No cerclage)
Heterogeneity: Tau2 = 0.0; Chi2 = 2.81, df = 3 (P = 0.42); I2 =0.0%
Test for overall effect: Z = 1.05 (P = 0.29)
4 Physical exam-indicated cerclage in high risk for PTL vs no cerclage
Althuisius 2003 (5) 1/16 4/14 3.7 % 0.22 [ 0.03, 1.73 ]
Subtotal (95% CI) 16 14 3.7 % 0.22 [ 0.03, 1.73 ]
Total events: 1 (Cerclage), 4 (No cerclage)
Heterogeneity: not applicable
Test for overall effect: Z = 1.44 (P = 0.15)
5 One-off ultrasound-indicated cerclage in low/unspecified risk for PTL vs no cerclage
Berghella 2004 1/3 2/7 4.0 % 1.17 [ 0.16, 8.48 ]
Rust 2000 4/43 3/37 7.7 % 1.15 [ 0.27, 4.80 ]
To 2004 7/101 4/96 11.0 % 1.66 [ 0.50, 5.50 ]
Subtotal (95% CI) 147 140 22.7 % 1.38 [ 0.60, 3.17 ]
0.01 0.1 1 10 100
Favours cerclage Favours no cerclage
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(. . . Continued)
Study or subgroup Cerclage No cerclage Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
Total events: 12 (Cerclage), 9 (No cerclage)
Heterogeneity: Tau2 = 0.0; Chi2 = 0.19, df = 2 (P = 0.91); I2 =0.0%
Test for overall effect: Z = 0.75 (P = 0.45)
Total (95% CI) 442 441 100.0 % 0.84 [ 0.57, 1.25 ]
Total events: 41 (Cerclage), 51 (No cerclage)
Heterogeneity: Tau2 = 0.0; Chi2 = 6.10, df = 8 (P = 0.64); I2 =0.0%
Test for overall effect: Z = 0.85 (P = 0.39)
Test for subgroup differences: Chi2 = 3.10, df = 3 (P = 0.38), I2 =3%
0.01 0.1 1 10 100
Favours cerclage Favours no cerclage
(1) Defined as bronchopulmonary dysplasia, IVH or PVH grade 3 or 4, retinopathy of prem, positive fetal blood culture.
(2) Serious morbidity defined as NICU admission.
(3) Defined as any of respiratory distress syndrome, intraventricular haemorrhage [III or IV], necrotizing enterocolitis, or sepsis.
(4) Defined as mechanical ventilation, respiratory distress syndrome, necrotizing enterocolitis, intraventricular hemorrhage, sepsis, or other life-threatening morbidity.
(5) Defined as admission to NICU.
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Analysis 1.3. Comparison 1 Cerclage versus no cerclage, Outcome 3 Baby discharged home healthy.
Review: Cervical stitch (cerclage) for preventing preterm birth in singleton pregnancy
Comparison: 1 Cerclage versus no cerclage
Outcome: 3 Baby discharged home healthy
Study or subgroup Cerclage No cerclage Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 History-indicated cerclage vs no cerclage
Rush 1984 (1) 85/90 88/93 28.9 % 1.00 [ 0.93, 1.07 ]
Subtotal (95% CI) 90 93 28.9 % 1.00 [ 0.93, 1.07 ]
Total events: 85 (Cerclage), 88 (No cerclage)
Heterogeneity: not applicable
Test for overall effect: Z = 0.05 (P = 0.96)
2 One-off ultrasound-indicated cerclage in high risk for PTL vs no cerclage
Subtotal (95% CI) 0 0 Not estimable
Total events: 0 (Cerclage), 0 (No cerclage)
Heterogeneity: not applicable
Test for overall effect: not applicable
3 Serial ultrasound-indicated cerclage in high risk for PTL vs no cerclage
Berghella 2004 (2) 19/25 17/25 5.7 % 1.12 [ 0.79, 1.58 ]
Rust 2000 (3) 85/92 87/96 28.4 % 1.02 [ 0.93, 1.11 ]
Subtotal (95% CI) 117 121 34.1 % 1.04 [ 0.94, 1.14 ]
Total events: 104 (Cerclage), 104 (No cerclage)
Heterogeneity: Chi2 = 0.31, df = 1 (P = 0.58); I2 =0.0%
Test for overall effect: Z = 0.74 (P = 0.46)
4 Physical exam-indicated cerclage in high risk for PTL vs no cerclage
Subtotal (95% CI) 0 0 Not estimable
Total events: 0 (Cerclage), 0 (No cerclage)
Heterogeneity: not applicable
Test for overall effect: not applicable
5 One-off ultrasound-indicated cerclage in low/unspecified risk for PTL vs no cerclage
To 2004 (4) 114/120 109/116 37.0 % 1.01 [ 0.95, 1.08 ]
Subtotal (95% CI) 120 116 37.0 % 1.01 [ 0.95, 1.08 ]
Total events: 114 (Cerclage), 109 (No cerclage)
Heterogeneity: not applicable
Test for overall effect: Z = 0.35 (P = 0.73)
Total (95% CI) 327 330 100.0 % 1.02 [ 0.97, 1.06 ]
Total events: 303 (Cerclage), 301 (No cerclage)
Heterogeneity: Chi2 = 0.56, df = 3 (P = 0.91); I2 =0.0%
Test for overall effect: Z = 0.69 (P = 0.49)
Test for subgroup differences: Chi2 = 0.39, df = 2 (P = 0.82), I2 =0.0%
0.5 0.7 1 1.5 2
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(1) Included women had a history of at least one preterm delivery < 37 weeks; women with cervical dilation > 2mm were excluded.
(2) From Jorgenson 2007 (excluding deaths from denominator. One-off and serial ultrasound together).
(3) From Jorgenson 2007 (excluding deaths from denominator).
(4) From Jorgenson 2007 (excluding deaths; both risk groups together.)
Analysis 1.4. Comparison 1 Cerclage versus no cerclage, Outcome 4 Stillbirths.
Review: Cervical stitch (cerclage) for preventing preterm birth in singleton pregnancy
Comparison: 1 Cerclage versus no cerclage
Outcome: 4 Stillbirths
Study or subgroup Cerclage No cerclage Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 History-indicated cerclage vs no cerclage
MRC/RCOG 1993 8/635 10/629 57.6 % 0.79 [ 0.31, 1.99 ]
Rush 1984 4/96 2/98 11.4 % 2.04 [ 0.38, 10.89 ]
Subtotal (95% CI) 731 727 69.0 % 1.00 [ 0.45, 2.20 ]
Total events: 12 (Cerclage), 12 (No cerclage)
Heterogeneity: Chi2 = 0.94, df = 1 (P = 0.33); I2 =0.0%
Test for overall effect: Z = 0.00 (P = 1.0)
2 One-off ultrasound-indicated cerclage in high risk for PTL vs no cerclage
To 2004 0/26 2/30 13.4 % 0.23 [ 0.01, 4.58 ]
Subtotal (95% CI) 26 30 13.4 % 0.23 [ 0.01, 4.58 ]
Total events: 0 (Cerclage), 2 (No cerclage)
Heterogeneity: not applicable
Test for overall effect: Z = 0.96 (P = 0.34)
3 Serial ultrasound-indicated cerclage in high risk for PTL vs no cerclage
Althuisius 2001 0/19 0/16 Not estimable
Berghella 2004 0/25 0/22 Not estimable
Subtotal (95% CI) 44 38 Not estimable
Total events: 0 (Cerclage), 0 (No cerclage)
Heterogeneity: not applicable
Test for overall effect: not applicable
4 Physical exam-indicated cerclage in high risk for PTL vs no cerclage
Subtotal (95% CI) 0 0 Not estimable
Total events: 0 (Cerclage), 0 (No cerclage)
0.01 0.1 1 10 100
Favours cerclage Favours no cerclage
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(. . . Continued)
Study or subgroup Cerclage No cerclage Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Heterogeneity: not applicable
Test for overall effect: not applicable
5 One-off ultrasound-indicated cerclage in low/unspecified risk for PTL vs no cerclage
Berghella 2004 0/3 0/7 Not estimable
To 2004 3/101 3/96 17.6 % 0.95 [ 0.20, 4.59 ]
Subtotal (95% CI) 104 103 17.6 % 0.95 [ 0.20, 4.59 ]
Total events: 3 (Cerclage), 3 (No cerclage)
Heterogeneity: not applicable
Test for overall effect: Z = 0.06 (P = 0.95)
Total (95% CI) 905 898 100.0 % 0.89 [ 0.45, 1.75 ]
Total events: 15 (Cerclage), 17 (No cerclage)
Heterogeneity: Chi2 = 1.80, df = 3 (P = 0.61); I2 =0.0%
Test for overall effect: Z = 0.35 (P = 0.73)
Test for subgroup differences: Chi2 = 0.87, df = 2 (P = 0.65), I2 =0.0%
0.01 0.1 1 10 100
Favours cerclage Favours no cerclage
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Analysis 1.5. Comparison 1 Cerclage versus no cerclage, Outcome 5 Neonatal deaths before discharge.
Review: Cervical stitch (cerclage) for preventing preterm birth in singleton pregnancy
Comparison: 1 Cerclage versus no cerclage
Outcome: 5 Neonatal deaths before discharge
Study or subgroup Cerclage No cerclage Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 History-indicated cerclage vs no cerclage
MRC/RCOG 1993 8/590 14/577 44.6 % 0.56 [ 0.24, 1.32 ]
Rush 1984 3/90 4/93 12.4 % 0.78 [ 0.18, 3.37 ]
Subtotal (95% CI) 680 670 57.0 % 0.61 [ 0.29, 1.27 ]
Total events: 11 (Cerclage), 18 (No cerclage)
Heterogeneity: Chi2 = 0.14, df = 1 (P = 0.71); I2 =0.0%
Test for overall effect: Z = 1.33 (P = 0.19)
2 One-off ultrasound-indicated cerclage in high risk for PTL vs no cerclage
To 2004 2/26 1/28 3.0 % 2.15 [ 0.21, 22.37 ]
Subtotal (95% CI) 26 28 3.0 % 2.15 [ 0.21, 22.37 ]
Total events: 2 (Cerclage), 1 (No cerclage)
Heterogeneity: not applicable
Test for overall effect: Z = 0.64 (P = 0.52)
3 Serial ultrasound-indicated cerclage in high risk for PTL vs no cerclage
Althuisius 2001 0/19 1/14 5.4 % 0.25 [ 0.01, 5.72 ]
Berghella 2004 1/22 0/18 1.7 % 2.48 [ 0.11, 57.40 ]
Subtotal (95% CI) 41 32 7.1 % 0.79 [ 0.12, 5.26 ]
Total events: 1 (Cerclage), 1 (No cerclage)
Heterogeneity: Chi2 = 1.03, df = 1 (P = 0.31); I2 =3%
Test for overall effect: Z = 0.24 (P = 0.81)
4 Physical exam-indicated cerclage in high risk for PTL vs no cerclage
Althuisius 2003 9/16 4/14 13.4 % 1.97 [ 0.77, 5.01 ]
Subtotal (95% CI) 16 14 13.4 % 1.97 [ 0.77, 5.01 ]
Total events: 9 (Cerclage), 4 (No cerclage)
Heterogeneity: not applicable
Test for overall effect: Z = 1.42 (P = 0.16)
5 One-off ultrasound-indicated cerclage in low/unspecified risk for PTL vs no cerclage
Berghella 2004 0/3 0/7 Not estimable
To 2004 4/101 6/96 19.4 % 0.63 [ 0.18, 2.18 ]
Subtotal (95% CI) 104 103 19.4 % 0.63 [ 0.18, 2.18 ]
Total events: 4 (Cerclage), 6 (No cerclage)
Heterogeneity: not applicable
Test for overall effect: Z = 0.72 (P = 0.47)
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Study or subgroup Cerclage No cerclage Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Total (95% CI) 867 847 100.0 % 0.85 [ 0.53, 1.39 ]
Total events: 27 (Cerclage), 30 (No cerclage)
Heterogeneity: Chi2 = 5.88, df = 6 (P = 0.44); I2 =0.0%
Test for overall effect: Z = 0.64 (P = 0.53)
Test for subgroup differences: Chi2 = 4.65, df = 4 (P = 0.33), I2 =14%
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Analysis 1.6. Comparison 1 Cerclage versus no cerclage, Outcome 6 Miscarriages.
Review: Cervical stitch (cerclage) for preventing preterm birth in singleton pregnancy
Comparison: 1 Cerclage versus no cerclage
Outcome: 6 Miscarriages
Study or subgroup Cerclage No cerclage Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 History-indicated cerclage vs no cerclage
Ezechi 2004 0/39 0/42 Not estimable
MRC/RCOG 1993 37/635 42/629 75.2 % 0.87 [ 0.57, 1.34 ]
Rush 1984 2/96 3/98 5.3 % 0.68 [ 0.12, 3.98 ]
Subtotal (95% CI) 770 769 80.5 % 0.86 [ 0.57, 1.30 ]
Total events: 39 (Cerclage), 45 (No cerclage)
Heterogeneity: Chi2 = 0.07, df = 1 (P = 0.79); I2 =0.0%
Test for overall effect: Z = 0.71 (P = 0.48)
2 One-off ultrasound-indicated cerclage in high risk for PTL vs no cerclage
To 2004 0/26 0/30 Not estimable
Subtotal (95% CI) 26 30 Not estimable
Total events: 0 (Cerclage), 0 (No cerclage)
Heterogeneity: not applicable
Test for overall effect: not applicable
3 Serial ultrasound-indicated cerclage in high risk for PTL vs no cerclage
Althuisius 2001 0/19 2/16 4.8 % 0.17 [ 0.01, 3.30 ]
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Study or subgroup Cerclage No cerclage Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Berghella 2004 3/25 4/22 7.6 % 0.66 [ 0.17, 2.63 ]
Rust 2000 3/61 3/66 5.1 % 1.08 [ 0.23, 5.16 ]
Subtotal (95% CI) 105 104 17.5 % 0.65 [ 0.25, 1.66 ]
Total events: 6 (Cerclage), 9 (No cerclage)
Heterogeneity: Chi2 = 1.20, df = 2 (P = 0.55); I2 =0.0%
Test for overall effect: Z = 0.90 (P = 0.37)
4 Physical exam-indicated cerclage in high risk for PTL vs no cerclage
Subtotal (95% CI) 0 0 Not estimable
Total events: 0 (Cerclage), 0 (No cerclage)
Heterogeneity: not applicable
Test for overall effect: not applicable
5 One-off ultrasound-indicated cerclage in low/unspecified risk for PTL vs no cerclage
Berghella 2004 0/3 0/7 Not estimable
Rust 2000 2/43 1/37 1.9 % 1.72 [ 0.16, 18.22 ]
To 2004 0/101 0/96 Not estimable
Subtotal (95% CI) 147 140 1.9 % 1.72 [ 0.16, 18.22 ]
Total events: 2 (Cerclage), 1 (No cerclage)
Heterogeneity: not applicable
Test for overall effect: Z = 0.45 (P = 0.65)
Total (95% CI) 1048 1043 100.0 % 0.84 [ 0.58, 1.22 ]
Total events: 47 (Cerclage), 55 (No cerclage)
Heterogeneity: Chi2 = 1.77, df = 5 (P = 0.88); I2 =0.0%
Test for overall effect: Z = 0.92 (P = 0.36)
Test for subgroup differences: Chi2 = 0.66, df = 2 (P = 0.72), I2 =0.0%
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Analysis 1.7. Comparison 1 Cerclage versus no cerclage, Outcome 7 Preterm birth before 37 completed
weeks.
Review: Cervical stitch (cerclage) for preventing preterm birth in singleton pregnancy
Comparison: 1 Cerclage versus no cerclage
Outcome: 7 Preterm birth before 37 completed weeks
Study or subgroup Cerclage No cerclage Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
1 History-indicated cerclage vs no cerclage
Ezechi 2004 3/39 15/42 1.8 % 0.22 [ 0.07, 0.69 ]
MRC/RCOG 1993 161/635 190/629 19.5 % 0.84 [ 0.70, 1.00 ]
Rush 1984 33/96 31/98 9.9 % 1.09 [ 0.73, 1.62 ]
Lazar 1984 18/268 13/238 4.5 % 1.23 [ 0.62, 2.46 ]
Subtotal (95% CI) 1038 1007 35.7 % 0.86 [ 0.59, 1.27 ]
Total events: 215 (Cerclage), 249 (No cerclage)
Heterogeneity: Tau2 = 0.09; Chi2 = 7.89, df = 3 (P = 0.05); I2 =62%
Test for overall effect: Z = 0.74 (P = 0.46)
2 One-off ultrasound-indicated cerclage in high risk for PTL vs no cerclage
To 2004 9/26 19/30 5.7 % 0.55 [ 0.30, 0.99 ]
Subtotal (95% CI) 26 30 5.7 % 0.55 [ 0.30, 0.99 ]
Total events: 9 (Cerclage), 19 (No cerclage)
Heterogeneity: not applicable
Test for overall effect: Z = 1.99 (P = 0.046)
3 Serial ultrasound-indicated cerclage in high risk for PTL vs no cerclage
Althuisius 2001 4/19 10/16 2.6 % 0.34 [ 0.13, 0.87 ]
Owen 2009 66/148 91/153 17.3 % 0.75 [ 0.60, 0.94 ]
Berghella 2004 13/25 14/22 7.6 % 0.82 [ 0.50, 1.34 ]
Rust 2000 27/61 29/66 10.2 % 1.01 [ 0.68, 1.49 ]
Subtotal (95% CI) 253 257 37.6 % 0.78 [ 0.60, 1.02 ]
Total events: 110 (Cerclage), 144 (No cerclage)
Heterogeneity: Tau2 = 0.03; Chi2 = 4.80, df = 3 (P = 0.19); I2 =38%
Test for overall effect: Z = 1.82 (P = 0.069)
4 Physical exam-indicated cerclage in high risk for PTL vs no cerclage
Subtotal (95% CI) 0 0 Not estimable
Total events: 0 (Cerclage), 0 (No cerclage)
Heterogeneity: not applicable
Test for overall effect: not applicable
5 One-off ultrasound-indicated cerclage in low/unspecified risk for PTL vs no cerclage
Berghella 2004 1/3 6/7 0.9 % 0.39 [ 0.08, 1.98 ]
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Study or subgroup Cerclage No cerclage Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
To 2004 32/101 44/96 11.3 % 0.69 [ 0.48, 0.99 ]
Rust 2000 22/43 18/37 8.8 % 1.05 [ 0.68, 1.64 ]
Subtotal (95% CI) 147 140 21.0 % 0.80 [ 0.55, 1.16 ]
Total events: 55 (Cerclage), 68 (No cerclage)
Heterogeneity: Tau2 = 0.03; Chi2 = 2.90, df = 2 (P = 0.23); I2 =31%
Test for overall effect: Z = 1.16 (P = 0.25)
Total (95% CI) 1464 1434 100.0 % 0.80 [ 0.69, 0.95 ]
Total events: 389 (Cerclage), 480 (No cerclage)
Heterogeneity: Tau2 = 0.03; Chi2 = 18.11, df = 11 (P = 0.08); I2 =39%
Test for overall effect: Z = 2.64 (P = 0.0082)
Test for subgroup differences: Chi2 = 1.66, df = 3 (P = 0.65), I2 =0.0%
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Analysis 1.8. Comparison 1 Cerclage versus no cerclage, Outcome 8 Preterm birth before 34 completed
weeks.
Review: Cervical stitch (cerclage) for preventing preterm birth in singleton pregnancy
Comparison: 1 Cerclage versus no cerclage
Outcome: 8 Preterm birth before 34 completed weeks
Study or subgroup Cerclage No cerclage Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
1 History-indicated cerclage vs no cerclage
Ezechi 2004 0/39 11/42 0.3 % 0.05 [ 0.00, 0.77 ]
MRC/RCOG 1993 92/635 113/629 36.0 % 0.81 [ 0.63, 1.04 ]
Rush 1984 14/96 14/98 4.9 % 1.02 [ 0.51, 2.03 ]
Subtotal (95% CI) 770 769 41.1 % 0.76 [ 0.40, 1.46 ]
Total events: 106 (Cerclage), 138 (No cerclage)
Heterogeneity: Tau2 = 0.17; Chi2 = 4.66, df = 2 (P = 0.10); I2 =57%
Test for overall effect: Z = 0.81 (P = 0.42)
2 One-off ultrasound-indicated cerclage in high risk for PTL vs no cerclage
To 2004 6/26 11/30 3.2 % 0.63 [ 0.27, 1.46 ]
Subtotal (95% CI) 26 30 3.2 % 0.63 [ 0.27, 1.46 ]
Total events: 6 (Cerclage), 11 (No cerclage)
Heterogeneity: not applicable
Test for overall effect: Z = 1.07 (P = 0.28)
3 Serial ultrasound-indicated cerclage in high risk for PTL vs no cerclage
Althuisius 2001 0/19 7/16 0.3 % 0.06 [ 0.00, 0.92 ]
Berghella 2004 10/25 11/22 5.6 % 0.80 [ 0.42, 1.51 ]
Owen 2009 42/148 57/153 21.2 % 0.76 [ 0.55, 1.06 ]
Rust 2000 13/61 15/66 5.3 % 0.94 [ 0.49, 1.81 ]
Subtotal (95% CI) 253 257 32.5 % 0.77 [ 0.55, 1.10 ]
Total events: 65 (Cerclage), 90 (No cerclage)
Heterogeneity: Tau2 = 0.03; Chi2 = 3.92, df = 3 (P = 0.27); I2 =23%
Test for overall effect: Z = 1.42 (P = 0.15)
4 Physical exam-indicated cerclage in high risk for PTL vs no cerclage
Althuisius 2003 7/13 10/10 9.0 % 0.56 [ 0.34, 0.93 ]
Subtotal (95% CI) 13 10 9.0 % 0.56 [ 0.34, 0.93 ]
Total events: 7 (Cerclage), 10 (No cerclage)
Heterogeneity: not applicable
Test for overall effect: Z = 2.24 (P = 0.025)
5 One-off ultrasound-indicated cerclage in low/unspecified risk for PTL vs no cerclage
Berghella 2004 0/3 1/7 0.3 % 0.67 [ 0.03, 12.96 ]
0.01 0.1 1 10 100
Favours cerclage Favours no cerclage
(Continued . . . )
82Cervical stitch (cerclage) for preventing preterm birth in singleton pregnancy (Review)
Copyright © 2017 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
(. . . Continued)
Study or subgroup Cerclage No cerclage Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
Rust 2000 11/43 12/37 4.8 % 0.79 [ 0.40, 1.57 ]
To 2004 22/101 25/96 9.1 % 0.84 [ 0.51, 1.38 ]
Subtotal (95% CI) 147 140 14.2 % 0.82 [ 0.55, 1.22 ]
Total events: 33 (Cerclage), 38 (No cerclage)
Heterogeneity: Tau2 = 0.0; Chi2 = 0.04, df = 2 (P = 0.98); I2 =0.0%
Test for overall effect: Z = 0.99 (P = 0.32)
Total (95% CI) 1209 1206 100.0 % 0.77 [ 0.66, 0.89 ]
Total events: 217 (Cerclage), 287 (No cerclage)
Heterogeneity: Tau2 = 0.0; Chi2 = 10.31, df = 11 (P = 0.50); I2 =0.0%
Test for overall effect: Z = 3.41 (P = 0.00065)
Test for subgroup differences: Chi2 = 1.59, df = 4 (P = 0.81), I2 =0.0%
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Analysis 1.9. Comparison 1 Cerclage versus no cerclage, Outcome 9 Preterm birth before 28 completed
weeks.
Review: Cervical stitch (cerclage) for preventing preterm birth in singleton pregnancy
Comparison: 1 Cerclage versus no cerclage
Outcome: 9 Preterm birth before 28 completed weeks
Study or subgroup Cerclage No cerclage Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 History-indicated cerclage vs no cerclage
Ezechi 2004 0/39 1/42 1.0 % 0.36 [ 0.02, 8.54 ]
MRC/RCOG 1993 53/635 65/629 43.8 % 0.81 [ 0.57, 1.14 ]
Rush 1984 7/96 7/98 4.6 % 1.02 [ 0.37, 2.80 ]
Subtotal (95% CI) 770 769 49.4 % 0.82 [ 0.59, 1.13 ]
Total events: 60 (Cerclage), 73 (No cerclage)
Heterogeneity: Chi2 = 0.45, df = 2 (P = 0.80); I2 =0.0%
Test for overall effect: Z = 1.21 (P = 0.23)
2 One-off ultrasound-indicated cerclage in high risk for PTL vs no cerclage
To 2004 3/26 5/30 3.1 % 0.69 [ 0.18, 2.62 ]
Subtotal (95% CI) 26 30 3.1 % 0.69 [ 0.18, 2.62 ]
Total events: 3 (Cerclage), 5 (No cerclage)
Heterogeneity: not applicable
Test for overall effect: Z = 0.54 (P = 0.59)
3 Serial ultrasound-indicated cerclage in high risk for PTL vs no cerclage
Althuisius 2001 0/19 3/16 2.5 % 0.12 [ 0.01, 2.19 ]
Berghella 2004 6/25 5/22 3.6 % 1.06 [ 0.37, 2.99 ]
Owen 2009 21/148 33/153 21.8 % 0.66 [ 0.40, 1.08 ]
Rust 2000 9/61 11/66 7.1 % 0.89 [ 0.39, 1.99 ]
Subtotal (95% CI) 253 257 35.0 % 0.71 [ 0.48, 1.04 ]
Total events: 36 (Cerclage), 52 (No cerclage)
Heterogeneity: Chi2 = 2.38, df = 3 (P = 0.50); I2 =0.0%
Test for overall effect: Z = 1.78 (P = 0.076)
4 Physical exam-indicated cerclage in high risk for PTL vs no cerclage
Subtotal (95% CI) 0 0 Not estimable
Total events: 0 (Cerclage), 0 (No cerclage)
Heterogeneity: not applicable
Test for overall effect: not applicable
5 One-off ultrasound-indicated cerclage in low/unspecified risk for PTL vs no cerclage
Berghella 2004 0/3 1/7 0.7 % 0.67 [ 0.03, 12.96 ]
Rust 2000 7/43 5/37 3.6 % 1.20 [ 0.42, 3.48 ]
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Study or subgroup Cerclage No cerclage Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
To 2004 12/101 12/96 8.3 % 0.95 [ 0.45, 2.01 ]
Subtotal (95% CI) 147 140 12.5 % 1.01 [ 0.55, 1.83 ]
Total events: 19 (Cerclage), 18 (No cerclage)
Heterogeneity: Chi2 = 0.21, df = 2 (P = 0.90); I2 =0.0%
Test for overall effect: Z = 0.03 (P = 0.98)
Total (95% CI) 1196 1196 100.0 % 0.80 [ 0.64, 1.00 ]
Total events: 118 (Cerclage), 148 (No cerclage)
Heterogeneity: Chi2 = 3.87, df = 10 (P = 0.95); I2 =0.0%
Test for overall effect: Z = 1.95 (P = 0.051)
Test for subgroup differences: Chi2 = 1.05, df = 3 (P = 0.79), I2 =0.0%
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Analysis 1.10. Comparison 1 Cerclage versus no cerclage, Outcome 10 Serious intracranial pathology (IVH
or periventricular leukomalacia).
Review: Cervical stitch (cerclage) for preventing preterm birth in singleton pregnancy
Comparison: 1 Cerclage versus no cerclage
Outcome: 10 Serious intracranial pathology (IVH or periventricular leukomalacia)
Study or subgroup Cerclage No cerclage Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
1 History-indicated cerclage vs no cerclage
Rush 1984 1/96 1/98 22.5 % 1.02 [ 0.06, 16.09 ]
Subtotal (95% CI) 96 98 22.5 % 1.02 [ 0.06, 16.09 ]
Total events: 1 (Cerclage), 1 (No cerclage)
Heterogeneity: not applicable
Test for overall effect: Z = 0.01 (P = 0.99)
2 One-off ultrasound-indicated cerclage in high risk for PTL vs no cerclage
To 2004 0/26 1/30 17.1 % 0.38 [ 0.02, 9.01 ]
Subtotal (95% CI) 26 30 17.1 % 0.38 [ 0.02, 9.01 ]
Total events: 0 (Cerclage), 1 (No cerclage)
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Study or subgroup Cerclage No cerclage Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
Heterogeneity: not applicable
Test for overall effect: Z = 0.60 (P = 0.55)
3 Serial ultrasound-indicated cerclage in high risk for PTL vs no cerclage
Althuisius 2001 0/19 0/16 Not estimable
Berghella 2004 2/25 0/22 19.2 % 4.42 [ 0.22, 87.44 ]
Owen 2009 0/148 2/152 18.7 % 0.21 [ 0.01, 4.24 ]
Subtotal (95% CI) 192 190 37.9 % 0.96 [ 0.05, 19.53 ]
Total events: 2 (Cerclage), 2 (No cerclage)
Heterogeneity: Tau2 = 2.36; Chi2 = 2.00, df = 1 (P = 0.16); I2 =50%
Test for overall effect: Z = 0.02 (P = 0.98)
4 Physical exam-indicated cerclage in high risk for PTL vs no cerclage
Subtotal (95% CI) 0 0 Not estimable
Total events: 0 (Cerclage), 0 (No cerclage)
Heterogeneity: not applicable
Test for overall effect: not applicable
5 One-off ultrasound-indicated cerclage in low/unspecified risk for PTL vs no cerclage
Berghella 2004 0/3 0/7 Not estimable
To 2004 1/101 1/96 22.5 % 0.95 [ 0.06, 14.98 ]
Subtotal (95% CI) 104 103 22.5 % 0.95 [ 0.06, 14.98 ]
Total events: 1 (Cerclage), 1 (No cerclage)
Heterogeneity: not applicable
Test for overall effect: Z = 0.04 (P = 0.97)
Total (95% CI) 418 421 100.0 % 0.83 [ 0.23, 3.09 ]
Total events: 4 (Cerclage), 5 (No cerclage)
Heterogeneity: Tau2 = 0.0; Chi2 = 2.29, df = 4 (P = 0.68); I2 =0.0%
Test for overall effect: Z = 0.27 (P = 0.79)
Test for subgroup differences: Chi2 = 0.27, df = 3 (P = 0.97), I2 =0.0%
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Analysis 1.11. Comparison 1 Cerclage versus no cerclage, Outcome 11 Serious respiratory morbidity (RDS
or oxygen dependency after 28 days of life).
Review: Cervical stitch (cerclage) for preventing preterm birth in singleton pregnancy
Comparison: 1 Cerclage versus no cerclage
Outcome: 11 Serious respiratory morbidity (RDS or oxygen dependency after 28 days of life)
Study or subgroup Cerclage No cerclage Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 History-indicated cerclage vs no cerclage
Rush 1984 3/96 1/98 4.2 % 3.06 [ 0.32, 28.93 ]
Subtotal (95% CI) 96 98 4.2 % 3.06 [ 0.32, 28.93 ]
Total events: 3 (Cerclage), 1 (No cerclage)
Heterogeneity: not applicable
Test for overall effect: Z = 0.98 (P = 0.33)
2 One-off ultrasound-indicated cerclage in high risk for PTL vs no cerclage
To 2004 1/26 2/30 7.9 % 0.58 [ 0.06, 6.00 ]
Subtotal (95% CI) 26 30 7.9 % 0.58 [ 0.06, 6.00 ]
Total events: 1 (Cerclage), 2 (No cerclage)
Heterogeneity: not applicable
Test for overall effect: Z = 0.46 (P = 0.65)
3 Serial ultrasound-indicated cerclage in high risk for PTL vs no cerclage
Althuisius 2001 0/19 0/16 Not estimable
Berghella 2004 5/25 5/22 22.5 % 0.88 [ 0.29, 2.64 ]
Owen 2009 13/148 13/152 54.3 % 1.03 [ 0.49, 2.14 ]
Subtotal (95% CI) 192 190 76.7 % 0.98 [ 0.53, 1.81 ]
Total events: 18 (Cerclage), 18 (No cerclage)
Heterogeneity: Chi2 = 0.05, df = 1 (P = 0.82); I2 =0.0%
Test for overall effect: Z = 0.05 (P = 0.96)
4 Physical exam-indicated cerclage in high risk for PTL vs no cerclage
Subtotal (95% CI) 0 0 Not estimable
Total events: 0 (Cerclage), 0 (No cerclage)
Heterogeneity: not applicable
Test for overall effect: not applicable
5 One-off ultrasound-indicated cerclage in low/unspecified risk for PTL vs no cerclage
Berghella 2004 1/3 1/7 2.5 % 2.33 [ 0.21, 26.23 ]
To 2004 3/101 2/96 8.7 % 1.43 [ 0.24, 8.35 ]
Subtotal (95% CI) 104 103 11.2 % 1.63 [ 0.39, 6.86 ]
Total events: 4 (Cerclage), 3 (No cerclage)
Heterogeneity: Chi2 = 0.11, df = 1 (P = 0.74); I2 =0.0%
Test for overall effect: Z = 0.67 (P = 0.50)
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Study or subgroup Cerclage No cerclage Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Total (95% CI) 418 421 100.0 % 1.11 [ 0.66, 1.88 ]
Total events: 26 (Cerclage), 24 (No cerclage)
Heterogeneity: Chi2 = 1.74, df = 5 (P = 0.88); I2 =0.0%
Test for overall effect: Z = 0.40 (P = 0.69)
Test for subgroup differences: Chi2 = 1.51, df = 3 (P = 0.68), I2 =0.0%
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Analysis 1.12. Comparison 1 Cerclage versus no cerclage, Outcome 12 Necrotising enterocolitis.
Review: Cervical stitch (cerclage) for preventing preterm birth in singleton pregnancy
Comparison: 1 Cerclage versus no cerclage
Outcome: 12 Necrotising enterocolitis
Study or subgroup Cerclage No cerclage Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 History-indicated cerclage vs no cerclage
Subtotal (95% CI) 0 0 Not estimable
Total events: 0 (Cerclage), 0 (No cerclage)
Heterogeneity: not applicable
Test for overall effect: not applicable
2 One-off ultrasound-indicated cerclage in high risk for PTL vs no cerclage
Subtotal (95% CI) 0 0 Not estimable
Total events: 0 (Cerclage), 0 (No cerclage)
Heterogeneity: not applicable
Test for overall effect: not applicable
3 Serial ultrasound-indicated cerclage in high risk for PTL vs no cerclage
Althuisius 2001 0/19 0/16 Not estimable
Berghella 2004 1/25 0/2 31.2 % 0.35 [ 0.02, 6.74 ]
Owen 2009 2/148 2/152 68.8 % 1.03 [ 0.15, 7.20 ]
Subtotal (95% CI) 192 170 100.0 % 0.81 [ 0.16, 4.12 ]
Total events: 3 (Cerclage), 2 (No cerclage)
Heterogeneity: Chi2 = 0.37, df = 1 (P = 0.54); I2 =0.0%
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Study or subgroup Cerclage No cerclage Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Test for overall effect: Z = 0.25 (P = 0.80)
4 Physical exam-indicated cerclage in high risk for PTL vs no cerclage
Subtotal (95% CI) 0 0 Not estimable
Total events: 0 (Cerclage), 0 (No cerclage)
Heterogeneity: not applicable
Test for overall effect: not applicable
5 One-off ultrasound-indicated cerclage in low/unspecified risk for PTL vs no cerclage
Berghella 2004 0/3 0/7 Not estimable
Subtotal (95% CI) 3 7 Not estimable
Total events: 0 (Cerclage), 0 (No cerclage)
Heterogeneity: not applicable
Test for overall effect: not applicable
Total (95% CI) 195 177 100.0 % 0.81 [ 0.16, 4.12 ]
Total events: 3 (Cerclage), 2 (No cerclage)
Heterogeneity: Chi2 = 0.37, df = 1 (P = 0.54); I2 =0.0%
Test for overall effect: Z = 0.25 (P = 0.80)
Test for subgroup differences: Not applicable
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Analysis 1.13. Comparison 1 Cerclage versus no cerclage, Outcome 13 Retinopathy of prematurity.
Review: Cervical stitch (cerclage) for preventing preterm birth in singleton pregnancy
Comparison: 1 Cerclage versus no cerclage
Outcome: 13 Retinopathy of prematurity
Study or subgroup Cerclage No cerclage Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 History-indicated cerclage vs no cerclage
Subtotal (95% CI) 0 0 Not estimable
Total events: 0 (Cerclage), 0 (No cerclage)
Heterogeneity: not applicable
Test for overall effect: not applicable
2 One-off ultrasound-indicated cerclage in high risk for PTL vs no cerclage
To 2004 0/26 2/30 26.5 % 0.23 [ 0.01, 4.58 ]
Subtotal (95% CI) 26 30 26.5 % 0.23 [ 0.01, 4.58 ]
Total events: 0 (Cerclage), 2 (No cerclage)
Heterogeneity: not applicable
Test for overall effect: Z = 0.96 (P = 0.34)
3 Serial ultrasound-indicated cerclage in high risk for PTL vs no cerclage
Owen 2009 3/148 5/152 56.1 % 0.62 [ 0.15, 2.53 ]
Subtotal (95% CI) 148 152 56.1 % 0.62 [ 0.15, 2.53 ]
Total events: 3 (Cerclage), 5 (No cerclage)
Heterogeneity: not applicable
Test for overall effect: Z = 0.67 (P = 0.50)
4 Physical exam-indicated cerclage in high risk for PTL vs no cerclage
Subtotal (95% CI) 0 0 Not estimable
Total events: 0 (Cerclage), 0 (No cerclage)
Heterogeneity: not applicable
Test for overall effect: not applicable
5 One-off ultrasound-indicated cerclage in low/unspecified risk for PTL vs no cerclage
To 2004 0/101 1/96 17.5 % 0.32 [ 0.01, 7.69 ]
Subtotal (95% CI) 101 96 17.5 % 0.32 [ 0.01, 7.69 ]
Total events: 0 (Cerclage), 1 (No cerclage)
Heterogeneity: not applicable
Test for overall effect: Z = 0.71 (P = 0.48)
Total (95% CI) 275 278 100.0 % 0.46 [ 0.14, 1.48 ]
Total events: 3 (Cerclage), 8 (No cerclage)
Heterogeneity: Chi2 = 0.42, df = 2 (P = 0.81); I2 =0.0%
Test for overall effect: Z = 1.30 (P = 0.19)
Test for subgroup differences: Chi2 = 0.42, df = 2 (P = 0.81), I2 =0.0%
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Analysis 1.14. Comparison 1 Cerclage versus no cerclage, Outcome 14 Apgar < 7 at 5 minutes.
Review: Cervical stitch (cerclage) for preventing preterm birth in singleton pregnancy
Comparison: 1 Cerclage versus no cerclage
Outcome: 14 Apgar < 7 at 5 minutes
Study or subgroup Cerclage No cerclage Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 History-indicated cerclage vs no cerclage
Subtotal (95% CI) 0 0 Not estimable
Total events: 0 (Cerclage), 0 (No cerclage)
Heterogeneity: not applicable
Test for overall effect: not applicable
2 One-off ultrasound-indicated cerclage in high risk for PTL vs no cerclage
Subtotal (95% CI) 0 0 Not estimable
Total events: 0 (Cerclage), 0 (No cerclage)
Heterogeneity: not applicable
Test for overall effect: not applicable
3 Serial ultrasound-indicated cerclage in high risk for PTL vs no cerclage
Owen 2009 19/148 29/153 100.0 % 0.68 [ 0.40, 1.15 ]
Subtotal (95% CI) 148 153 100.0 % 0.68 [ 0.40, 1.15 ]
Total events: 19 (Cerclage), 29 (No cerclage)
Heterogeneity: not applicable
Test for overall effect: Z = 1.43 (P = 0.15)
4 Physical exam-indicated cerclage in high risk for PTL vs no cerclage
Subtotal (95% CI) 0 0 Not estimable
Total events: 0 (Cerclage), 0 (No cerclage)
Heterogeneity: not applicable
Test for overall effect: not applicable
5 One-off ultrasound-indicated cerclage in low/unspecified risk for PTL vs no cerclage
Subtotal (95% CI) 0 0 Not estimable
Total events: 0 (Cerclage), 0 (No cerclage)
Heterogeneity: not applicable
Test for overall effect: not applicable
Total (95% CI) 148 153 100.0 % 0.68 [ 0.40, 1.15 ]
Total events: 19 (Cerclage), 29 (No cerclage)
Heterogeneity: not applicable
Test for overall effect: Z = 1.43 (P = 0.15)
Test for subgroup differences: Not applicable
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Analysis 1.15. Comparison 1 Cerclage versus no cerclage, Outcome 15 Caesarean section (elective and
emergency).
Review: Cervical stitch (cerclage) for preventing preterm birth in singleton pregnancy
Comparison: 1 Cerclage versus no cerclage
Outcome: 15 Caesarean section (elective and emergency)
Study or subgroup Cerclage No cerclage Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 History-indicated cerclage vs no cerclage
Lazar 1984 33/268 22/238 10.9 % 1.33 [ 0.80, 2.22 ]
MRC/RCOG 1993 91/635 77/629 36.2 % 1.17 [ 0.88, 1.55 ]
Rush 1984 19/96 16/98 7.4 % 1.21 [ 0.66, 2.21 ]
Subtotal (95% CI) 999 965 54.6 % 1.21 [ 0.96, 1.52 ]
Total events: 143 (Cerclage), 115 (No cerclage)
Heterogeneity: Chi2 = 0.19, df = 2 (P = 0.91); I2 =0.0%
Test for overall effect: Z = 1.62 (P = 0.10)
2 One-off ultrasound-indicated cerclage in high risk for PTL vs no cerclage
To 2004 7/26 6/30 2.6 % 1.35 [ 0.52, 3.50 ]
Subtotal (95% CI) 26 30 2.6 % 1.35 [ 0.52, 3.50 ]
Total events: 7 (Cerclage), 6 (No cerclage)
Heterogeneity: not applicable
Test for overall effect: Z = 0.61 (P = 0.54)
3 Serial ultrasound-indicated cerclage in high risk for PTL vs no cerclage
Althuisius 2001 4/19 3/16 1.5 % 1.12 [ 0.29, 4.29 ]
Berghella 2004 6/25 7/22 3.5 % 0.75 [ 0.30, 1.91 ]
Owen 2009 46/148 37/153 17.0 % 1.29 [ 0.89, 1.86 ]
Rust 2000 14/61 18/66 8.1 % 0.84 [ 0.46, 1.54 ]
Subtotal (95% CI) 253 257 30.1 % 1.10 [ 0.82, 1.46 ]
Total events: 70 (Cerclage), 65 (No cerclage)
Heterogeneity: Chi2 = 2.07, df = 3 (P = 0.56); I2 =0.0%
Test for overall effect: Z = 0.62 (P = 0.53)
4 Physical exam-indicated cerclage in high risk for PTL vs no cerclage
Subtotal (95% CI) 0 0 Not estimable
Total events: 0 (Cerclage), 0 (No cerclage)
Heterogeneity: not applicable
Test for overall effect: not applicable
5 One-off ultrasound-indicated cerclage in low/unspecified risk for PTL vs no cerclage
Berghella 2004 0/3 0/7 Not estimable
Rust 2000 11/43 9/37 4.5 % 1.05 [ 0.49, 2.26 ]
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(. . . Continued)
Study or subgroup Cerclage No cerclage Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
To 2004 26/101 17/96 8.2 % 1.45 [ 0.84, 2.50 ]
Subtotal (95% CI) 147 140 12.7 % 1.31 [ 0.84, 2.04 ]
Total events: 37 (Cerclage), 26 (No cerclage)
Heterogeneity: Chi2 = 0.46, df = 1 (P = 0.50); I2 =0.0%
Test for overall effect: Z = 1.20 (P = 0.23)
Total (95% CI) 1425 1392 100.0 % 1.19 [ 1.01, 1.40 ]
Total events: 257 (Cerclage), 212 (No cerclage)
Heterogeneity: Chi2 = 3.25, df = 9 (P = 0.95); I2 =0.0%
Test for overall effect: Z = 2.09 (P = 0.037)
Test for subgroup differences: Chi2 = 0.57, df = 3 (P = 0.90), I2 =0.0%
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Analysis 1.16. Comparison 1 Cerclage versus no cerclage, Outcome 16 Maternal side effects (vaginal
discharge, bleeding, pyrexia not requiring antibiotics).
Review: Cervical stitch (cerclage) for preventing preterm birth in singleton pregnancy
Comparison: 1 Cerclage versus no cerclage
Outcome: 16 Maternal side effects (vaginal discharge, bleeding, pyrexia not requiring antibiotics)
Study or subgroup Cerclage No cerclage Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
1 History-indicated cerclage vs no cerclage
Lazar 1984 60/268 43/238 47.9 % 1.24 [ 0.87, 1.76 ]
Rush 1984 11/96 4/98 29.7 % 2.81 [ 0.93, 8.51 ]
Subtotal (95% CI) 364 336 77.6 % 1.57 [ 0.76, 3.24 ]
Total events: 71 (Cerclage), 47 (No cerclage)
Heterogeneity: Tau2 = 0.16; Chi2 = 1.92, df = 1 (P = 0.17); I2 =48%
Test for overall effect: Z = 1.21 (P = 0.23)
2 One-off ultrasound-indicated cerclage in high risk for PTL vs no cerclage
Subtotal (95% CI) 0 0 Not estimable
Total events: 0 (Cerclage), 0 (No cerclage)
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(. . . Continued)
Study or subgroup Cerclage No cerclage Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
Heterogeneity: not applicable
Test for overall effect: not applicable
3 Serial ultrasound-indicated cerclage in high risk for PTL vs no cerclage
Subtotal (95% CI) 0 0 Not estimable
Total events: 0 (Cerclage), 0 (No cerclage)
Heterogeneity: not applicable
Test for overall effect: not applicable
4 Physical exam-indicated cerclage in high risk for PTL vs no cerclage
Subtotal (95% CI) 0 0 Not estimable
Total events: 0 (Cerclage), 0 (No cerclage)
Heterogeneity: not applicable
Test for overall effect: not applicable
5 One-off ultrasound-indicated cerclage in low/unspecified risk for PTL vs no cerclage
To 2004 12/127 2/126 22.4 % 5.95 [ 1.36, 26.06 ]
Subtotal (95% CI) 127 126 22.4 % 5.95 [ 1.36, 26.06 ]
Total events: 12 (Cerclage), 2 (No cerclage)
Heterogeneity: not applicable
Test for overall effect: Z = 2.37 (P = 0.018)
Total (95% CI) 491 462 100.0 % 2.25 [ 0.89, 5.69 ]
Total events: 83 (Cerclage), 49 (No cerclage)
Heterogeneity: Tau2 = 0.44; Chi2 = 5.83, df = 2 (P = 0.05); I2 =66%
Test for overall effect: Z = 1.70 (P = 0.088)
Test for subgroup differences: Chi2 = 2.53, df = 1 (P = 0.11), I2 =60%
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Analysis 1.17. Comparison 1 Cerclage versus no cerclage, Outcome 17 Pyrexia.
Review: Cervical stitch (cerclage) for preventing preterm birth in singleton pregnancy
Comparison: 1 Cerclage versus no cerclage
Outcome: 17 Pyrexia
Study or subgroup Cerclage No cerclage Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 History-indicated vs. no cerclage
MRC/RCOG 1993 23/407 11/391 69.4 % 2.01 [ 0.99, 4.07 ]
Rush 1984 11/96 4/98 24.5 % 2.81 [ 0.93, 8.51 ]
Subtotal (95% CI) 503 489 93.9 % 2.22 [ 1.22, 4.01 ]
Total events: 34 (Cerclage), 15 (No cerclage)
Heterogeneity: Chi2 = 0.25, df = 1 (P = 0.62); I2 =0.0%
Test for overall effect: Z = 2.63 (P = 0.0085)
2 One-off ultrasound-indicated cerclage in high risk for PTL vs no cerclage
To 2004 1/26 0/30 2.9 % 3.44 [ 0.15, 81.09 ]
Subtotal (95% CI) 26 30 2.9 % 3.44 [ 0.15, 81.09 ]
Total events: 1 (Cerclage), 0 (No cerclage)
Heterogeneity: not applicable
Test for overall effect: Z = 0.77 (P = 0.44)
3 One-off ultrasound-indicated cerclage in low/unspecified risk for PTL vs no cerclage
To 2004 3/101 0/96 3.2 % 6.66 [ 0.35, 127.20 ]
Subtotal (95% CI) 101 96 3.2 % 6.66 [ 0.35, 127.20 ]
Total events: 3 (Cerclage), 0 (No cerclage)
Heterogeneity: not applicable
Test for overall effect: Z = 1.26 (P = 0.21)
Total (95% CI) 630 615 100.0 % 2.39 [ 1.35, 4.23 ]
Total events: 38 (Cerclage), 15 (No cerclage)
Heterogeneity: Chi2 = 0.83, df = 3 (P = 0.84); I2 =0.0%
Test for overall effect: Z = 3.00 (P = 0.0027)
Test for subgroup differences: Chi2 = 0.57, df = 2 (P = 0.75), I2 =0.0%
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Analysis 1.18. Comparison 1 Cerclage versus no cerclage, Outcome 18 Any intravenous, oral or combined
tocolysis (not prespecified).
Review: Cervical stitch (cerclage) for preventing preterm birth in singleton pregnancy
Comparison: 1 Cerclage versus no cerclage
Outcome: 18 Any intravenous, oral or combined tocolysis (not prespecified)
Study or subgroup Cerclage No cerclage Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 History-indicated vs. no cerclage
Rush 1984 12/96 8/98 46.7 % 1.53 [ 0.66, 3.58 ]
Subtotal (95% CI) 96 98 46.7 % 1.53 [ 0.66, 3.58 ]
Total events: 12 (Cerclage), 8 (No cerclage)
Heterogeneity: not applicable
Test for overall effect: Z = 0.98 (P = 0.33)
2 Physical exam-indicated cerclage in high risk for PTL versus no cerclage
Althuisius 2003 11/13 8/10 53.3 % 1.06 [ 0.72, 1.56 ]
Subtotal (95% CI) 13 10 53.3 % 1.06 [ 0.72, 1.56 ]
Total events: 11 (Cerclage), 8 (No cerclage)
Heterogeneity: not applicable
Test for overall effect: Z = 0.28 (P = 0.78)
Total (95% CI) 109 108 100.0 % 1.28 [ 0.80, 2.05 ]
Total events: 23 (Cerclage), 16 (No cerclage)
Heterogeneity: Chi2 = 1.10, df = 1 (P = 0.29); I2 =9%
Test for overall effect: Z = 1.02 (P = 0.31)
Test for subgroup differences: Chi2 = 0.60, df = 1 (P = 0.44), I2 =0.0%
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Analysis 1.19. Comparison 1 Cerclage versus no cerclage, Outcome 19 PPROM (not prespecified).
Review: Cervical stitch (cerclage) for preventing preterm birth in singleton pregnancy
Comparison: 1 Cerclage versus no cerclage
Outcome: 19 PPROM (not prespecified)
Study or subgroup Cerclage No cerclage Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
1 History-indicated vs. no cerclage
MRC/RCOG 1993 3/635 0/629 2.1 % 6.93 [ 0.36, 133.96 ]
Rush 1984 17/96 12/98 19.7 % 1.45 [ 0.73, 2.86 ]
Subtotal (95% CI) 731 727 21.8 % 1.63 [ 0.71, 3.70 ]
Total events: 20 (Cerclage), 12 (No cerclage)
Heterogeneity: Tau2 = 0.07; Chi2 = 1.06, df = 1 (P = 0.30); I2 =5%
Test for overall effect: Z = 1.16 (P = 0.25)
2 One-off ultrasound-indicated cerclage in high risk for PTL vs no cerclage
To 2004 3/26 7/30 9.3 % 0.49 [ 0.14, 1.72 ]
Subtotal (95% CI) 26 30 9.3 % 0.49 [ 0.14, 1.72 ]
Total events: 3 (Cerclage), 7 (No cerclage)
Heterogeneity: not applicable
Test for overall effect: Z = 1.11 (P = 0.27)
3 Serial ultrasound-indicated cerclage in high risk for PTL vs no cerclage
Althuisius 2001 0/19 8/16 2.3 % 0.05 [ 0.00, 0.80 ]
Berghella 2004 8/25 9/22 17.7 % 0.78 [ 0.37, 1.67 ]
Rust 2000 5/61 9/66 12.1 % 0.60 [ 0.21, 1.69 ]
Subtotal (95% CI) 105 104 32.2 % 0.51 [ 0.18, 1.45 ]
Total events: 13 (Cerclage), 26 (No cerclage)
Heterogeneity: Tau2 = 0.43; Chi2 = 4.32, df = 2 (P = 0.12); I2 =54%
Test for overall effect: Z = 1.26 (P = 0.21)
4 One-off ultrasound-indicated cerclage in low/unspecified risk for PTL vs no cerclage
Berghella 2004 0/3 1/7 2.1 % 0.67 [ 0.03, 12.96 ]
Rust 2000 8/43 7/37 14.3 % 0.98 [ 0.39, 2.45 ]
To 2004 20/101 12/96 20.4 % 1.58 [ 0.82, 3.06 ]
Subtotal (95% CI) 147 140 36.8 % 1.32 [ 0.78, 2.23 ]
Total events: 28 (Cerclage), 20 (No cerclage)
Heterogeneity: Tau2 = 0.0; Chi2 = 0.90, df = 2 (P = 0.64); I2 =0.0%
Test for overall effect: Z = 1.02 (P = 0.31)
Total (95% CI) 1009 1001 100.0 % 0.96 [ 0.62, 1.48 ]
Total events: 64 (Cerclage), 65 (No cerclage)
Heterogeneity: Tau2 = 0.13; Chi2 = 11.86, df = 8 (P = 0.16); I2 =33%
Test for overall effect: Z = 0.20 (P = 0.84)
Test for subgroup differences: Chi2 = 4.96, df = 3 (P = 0.17), I2 =40%
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Analysis 1.20. Comparison 1 Cerclage versus no cerclage, Outcome 20 Chorioamnionitis (not prespecified).
Review: Cervical stitch (cerclage) for preventing preterm birth in singleton pregnancy
Comparison: 1 Cerclage versus no cerclage
Outcome: 20 Chorioamnionitis (not prespecified)
Study or subgroup Cerclage No cerclage Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
1 History-indicated vs. no cerclage
MRC/RCOG 1993 1/635 0/629 10.5 % 2.97 [ 0.12, 72.81 ]
Subtotal (95% CI) 635 629 10.5 % 2.97 [ 0.12, 72.81 ]
Total events: 1 (Cerclage), 0 (No cerclage)
Heterogeneity: not applicable
Test for overall effect: Z = 0.67 (P = 0.50)
2 Serial ultrasound-indicated cerclage in high risk for PTL vs no cerclage
Althuisius 2001 1/19 9/16 20.4 % 0.09 [ 0.01, 0.66 ]
Rust 2000 10/61 8/66 37.4 % 1.35 [ 0.57, 3.20 ]
Subtotal (95% CI) 80 82 57.8 % 0.41 [ 0.03, 6.21 ]
Total events: 11 (Cerclage), 17 (No cerclage)
Heterogeneity: Tau2 = 3.31; Chi2 = 6.56, df = 1 (P = 0.01); I2 =85%
Test for overall effect: Z = 0.65 (P = 0.52)
3 One-off ultrasound-indicated cerclage in low/unspecified risk for PTL vs no cerclage
Rust 2000 6/43 4/37 31.7 % 1.29 [ 0.39, 4.23 ]
Subtotal (95% CI) 43 37 31.7 % 1.29 [ 0.39, 4.23 ]
Total events: 6 (Cerclage), 4 (No cerclage)
Heterogeneity: not applicable
Test for overall effect: Z = 0.42 (P = 0.67)
Total (95% CI) 758 748 100.0 % 0.84 [ 0.26, 2.72 ]
Total events: 18 (Cerclage), 21 (No cerclage)
Heterogeneity: Tau2 = 0.77; Chi2 = 7.19, df = 3 (P = 0.07); I2 =58%
Test for overall effect: Z = 0.29 (P = 0.77)
Test for subgroup differences: Chi2 = 0.93, df = 2 (P = 0.63), I2 =0.0%
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Analysis 2.1. Comparison 2 Cerclage versus vaginal progesterone, Outcome 1 All perinatal losses.
Review: Cervical stitch (cerclage) for preventing preterm birth in singleton pregnancy
Comparison: 2 Cerclage versus vaginal progesterone
Outcome: 1 All perinatal losses
Study or subgroup Cerclage Vaginal progesterone Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Chandiramani 2010 5/19 5/17 80.5 % 0.89 [ 0.31, 2.56 ]
Ionescu 2012 2/46 1/26 19.5 % 1.13 [ 0.11, 11.87 ]
Total (95% CI) 65 43 100.0 % 0.94 [ 0.36, 2.48 ]
Total events: 7 (Cerclage), 6 (Vaginal progesterone)
Heterogeneity: Chi2 = 0.03, df = 1 (P = 0.86); I2 =0.0%
Test for overall effect: Z = 0.12 (P = 0.90)
Test for subgroup differences: Not applicable
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Analysis 2.2. Comparison 2 Cerclage versus vaginal progesterone, Outcome 2 Serious neonatal morbidity.
Review: Cervical stitch (cerclage) for preventing preterm birth in singleton pregnancy
Comparison: 2 Cerclage versus vaginal progesterone
Outcome: 2 Serious neonatal morbidity
Study or subgroup Cerclage Vaginal progesterone Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
Chandiramani 2010 (1) 2/15 11/13 49.3 % 0.16 [ 0.04, 0.58 ]
Ionescu 2012 6/46 4/46 50.7 % 1.50 [ 0.45, 4.97 ]
Total (95% CI) 61 59 100.0 % 0.49 [ 0.05, 4.52 ]
Total events: 8 (Cerclage), 15 (Vaginal progesterone)
Heterogeneity: Tau2 = 2.14; Chi2 = 6.22, df = 1 (P = 0.01); I2 =84%
Test for overall effect: Z = 0.62 (P = 0.53)
Test for subgroup differences: Not applicable
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(1) Includes neonatal infection (4 progesterone; 2 cerclage); RDS (4 progesterone); Brain abnormality on ultrasound (2 progesterone); IVH (1 progesterone).
Analysis 2.3. Comparison 2 Cerclage versus vaginal progesterone, Outcome 3 Baby discharged home
healthy.
Review: Cervical stitch (cerclage) for preventing preterm birth in singleton pregnancy
Comparison: 2 Cerclage versus vaginal progesterone
Outcome: 3 Baby discharged home healthy
Study or subgroup Cerclage Vaginal progesterone Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Chandiramani 2010 14/15 11/12 21.7 % 1.02 [ 0.82, 1.27 ]
Ionescu 2012 42/46 44/46 78.3 % 0.95 [ 0.86, 1.06 ]
Total (95% CI) 61 58 100.0 % 0.97 [ 0.88, 1.07 ]
Total events: 56 (Cerclage), 55 (Vaginal progesterone)
Heterogeneity: Chi2 = 0.27, df = 1 (P = 0.60); I2 =0.0%
Test for overall effect: Z = 0.65 (P = 0.52)
Test for subgroup differences: Not applicable
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Analysis 2.4. Comparison 2 Cerclage versus vaginal progesterone, Outcome 4 Stillbirths.
Review: Cervical stitch (cerclage) for preventing preterm birth in singleton pregnancy
Comparison: 2 Cerclage versus vaginal progesterone
Outcome: 4 Stillbirths
Study or subgroup Cerclage Vaginal progesterone Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Chandiramani 2010 1/19 0/17 100.0 % 2.70 [ 0.12, 62.17 ]
Ionescu 2012 0/46 0/46 Not estimable
Total (95% CI) 65 63 100.0 % 2.70 [ 0.12, 62.17 ]
Total events: 1 (Cerclage), 0 (Vaginal progesterone)
Heterogeneity: not applicable
Test for overall effect: Z = 0.62 (P = 0.53)
Test for subgroup differences: Not applicable
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Analysis 2.5. Comparison 2 Cerclage versus vaginal progesterone, Outcome 5 Neonatal deaths before
discharge.
Review: Cervical stitch (cerclage) for preventing preterm birth in singleton pregnancy
Comparison: 2 Cerclage versus vaginal progesterone
Outcome: 5 Neonatal deaths before discharge
Study or subgroup Cerclage Vaginal progesterone Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Chandiramani 2010 1/15 1/13 68.2 % 0.87 [ 0.06, 12.52 ]
Ionescu 2012 2/46 0/46 31.8 % 5.00 [ 0.25, 101.37 ]
Total (95% CI) 61 59 100.0 % 2.18 [ 0.34, 13.86 ]
Total events: 3 (Cerclage), 1 (Vaginal progesterone)
Heterogeneity: Chi2 = 0.75, df = 1 (P = 0.39); I2 =0.0%
Test for overall effect: Z = 0.83 (P = 0.41)
Test for subgroup differences: Not applicable
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Analysis 2.6. Comparison 2 Cerclage versus vaginal progesterone, Outcome 6 Miscarriages.
Review: Cervical stitch (cerclage) for preventing preterm birth in singleton pregnancy
Comparison: 2 Cerclage versus vaginal progesterone
Outcome: 6 Miscarriages
Study or subgroup Cerclage Vaginal progesterone Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Chandiramani 2010 3/19 4/17 73.8 % 0.67 [ 0.17, 2.58 ]
Ionescu 2012 0/46 1/46 26.2 % 0.33 [ 0.01, 7.98 ]
Total (95% CI) 65 63 100.0 % 0.58 [ 0.17, 2.01 ]
Total events: 3 (Cerclage), 5 (Vaginal progesterone)
Heterogeneity: Chi2 = 0.16, df = 1 (P = 0.69); I2 =0.0%
Test for overall effect: Z = 0.86 (P = 0.39)
Test for subgroup differences: Not applicable
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Analysis 2.7. Comparison 2 Cerclage versus vaginal progesterone, Outcome 7 Preterm birth before 37
completed weeks.
Review: Cervical stitch (cerclage) for preventing preterm birth in singleton pregnancy
Comparison: 2 Cerclage versus vaginal progesterone
Outcome: 7 Preterm birth before 37 completed weeks
Study or subgroup Cerclage Vaginal progesterone Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Chandiramani 2010 10/19 9/17 76.0 % 0.99 [ 0.54, 1.85 ]
Ionescu 2012 5/46 3/46 24.0 % 1.67 [ 0.42, 6.57 ]
Total (95% CI) 65 63 100.0 % 1.16 [ 0.64, 2.08 ]
Total events: 15 (Cerclage), 12 (Vaginal progesterone)
Heterogeneity: Chi2 = 0.50, df = 1 (P = 0.48); I2 =0.0%
Test for overall effect: Z = 0.48 (P = 0.63)
Test for subgroup differences: Not applicable
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Analysis 2.8. Comparison 2 Cerclage versus vaginal progesterone, Outcome 8 Preterm birth before 34
completed weeks.
Review: Cervical stitch (cerclage) for preventing preterm birth in singleton pregnancy
Comparison: 2 Cerclage versus vaginal progesterone
Outcome: 8 Preterm birth before 34 completed weeks
Study or subgroup Cerclage Vaginal progesterone Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Chandiramani 2010 7/19 8/17 73.8 % 0.78 [ 0.36, 1.70 ]
Ionescu 2012 5/46 3/46 26.2 % 1.67 [ 0.42, 6.57 ]
Total (95% CI) 65 63 100.0 % 1.01 [ 0.51, 2.01 ]
Total events: 12 (Cerclage), 11 (Vaginal progesterone)
Heterogeneity: Chi2 = 0.93, df = 1 (P = 0.33); I2 =0.0%
Test for overall effect: Z = 0.04 (P = 0.97)
Test for subgroup differences: Not applicable
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Analysis 2.9. Comparison 2 Cerclage versus vaginal progesterone, Outcome 9 Preterm birth before 28
completed weeks.
Review: Cervical stitch (cerclage) for preventing preterm birth in singleton pregnancy
Comparison: 2 Cerclage versus vaginal progesterone
Outcome: 9 Preterm birth before 28 completed weeks
Study or subgroup Cerclage Vaginal progesterone Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Chandiramani 2010 5/19 6/17 86.4 % 0.75 [ 0.28, 2.01 ]
Ionescu 2012 2/46 1/46 13.6 % 2.00 [ 0.19, 21.30 ]
Total (95% CI) 65 63 100.0 % 0.92 [ 0.37, 2.27 ]
Total events: 7 (Cerclage), 7 (Vaginal progesterone)
Heterogeneity: Chi2 = 0.59, df = 1 (P = 0.44); I2 =0.0%
Test for overall effect: Z = 0.19 (P = 0.85)
Test for subgroup differences: Not applicable
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Analysis 2.10. Comparison 2 Cerclage versus vaginal progesterone, Outcome 10 Serious intracranial
pathology (IVH or periventricular leucomalacia).
Review: Cervical stitch (cerclage) for preventing preterm birth in singleton pregnancy
Comparison: 2 Cerclage versus vaginal progesterone
Outcome: 10 Serious intracranial pathology (IVH or periventricular leucomalacia)
Study or subgroup Cerclage Vaginal progesterone Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Chandiramani 2010 0/19 1/17 61.2 % 0.30 [ 0.01, 6.91 ]
Ionescu 2012 2/46 1/46 38.8 % 2.00 [ 0.19, 21.30 ]
Total (95% CI) 65 63 100.0 % 0.96 [ 0.17, 5.28 ]
Total events: 2 (Cerclage), 2 (Vaginal progesterone)
Heterogeneity: Chi2 = 0.90, df = 1 (P = 0.34); I2 =0.0%
Test for overall effect: Z = 0.05 (P = 0.96)
Test for subgroup differences: Not applicable
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Analysis 2.11. Comparison 2 Cerclage versus vaginal progesterone, Outcome 11 Serious respiratory
morbidity (RDS or oxygen dependency after 28 days of life).
Review: Cervical stitch (cerclage) for preventing preterm birth in singleton pregnancy
Comparison: 2 Cerclage versus vaginal progesterone
Outcome: 11 Serious respiratory morbidity (RDS or oxygen dependency after 28 days of life)
Study or subgroup Cerclage Vaginal progesterone Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
Chandiramani 2010 0/19 4/17 39.2 % 0.10 [ 0.01, 1.73 ]
Ionescu 2012 4/46 3/46 60.8 % 1.33 [ 0.32, 5.63 ]
Total (95% CI) 65 63 100.0 % 0.48 [ 0.04, 6.41 ]
Total events: 4 (Cerclage), 7 (Vaginal progesterone)
Heterogeneity: Tau2 = 2.32; Chi2 = 2.75, df = 1 (P = 0.10); I2 =64%
Test for overall effect: Z = 0.55 (P = 0.58)
Test for subgroup differences: Not applicable
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Analysis 2.12. Comparison 2 Cerclage versus vaginal progesterone, Outcome 12 Necrotising enterocolitis.
Review: Cervical stitch (cerclage) for preventing preterm birth in singleton pregnancy
Comparison: 2 Cerclage versus vaginal progesterone
Outcome: 12 Necrotising enterocolitis
Study or subgroup Cerclage Vaginal progesterone Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Ionescu 2012 1/46 0/46 100.0 % 3.00 [ 0.13, 71.78 ]
Total (95% CI) 46 46 100.0 % 3.00 [ 0.13, 71.78 ]
Total events: 1 (Cerclage), 0 (Vaginal progesterone)
Heterogeneity: not applicable
Test for overall effect: Z = 0.68 (P = 0.50)
Test for subgroup differences: Not applicable
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Analysis 2.13. Comparison 2 Cerclage versus vaginal progesterone, Outcome 13 Retinopathy of
prematurity.
Review: Cervical stitch (cerclage) for preventing preterm birth in singleton pregnancy
Comparison: 2 Cerclage versus vaginal progesterone
Outcome: 13 Retinopathy of prematurity
Study or subgroup Cerclage Vaginal progesterone Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Ionescu 2012 1/46 1/46 100.0 % 1.00 [ 0.06, 15.51 ]
Total (95% CI) 46 46 100.0 % 1.00 [ 0.06, 15.51 ]
Total events: 1 (Cerclage), 1 (Vaginal progesterone)
Heterogeneity: not applicable
Test for overall effect: Z = 0.0 (P = 1.0)
Test for subgroup differences: Not applicable
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Analysis 2.14. Comparison 2 Cerclage versus vaginal progesterone, Outcome 14 Apgar < 7 at 5 minutes.
Review: Cervical stitch (cerclage) for preventing preterm birth in singleton pregnancy
Comparison: 2 Cerclage versus vaginal progesterone
Outcome: 14 Apgar < 7 at 5 minutes
Study or subgroup Cerclage Vaginal progesterone Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Chandiramani 2010 1/15 1/13 51.7 % 0.87 [ 0.06, 12.52 ]
Ionescu 2012 3/46 1/46 48.3 % 3.00 [ 0.32, 27.79 ]
Total (95% CI) 61 59 100.0 % 1.90 [ 0.37, 9.80 ]
Total events: 4 (Cerclage), 2 (Vaginal progesterone)
Heterogeneity: Chi2 = 0.49, df = 1 (P = 0.48); I2 =0.0%
Test for overall effect: Z = 0.76 (P = 0.45)
Test for subgroup differences: Not applicable
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Analysis 2.15. Comparison 2 Cerclage versus vaginal progesterone, Outcome 15 Caesarean section
(elective and emergency).
Review: Cervical stitch (cerclage) for preventing preterm birth in singleton pregnancy
Comparison: 2 Cerclage versus vaginal progesterone
Outcome: 15 Caesarean section (elective and emergency)
Study or subgroup Cerclage Vaginal progesterone Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
Chandiramani 2010 2/19 6/17 35.9 % 0.30 [ 0.07, 1.28 ]
Ionescu 2012 35/46 33/46 64.1 % 1.06 [ 0.83, 1.35 ]
Total (95% CI) 65 63 100.0 % 0.67 [ 0.18, 2.47 ]
Total events: 37 (Cerclage), 39 (Vaginal progesterone)
Heterogeneity: Tau2 = 0.67; Chi2 = 3.35, df = 1 (P = 0.07); I2 =70%
Test for overall effect: Z = 0.60 (P = 0.55)
Test for subgroup differences: Not applicable
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Analysis 2.17. Comparison 2 Cerclage versus vaginal progesterone, Outcome 17 Maternal side effects
(vaginal discharge, bleeding, pyrexia not requiring antibiotics).
Review: Cervical stitch (cerclage) for preventing preterm birth in singleton pregnancy
Comparison: 2 Cerclage versus vaginal progesterone
Outcome: 17 Maternal side effects (vaginal discharge, bleeding, pyrexia not requiring antibiotics)
Study or subgroup Cerclage Vaginal progesterone Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Ionescu 2012 3/46 1/46 100.0 % 3.00 [ 0.32, 27.79 ]
Total (95% CI) 46 46 100.0 % 3.00 [ 0.32, 27.79 ]
Total events: 3 (Cerclage), 1 (Vaginal progesterone)
Heterogeneity: not applicable
Test for overall effect: Z = 0.97 (P = 0.33)
Test for subgroup differences: Not applicable
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Analysis 2.18. Comparison 2 Cerclage versus vaginal progesterone, Outcome 18 Pyrexia.
Review: Cervical stitch (cerclage) for preventing preterm birth in singleton pregnancy
Comparison: 2 Cerclage versus vaginal progesterone
Outcome: 18 Pyrexia
Study or subgroup Cerclage Vaginal progesterone Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Ionescu 2012 0/46 0/46 Not estimable
Total (95% CI) 46 46 Not estimable
Total events: 0 (Cerclage), 0 (Vaginal progesterone)
Heterogeneity: not applicable
Test for overall effect: not applicable
Test for subgroup differences: Not applicable
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Analysis 2.19. Comparison 2 Cerclage versus vaginal progesterone, Outcome 19 Any intravenous, oral or
combined tocolysis (not prespecified).
Review: Cervical stitch (cerclage) for preventing preterm birth in singleton pregnancy
Comparison: 2 Cerclage versus vaginal progesterone
Outcome: 19 Any intravenous, oral or combined tocolysis (not prespecified)
Study or subgroup Cerclage Vaginal progesterone Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Ionescu 2012 30/46 8/46 100.0 % 3.75 [ 1.93, 7.29 ]
Total (95% CI) 46 46 100.0 % 3.75 [ 1.93, 7.29 ]
Total events: 30 (Cerclage), 8 (Vaginal progesterone)
Heterogeneity: not applicable
Test for overall effect: Z = 3.90 (P = 0.000096)
Test for subgroup differences: Not applicable
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Analysis 2.20. Comparison 2 Cerclage versus vaginal progesterone, Outcome 20 PPROM (not prespecified).
Review: Cervical stitch (cerclage) for preventing preterm birth in singleton pregnancy
Comparison: 2 Cerclage versus vaginal progesterone
Outcome: 20 PPROM (not prespecified)
Study or subgroup Cerclage Vaginal progesterone Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Ionescu 2012 8/46 1/46 100.0 % 8.00 [ 1.04, 61.42 ]
Total (95% CI) 46 46 100.0 % 8.00 [ 1.04, 61.42 ]
Total events: 8 (Cerclage), 1 (Vaginal progesterone)
Heterogeneity: not applicable
Test for overall effect: Z = 2.00 (P = 0.046)
Test for subgroup differences: Not applicable
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Analysis 2.21. Comparison 2 Cerclage versus vaginal progesterone, Outcome 21 Chorioamnionitis (not
prespecified).
Review: Cervical stitch (cerclage) for preventing preterm birth in singleton pregnancy
Comparison: 2 Cerclage versus vaginal progesterone
Outcome: 21 Chorioamnionitis (not prespecified)
Study or subgroup Cerclage Vaginal progesterone Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
Chandiramani 2010 1/19 2/17 55.4 % 0.45 [ 0.04, 4.50 ]
Ionescu 2012 3/46 0/46 44.6 % 7.00 [ 0.37, 131.81 ]
Total (95% CI) 65 63 100.0 % 1.53 [ 0.10, 23.61 ]
Total events: 4 (Cerclage), 2 (Vaginal progesterone)
Heterogeneity: Tau2 = 2.14; Chi2 = 2.18, df = 1 (P = 0.14); I2 =54%
Test for overall effect: Z = 0.30 (P = 0.76)
Test for subgroup differences: Not applicable
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Analysis 3.1. Comparison 3 Cerclage versus intramuscular progesterone, Outcome 1 All perinatal losses.
Review: Cervical stitch (cerclage) for preventing preterm birth in singleton pregnancy
Comparison: 3 Cerclage versus intramuscular progesterone
Outcome: 1 All perinatal losses
Study or subgroup Cerclage IM Progesterone Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Keeler 2009 14/42 11/37 100.0 % 1.12 [ 0.58, 2.16 ]
Total (95% CI) 42 37 100.0 % 1.12 [ 0.58, 2.16 ]
Total events: 14 (Cerclage), 11 (IM Progesterone)
Heterogeneity: not applicable
Test for overall effect: Z = 0.34 (P = 0.73)
Test for subgroup differences: Not applicable
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Analysis 3.2. Comparison 3 Cerclage versus intramuscular progesterone, Outcome 2 Serious neonatal
morbidity.
Review: Cervical stitch (cerclage) for preventing preterm birth in singleton pregnancy
Comparison: 3 Cerclage versus intramuscular progesterone
Outcome: 2 Serious neonatal morbidity
Study or subgroup Cerclage IM Progesterone Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Keeler 2009 9/42 7/37 100.0 % 1.13 [ 0.47, 2.74 ]
Total (95% CI) 42 37 100.0 % 1.13 [ 0.47, 2.74 ]
Total events: 9 (Cerclage), 7 (IM Progesterone)
Heterogeneity: not applicable
Test for overall effect: Z = 0.28 (P = 0.78)
Test for subgroup differences: Not applicable
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Analysis 3.3. Comparison 3 Cerclage versus intramuscular progesterone, Outcome 3 Baby discharged
home healthy.
Review: Cervical stitch (cerclage) for preventing preterm birth in singleton pregnancy
Comparison: 3 Cerclage versus intramuscular progesterone
Outcome: 3 Baby discharged home healthy
Study or subgroup Cerclage IM Progesterone Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Keeler 2009 28/42 21/37 100.0 % 1.17 [ 0.82, 1.67 ]
Total (95% CI) 42 37 100.0 % 1.17 [ 0.82, 1.67 ]
Total events: 28 (Cerclage), 21 (IM Progesterone)
Heterogeneity: not applicable
Test for overall effect: Z = 0.89 (P = 0.37)
Test for subgroup differences: Not applicable
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Analysis 3.6. Comparison 3 Cerclage versus intramuscular progesterone, Outcome 6 Miscarriages.
Review: Cervical stitch (cerclage) for preventing preterm birth in singleton pregnancy
Comparison: 3 Cerclage versus intramuscular progesterone
Outcome: 6 Miscarriages
Study or subgroup Cerclage IM Progesterone Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Keeler 2009 5/42 3/37 100.0 % 1.47 [ 0.38, 5.73 ]
Total (95% CI) 42 37 100.0 % 1.47 [ 0.38, 5.73 ]
Total events: 5 (Cerclage), 3 (IM Progesterone)
Heterogeneity: not applicable
Test for overall effect: Z = 0.55 (P = 0.58)
Test for subgroup differences: Not applicable
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Analysis 3.7. Comparison 3 Cerclage versus intramuscular progesterone, Outcome 7 Preterm birth before
37 completed weeks.
Review: Cervical stitch (cerclage) for preventing preterm birth in singleton pregnancy
Comparison: 3 Cerclage versus intramuscular progesterone
Outcome: 7 Preterm birth before 37 completed weeks
Study or subgroup Cerclage IM Progesterone Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Keeler 2009 22/42 22/37 100.0 % 0.88 [ 0.60, 1.30 ]
Total (95% CI) 42 37 100.0 % 0.88 [ 0.60, 1.30 ]
Total events: 22 (Cerclage), 22 (IM Progesterone)
Heterogeneity: not applicable
Test for overall effect: Z = 0.63 (P = 0.53)
Test for subgroup differences: Not applicable
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Analysis 3.9. Comparison 3 Cerclage versus intramuscular progesterone, Outcome 9 Preterm birth before
28 completed weeks.
Review: Cervical stitch (cerclage) for preventing preterm birth in singleton pregnancy
Comparison: 3 Cerclage versus intramuscular progesterone
Outcome: 9 Preterm birth before 28 completed weeks
Study or subgroup Cerclage IM Progesterone Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Keeler 2009 10/42 7/37 100.0 % 1.26 [ 0.53, 2.97 ]
Total (95% CI) 42 37 100.0 % 1.26 [ 0.53, 2.97 ]
Total events: 10 (Cerclage), 7 (IM Progesterone)
Heterogeneity: not applicable
Test for overall effect: Z = 0.52 (P = 0.60)
Test for subgroup differences: Not applicable
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Analysis 3.19. Comparison 3 Cerclage versus intramuscular progesterone, Outcome 19 PPROM (not
prespecified).
Review: Cervical stitch (cerclage) for preventing preterm birth in singleton pregnancy
Comparison: 3 Cerclage versus intramuscular progesterone
Outcome: 19 PPROM (not prespecified)
Study or subgroup Cerclage IM Progesterone Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Keeler 2009 13/42 13/37 100.0 % 0.88 [ 0.47, 1.65 ]
Total (95% CI) 42 37 100.0 % 0.88 [ 0.47, 1.65 ]
Total events: 13 (Cerclage), 13 (IM Progesterone)
Heterogeneity: not applicable
Test for overall effect: Z = 0.39 (P = 0.69)
Test for subgroup differences: Not applicable
0.01 0.1 1 10 100
Favours cerclage Favours progesterone IM
114Cervical stitch (cerclage) for preventing preterm birth in singleton pregnancy (Review)
Copyright © 2017 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Analysis 3.20. Comparison 3 Cerclage versus intramuscular progesterone, Outcome 20 Chorioamnionitis
(not prespecified).
Review: Cervical stitch (cerclage) for preventing preterm birth in singleton pregnancy
Comparison: 3 Cerclage versus intramuscular progesterone
Outcome: 20 Chorioamnionitis (not prespecified)
Study or subgroup Cerclage IM Progesterone Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Keeler 2009 12/42 8/37 100.0 % 1.32 [ 0.61, 2.88 ]
Total (95% CI) 42 37 100.0 % 1.32 [ 0.61, 2.88 ]
Total events: 12 (Cerclage), 8 (IM Progesterone)
Heterogeneity: not applicable
Test for overall effect: Z = 0.70 (P = 0.48)
Test for subgroup differences: Not applicable
0.01 0.1 1 10 100
Favours cerclage Favours progesterone IM
Analysis 5.1. Comparison 5 Any comparison of different cerclage protocols, Outcome 1 All perinatal losses.
Review: Cervical stitch (cerclage) for preventing preterm birth in singleton pregnancy
Comparison: 5 Any comparison of different cerclage protocols
Outcome: 1 All perinatal losses
Study or subgroup
Cerclage
based on
history
Cerclage
based on
US Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 History-indicated cerclage vs ultrasound-indicated cerclage
Simcox 2009 14/125 10/122 100.0 % 1.37 [ 0.63, 2.96 ]
Subtotal (95% CI) 125 122 100.0 % 1.37 [ 0.63, 2.96 ]
Total events: 14 (Cerclage based on history), 10 (Cerclage based on US)
Heterogeneity: not applicable
Test for overall effect: Z = 0.79 (P = 0.43)
Test for subgroup differences: Not applicable
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Analysis 5.2. Comparison 5 Any comparison of different cerclage protocols, Outcome 2 Serious neonatal
morbidity.
Review: Cervical stitch (cerclage) for preventing preterm birth in singleton pregnancy
Comparison: 5 Any comparison of different cerclage protocols
Outcome: 2 Serious neonatal morbidity
Study or subgroup
Cerclage
based on
history
Cerclage
based on
US Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 History-indicated cerclage vs ultrasound-indicated cerclage
Simcox 2009 7/125 4/122 100.0 % 1.71 [ 0.51, 5.69 ]
Subtotal (95% CI) 125 122 100.0 % 1.71 [ 0.51, 5.69 ]
Total events: 7 (Cerclage based on history), 4 (Cerclage based on US)
Heterogeneity: not applicable
Test for overall effect: Z = 0.87 (P = 0.38)
Test for subgroup differences: Not applicable
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Analysis 5.4. Comparison 5 Any comparison of different cerclage protocols, Outcome 4 Stillbirths.
Review: Cervical stitch (cerclage) for preventing preterm birth in singleton pregnancy
Comparison: 5 Any comparison of different cerclage protocols
Outcome: 4 Stillbirths
Study or subgroup
Cerclage
based on
history
Cerclage
based on
US Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 History-indicated cerclage vs ultrasound-indicated cerclage
Simcox 2009 1/125 2/122 100.0 % 0.49 [ 0.04, 5.31 ]
Subtotal (95% CI) 125 122 100.0 % 0.49 [ 0.04, 5.31 ]
Total events: 1 (Cerclage based on history), 2 (Cerclage based on US)
Heterogeneity: not applicable
Test for overall effect: Z = 0.59 (P = 0.56)
Test for subgroup differences: Not applicable
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Analysis 5.5. Comparison 5 Any comparison of different cerclage protocols, Outcome 5 Neonatal deaths
before discharge.
Review: Cervical stitch (cerclage) for preventing preterm birth in singleton pregnancy
Comparison: 5 Any comparison of different cerclage protocols
Outcome: 5 Neonatal deaths before discharge
Study or subgroup
Cerclage
based on
history
Cerclage
based on
US Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 History-indicated cerclage vs ultrasound-indicated cerclage
Simcox 2009 1/125 4/122 100.0 % 0.24 [ 0.03, 2.15 ]
Subtotal (95% CI) 125 122 100.0 % 0.24 [ 0.03, 2.15 ]
Total events: 1 (Cerclage based on history), 4 (Cerclage based on US)
Heterogeneity: not applicable
Test for overall effect: Z = 1.27 (P = 0.20)
2 History-indicated cerclage vs physical exam-indicated cerclage
Subtotal (95% CI) 0 0 Not estimable
Total events: 0 (Cerclage based on history), 0 (Cerclage based on US)
Heterogeneity: not applicable
Test for overall effect: not applicable
Test for subgroup differences: Not applicable
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Analysis 5.6. Comparison 5 Any comparison of different cerclage protocols, Outcome 6 Miscarriages.
Review: Cervical stitch (cerclage) for preventing preterm birth in singleton pregnancy
Comparison: 5 Any comparison of different cerclage protocols
Outcome: 6 Miscarriages
Study or subgroup
Cerclage
based on
history
Cerclage
based on
US Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
1 History-indicated cerclage vs ultrasound-indicated cerclage
Beigi 2005 4/45 5/52 46.6 % 0.92 [ 0.26, 3.24 ]
Simcox 2009 12/125 4/122 53.4 % 2.93 [ 0.97, 8.83 ]
Total (95% CI) 170 174 100.0 % 1.71 [ 0.55, 5.30 ]
Total events: 16 (Cerclage based on history), 9 (Cerclage based on US)
Heterogeneity: Tau2 = 0.31; Chi2 = 1.85, df = 1 (P = 0.17); I2 =46%
Test for overall effect: Z = 0.93 (P = 0.35)
Test for subgroup differences: Not applicable
0.01 0.1 1 10 100
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Analysis 5.7. Comparison 5 Any comparison of different cerclage protocols, Outcome 7 Preterm birth
before 37 completed weeks.
Review: Cervical stitch (cerclage) for preventing preterm birth in singleton pregnancy
Comparison: 5 Any comparison of different cerclage protocols
Outcome: 7 Preterm birth before 37 completed weeks
Study or subgroup
Cerclage
based on
history
Cerclage
based on
US Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 History-indicated cerclage vs ultrasound-indicated cerclage
Beigi 2005 5/45 8/52 100.0 % 0.72 [ 0.25, 2.05 ]
Subtotal (95% CI) 45 52 100.0 % 0.72 [ 0.25, 2.05 ]
Total events: 5 (Cerclage based on history), 8 (Cerclage based on US)
Heterogeneity: not applicable
Test for overall effect: Z = 0.61 (P = 0.54)
Test for subgroup differences: Not applicable
0.01 0.1 1 10 100
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Analysis 5.8. Comparison 5 Any comparison of different cerclage protocols, Outcome 8 Preterm birth
before 34 completed weeks.
Review: Cervical stitch (cerclage) for preventing preterm birth in singleton pregnancy
Comparison: 5 Any comparison of different cerclage protocols
Outcome: 8 Preterm birth before 34 completed weeks
Study or subgroup
Cerclage
based on
history
Cerclage
based on
US Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 History-indicated cerclage vs ultrasound-indicated cerclage
Simcox 2009 19/125 18/122 100.0 % 1.03 [ 0.57, 1.87 ]
Subtotal (95% CI) 125 122 100.0 % 1.03 [ 0.57, 1.87 ]
Total events: 19 (Cerclage based on history), 18 (Cerclage based on US)
Heterogeneity: not applicable
Test for overall effect: Z = 0.10 (P = 0.92)
Test for subgroup differences: Not applicable
0.01 0.1 1 10 100
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Analysis 5.10. Comparison 5 Any comparison of different cerclage protocols, Outcome 10 Serious
intracranial pathology (IVH or periventricular leucomalacia).
Review: Cervical stitch (cerclage) for preventing preterm birth in singleton pregnancy
Comparison: 5 Any comparison of different cerclage protocols
Outcome: 10 Serious intracranial pathology (IVH or periventricular leucomalacia)
Study or subgroup
Cerclage
based on
history
Cerclage
based on
US Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 History-indicated cerclage vs ultrasound-indicated cerclage
Simcox 2009 4/125 2/122 100.0 % 1.95 [ 0.36, 10.46 ]
Subtotal (95% CI) 125 122 100.0 % 1.95 [ 0.36, 10.46 ]
Total events: 4 (Cerclage based on history), 2 (Cerclage based on US)
Heterogeneity: not applicable
Test for overall effect: Z = 0.78 (P = 0.43)
2 History-indicated cerclage vs physical exam-indicated cerclage
Subtotal (95% CI) 0 0 Not estimable
Total events: 0 (Cerclage based on history), 0 (Cerclage based on US)
Heterogeneity: not applicable
Test for overall effect: not applicable
Test for subgroup differences: Not applicable
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Analysis 5.11. Comparison 5 Any comparison of different cerclage protocols, Outcome 11 Serious
respiratory morbidity (RDS or oxygen dependency after 28 days of life).
Review: Cervical stitch (cerclage) for preventing preterm birth in singleton pregnancy
Comparison: 5 Any comparison of different cerclage protocols
Outcome: 11 Serious respiratory morbidity (RDS or oxygen dependency after 28 days of life)
Study or subgroup
Cerclage
based on
history
Cerclage
based on
US Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 History-indicated cerclage vs ultrasound-indicated cerclage
Simcox 2009 3/125 2/122 100.0 % 1.46 [ 0.25, 8.61 ]
Subtotal (95% CI) 125 122 100.0 % 1.46 [ 0.25, 8.61 ]
Total events: 3 (Cerclage based on history), 2 (Cerclage based on US)
Heterogeneity: not applicable
Test for overall effect: Z = 0.42 (P = 0.67)
2 History-indicated cerclage vs physical exam-indicated cerclage
Subtotal (95% CI) 0 0 Not estimable
Total events: 0 (Cerclage based on history), 0 (Cerclage based on US)
Heterogeneity: not applicable
Test for overall effect: not applicable
Test for subgroup differences: Not applicable
0.01 0.1 1 10 100
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Analysis 5.16. Comparison 5 Any comparison of different cerclage protocols, Outcome 16 Maternal
infection requiring intervention(antibiotics or delivery).
Review: Cervical stitch (cerclage) for preventing preterm birth in singleton pregnancy
Comparison: 5 Any comparison of different cerclage protocols
Outcome: 16 Maternal infection requiring intervention(antibiotics or delivery)
Study or subgroup
Cerclage
based on
history
Cerclage
based on
US Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 History-indicated cerclage vs ultrasound-indicated cerclage
Simcox 2009 0/125 1/122 100.0 % 0.33 [ 0.01, 7.91 ]
Subtotal (95% CI) 125 122 100.0 % 0.33 [ 0.01, 7.91 ]
Total events: 0 (Cerclage based on history), 1 (Cerclage based on US)
Heterogeneity: not applicable
Test for overall effect: Z = 0.69 (P = 0.49)
2 History-indicated cerclage vs physical exam-indicated cerclage
Subtotal (95% CI) 0 0 Not estimable
Total events: 0 (Cerclage based on history), 0 (Cerclage based on US)
Heterogeneity: not applicable
Test for overall effect: not applicable
Test for subgroup differences: Not applicable
0.01 0.1 1 10 100
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Analysis 5.17. Comparison 5 Any comparison of different cerclage protocols, Outcome 17 Maternal side
effects (vaginal discharge, bleeding, pyrexia not requiring antibiotics).
Review: Cervical stitch (cerclage) for preventing preterm birth in singleton pregnancy
Comparison: 5 Any comparison of different cerclage protocols
Outcome: 17 Maternal side effects (vaginal discharge, bleeding, pyrexia not requiring antibiotics)
Study or subgroup
Cerclage
based on
history
Cerclage
based on
US Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 History-indicated cerclage vs ultrasound-indicated cerclage
Simcox 2009 6/122 11/121 100.0 % 0.54 [ 0.21, 1.42 ]
Subtotal (95% CI) 122 121 100.0 % 0.54 [ 0.21, 1.42 ]
Total events: 6 (Cerclage based on history), 11 (Cerclage based on US)
Heterogeneity: not applicable
Test for overall effect: Z = 1.25 (P = 0.21)
2 History-indicated cerclage vs physical exam-indicated cerclage
Subtotal (95% CI) 0 0 Not estimable
Total events: 0 (Cerclage based on history), 0 (Cerclage based on US)
Heterogeneity: not applicable
Test for overall effect: not applicable
Test for subgroup differences: Not applicable
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Analysis 5.18. Comparison 5 Any comparison of different cerclage protocols, Outcome 18 Tocolysis (not
prespecified).
Review: Cervical stitch (cerclage) for preventing preterm birth in singleton pregnancy
Comparison: 5 Any comparison of different cerclage protocols
Outcome: 18 Tocolysis (not prespecified)
Study or subgroup
Cerclage
based on
history
Cerclage
based on
US Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 History-indicated cerclage vs ultrasound-indicated cerclage
Simcox 2009 5/125 11/122 100.0 % 0.44 [ 0.16, 1.24 ]
Subtotal (95% CI) 125 122 100.0 % 0.44 [ 0.16, 1.24 ]
Total events: 5 (Cerclage based on history), 11 (Cerclage based on US)
Heterogeneity: not applicable
Test for overall effect: Z = 1.55 (P = 0.12)
Test for subgroup differences: Not applicable
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Analysis 6.1. Comparison 6 Cerclage versus no cerclage (Summary of findings outcomes), Outcome 1 All
perinatal losses.
Review: Cervical stitch (cerclage) for preventing preterm birth in singleton pregnancy
Comparison: 6 Cerclage versus no cerclage (Summary of findings outcomes)
Outcome: 1 All perinatal losses
Study or subgroup Cerclage No cerclage Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Berghella 2004 0/3 0/7 Not estimable
Lazar 1984 2/268 1/238 0.8 % 1.78 [ 0.16, 19.46 ]
Rust 2000 5/43 2/37 1.6 % 2.15 [ 0.44, 10.44 ]
Ezechi 2004 0/39 2/42 1.8 % 0.22 [ 0.01, 4.34 ]
To 2004 2/26 3/30 2.1 % 0.77 [ 0.14, 4.25 ]
Althuisius 2001 0/19 3/16 2.8 % 0.12 [ 0.01, 2.19 ]
Berghella 2004 4/25 4/22 3.2 % 0.88 [ 0.25, 3.11 ]
Althuisius 2003 9/16 4/14 3.2 % 1.97 [ 0.77, 5.01 ]
Rust 2000 7/61 5/66 3.6 % 1.51 [ 0.51, 4.52 ]
Rush 1984 9/96 9/98 6.6 % 1.02 [ 0.42, 2.46 ]
To 2004 7/101 9/96 6.9 % 0.74 [ 0.29, 1.91 ]
Owen 2009 13/148 25/152 18.3 % 0.53 [ 0.28, 1.00 ]
MRC/RCOG 1993 53/635 66/629 49.3 % 0.80 [ 0.56, 1.12 ]
Total (95% CI) 1480 1447 100.0 % 0.82 [ 0.65, 1.04 ]
Total events: 111 (Cerclage), 133 (No cerclage)
Heterogeneity: Chi2 = 10.95, df = 11 (P = 0.45); I2 =0.0%
Test for overall effect: Z = 1.60 (P = 0.11)
Test for subgroup differences: Not applicable
0.002 0.1 1 10 500
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Analysis 6.2. Comparison 6 Cerclage versus no cerclage (Summary of findings outcomes), Outcome 2
Serious neonatal morbidity.
Review: Cervical stitch (cerclage) for preventing preterm birth in singleton pregnancy
Comparison: 6 Cerclage versus no cerclage (Summary of findings outcomes)
Outcome: 2 Serious neonatal morbidity
Study or subgroup Cerclage No cerclage Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Althuisius 2001 (1) 1/19 5/16 10.7 % 0.17 [ 0.02, 1.30 ]
Althuisius 2003 (2) 1/16 4/14 8.4 % 0.22 [ 0.03, 1.73 ]
Berghella 2004 6/25 6/22 12.6 % 0.88 [ 0.33, 2.33 ]
Berghella 2004 1/3 2/7 2.4 % 1.17 [ 0.16, 8.48 ]
Owen 2009 16/148 18/153 34.8 % 0.92 [ 0.49, 1.73 ]
Rust 2000 3/61 6/66 11.3 % 0.54 [ 0.14, 2.07 ]
Rust 2000 4/43 3/37 6.3 % 1.15 [ 0.27, 4.80 ]
To 2004 2/26 3/30 5.5 % 0.77 [ 0.14, 4.25 ]
To 2004 7/101 4/96 8.1 % 1.66 [ 0.50, 5.50 ]
Total (95% CI) 442 441 100.0 % 0.80 [ 0.55, 1.18 ]
Total events: 41 (Cerclage), 51 (No cerclage)
Heterogeneity: Chi2 = 6.10, df = 8 (P = 0.64); I2 =0.0%
Test for overall effect: Z = 1.11 (P = 0.27)
Test for subgroup differences: Not applicable
0.01 0.1 1 10 100
Favours cerclage Favours no cerclage
(1) NEW data from Althusius 2001 why not included last time?; serious morbidity defined as NICU admission.
(2) Defined as admission to NICU.
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Analysis 6.3. Comparison 6 Cerclage versus no cerclage (Summary of findings outcomes), Outcome 3 Baby
discharged home healthy.
Review: Cervical stitch (cerclage) for preventing preterm birth in singleton pregnancy
Comparison: 6 Cerclage versus no cerclage (Summary of findings outcomes)
Outcome: 3 Baby discharged home healthy
Study or subgroup Cerclage No cerclage Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Berghella 2004 (1) 19/25 17/25 5.7 % 1.12 [ 0.79, 1.58 ]
Rush 1984 (2) 85/90 88/93 28.9 % 1.00 [ 0.93, 1.07 ]
Rust 2000 (3) 85/92 87/96 28.4 % 1.02 [ 0.93, 1.11 ]
To 2004 (4) 114/120 109/116 37.0 % 1.01 [ 0.95, 1.08 ]
Total (95% CI) 327 330 100.0 % 1.02 [ 0.97, 1.06 ]
Total events: 303 (Cerclage), 301 (No cerclage)
Heterogeneity: Chi2 = 0.56, df = 3 (P = 0.91); I2 =0.0%
Test for overall effect: Z = 0.69 (P = 0.49)
Test for subgroup differences: Not applicable
0.5 0.7 1 1.5 2
Favours no cerclage Favours cerclage
(1) From Jorgenson 2007 (excluding deaths from denominator. One-off and serial ultrasound together).
(2) Included women had a history of at least one preterm delivery < 37 weeks; women with cervical dilation > 2mm were excluded.
(3) From Jorgenson 2007 (excluding deaths from denominator).
(4) From Jorgenson 2007 (excluding deaths; both risk groups together.)
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Analysis 6.4. Comparison 6 Cerclage versus no cerclage (Summary of findings outcomes), Outcome 4
Stillbirths.
Review: Cervical stitch (cerclage) for preventing preterm birth in singleton pregnancy
Comparison: 6 Cerclage versus no cerclage (Summary of findings outcomes)
Outcome: 4 Stillbirths
Study or subgroup Cerclage No cerclage Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Althuisius 2001 0/19 0/16 Not estimable
Berghella 2004 0/25 0/22 Not estimable
Berghella 2004 0/3 0/7 Not estimable
MRC/RCOG 1993 8/635 10/629 57.6 % 0.79 [ 0.31, 1.99 ]
Rush 1984 4/96 2/98 11.4 % 2.04 [ 0.38, 10.89 ]
To 2004 3/101 3/96 17.6 % 0.95 [ 0.20, 4.59 ]
To 2004 0/26 2/30 13.4 % 0.23 [ 0.01, 4.58 ]
Total (95% CI) 905 898 100.0 % 0.89 [ 0.45, 1.75 ]
Total events: 15 (Cerclage), 17 (No cerclage)
Heterogeneity: Chi2 = 1.80, df = 3 (P = 0.61); I2 =0.0%
Test for overall effect: Z = 0.35 (P = 0.73)
Test for subgroup differences: Not applicable
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Analysis 6.5. Comparison 6 Cerclage versus no cerclage (Summary of findings outcomes), Outcome 5
Neonatal deaths before discharge.
Review: Cervical stitch (cerclage) for preventing preterm birth in singleton pregnancy
Comparison: 6 Cerclage versus no cerclage (Summary of findings outcomes)
Outcome: 5 Neonatal deaths before discharge
Study or subgroup Cerclage No cerclage Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Althuisius 2001 0/19 1/14 5.4 % 0.25 [ 0.01, 5.72 ]
Althuisius 2003 9/16 4/14 13.4 % 1.97 [ 0.77, 5.01 ]
Berghella 2004 1/22 0/18 1.7 % 2.48 [ 0.11, 57.40 ]
Berghella 2004 0/3 0/7 Not estimable
MRC/RCOG 1993 8/590 14/577 44.6 % 0.56 [ 0.24, 1.32 ]
Rush 1984 3/90 4/93 12.4 % 0.78 [ 0.18, 3.37 ]
To 2004 2/26 1/28 3.0 % 2.15 [ 0.21, 22.37 ]
To 2004 4/101 6/96 19.4 % 0.63 [ 0.18, 2.18 ]
Total (95% CI) 867 847 100.0 % 0.85 [ 0.53, 1.39 ]
Total events: 27 (Cerclage), 30 (No cerclage)
Heterogeneity: Chi2 = 5.88, df = 6 (P = 0.44); I2 =0.0%
Test for overall effect: Z = 0.64 (P = 0.53)
Test for subgroup differences: Not applicable
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Analysis 6.6. Comparison 6 Cerclage versus no cerclage (Summary of findings outcomes), Outcome 6
Preterm birth before 34 completed weeks.
Review: Cervical stitch (cerclage) for preventing preterm birth in singleton pregnancy
Comparison: 6 Cerclage versus no cerclage (Summary of findings outcomes)
Outcome: 6 Preterm birth before 34 completed weeks
Study or subgroup Cerclage No cerclage Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
Althuisius 2001 0/19 7/16 0.3 % 0.06 [ 0.00, 0.92 ]
Althuisius 2003 7/13 10/10 9.0 % 0.56 [ 0.34, 0.93 ]
Berghella 2004 0/3 1/7 0.3 % 0.67 [ 0.03, 12.96 ]
Berghella 2004 10/25 11/22 5.6 % 0.80 [ 0.42, 1.51 ]
Ezechi 2004 0/39 11/42 0.3 % 0.05 [ 0.00, 0.77 ]
MRC/RCOG 1993 92/635 113/629 36.0 % 0.81 [ 0.63, 1.04 ]
Owen 2009 42/148 57/153 21.2 % 0.76 [ 0.55, 1.06 ]
Rush 1984 14/96 14/98 4.9 % 1.02 [ 0.51, 2.03 ]
Rust 2000 11/43 12/37 4.8 % 0.79 [ 0.40, 1.57 ]
Rust 2000 13/61 15/66 5.3 % 0.94 [ 0.49, 1.81 ]
To 2004 22/101 25/96 9.1 % 0.84 [ 0.51, 1.38 ]
To 2004 6/26 11/30 3.2 % 0.63 [ 0.27, 1.46 ]
Total (95% CI) 1209 1206 100.0 % 0.77 [ 0.66, 0.89 ]
Total events: 217 (Cerclage), 287 (No cerclage)
Heterogeneity: Tau2 = 0.0; Chi2 = 10.31, df = 11 (P = 0.50); I2 =0.0%
Test for overall effect: Z = 3.41 (P = 0.00065)
Test for subgroup differences: Not applicable
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WH A T ’ S N E W
Last assessed as up-to-date: 30 June 2016.
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Date Event Description
30 June 2016 New search has been performed Search updated and three trials added data to the review
(Chandiramani 2010; Ionescu 2012; Althuisius 2003).
We added a ’Summary of findings’ table with GRADE
assessments
30 June 2016 New citation required but conclusions have not changed Conclusions have not changed. There is still a lack of
evidence comparing cervical cerclage with cervical pessary
or vaginal progesterone
C O N T R I B U T I O N S O F A U T H O R S
Nancy Medley assessed reports for inclusion, extracted and entered data, created the SoF table and contributed to writing the text of
the review.
Tamara Stampilija assessed reports for inclusion, extracted and entered data, created the SoF table and contributed to writing the text
of the review.
Zarko Alfirevic assessed reports for inclusion and contributed to writing the text of the review.
D E C L A R A T I O N S O F I N T E R E S T
Zarko Alfirevic: My employer (University of Liverpool) has received grants from UK National Institute of Health Research, Wellbeing
ofWomen charity and Perkin Elmer to support my research group’s work related to preterm birth prevention and my Cochrane editorial
work.
Tamara Stampalija: none known.
Nancy Medley: Nancy Medley’s work was financially supported by the University of Liverpool’s Harris-Wellbeing of Women Preterm
Birth Centre research award.
S O U R C E S O F S U P P O R T
Internal sources
• University of Liverpool, UK.
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External sources
• Harris-Wellbeing of Women Preterm Birth Centre, UK.
D I F F E R E N C E S B E TW E E N P R O T O C O L A N D R E V I E W
For the 2012 update we replaced ’any preventable perinatal loss’ with ’all perinatal losses’. We also added the non-prespecified outcomes:
• Any intravenous, oral or combined tocolysis.
• Preterm premature rupture of membranes (PPROM).
• Chorioamnionitis.
For the 2017 update, we removed the primary outcome of composite perinatal deaths and serious neonatal morbidity. We were
concerned about the possible double counting of babies with serious morbidity who also died. A clearer indicator of efficacy and safety
together is whether or not babies go home without serious morbidity. Therefore, we moved the outcome of baby discharged home
healthy to primary outcomes. Methods have been updated to current Cochrane Pregnancy and Childbirth standards and a ’Summary
of findings’ table was added for this update.
I N D E X T E R M S
Medical Subject Headings (MeSH)
Cerclage, Cervical [adverse effects; ∗methods]; Cesarean Section [utilization]; Premature Birth [∗prevention & control]; Randomized
Controlled Trials as Topic; Suture Techniques
MeSH check words
Female; Humans; Pregnancy
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